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Abstract 
Hydrogel matrices have been used as structural surrogates in 3D bioprinting as a 
mechanism to provide the appropriate environment for cell adhesion and proliferation. In 
this research, the preparation and optimization of a hydrogel bioink containing a cage 
protein was investigated; specifically a Horse Spleen Ferritin (HSF)-poly (ethyleneglycol) 
diacrylate (PEGDA)-based bioink was developed. Studies were also undertaken to 
optimize the formulation of these bioinks for use in 3D bioprinting strategies, to develop 
techniques to precisely deposit cage proteins in hydrogels while maintaining their 
quaternary protein structures. In addition, the rheological properties of these various 
bioinks were evaluated. Finally, an optimized set of hydrogels was studied with respect 
to their effects on the growth of E. coli expressing a green fluorescent protein variant (His-
tag GFP-S65T). Confocal microscopy experiments employed the presence of the 
bacterially expressed GFP fluorescence to follow bacterial cell migration in bioprinted and 
casted hydrogel constructs. Evaluation of cell viability within these constructs was also 
determined. Results indicated that the system had good potential for fabricating hydrogel 
scaffolds with high accuracy, fidelity and resolution.   
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Chapter 1. Introduction 
1.1 Cage proteins 
The frequency at which nanotechnology has turned to biological systems in the 
search for an adequate template for reactions has risen over the last few years. 
Additionally, supramolecular chemistry has prioritized the development of systems that 
can render specific architectures, which can be assembled or disassembled 
systematically in response to changes in the biochemical environment.1 Therefore, 
scientists have used hierarchical structures such as cage-like proteins (CLP) to satisfy 
these needs. These are self-assembled hollow protein spheres that are usually between 
10-100 nm in diameter, which are structurally comprised of an assembly of a limited 
number of subunits to form robust nanostructures.1 They can be genetically engineered, 
resulting in alteration of their amino acid sequence and the ability to place certain amino 
acid residues in well-defined three-dimensional space.2 Considering that CLP’s offer 
distinct attributes such as enhanced physicochemical stability, periodic and 
monodispersed size ranges, capability of bioconjugation with other molecules on either 
their inner or outer surfaces, enhanced biological recognition and most importantly, well-
defined assembly-disassembly pathways, it can be concluded that they are ideal 
structures to be used as constrained reaction vessels with biological recognition 
capabilities.3,4,5  
Their symmetries usually have been used to classify CLP's. For instance, 12-mers 
and 24-mers can assemble themselves into tetrahedral and octahedral symmetries, 
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respectively, whereas 60-mers or multiples of the latter tend to self-assemble into 
icosahedral symmetries.6 Robust CLP’s can range from virus-like, ferritin-like, and 
chaperonin proteins and have been employed as templates to render functional 
biomaterials.4 Further examples of these CLP are the icosahedral, tetrahedral, or 
octahedral symmetric proteins such as cowpea chlorotic mottle virus (CCMV), horse 
spleen ferritin (HSF), and heat shock protein (HSP), respectively (Figure 1).1  
 
Figure 1. Depiction of CLP of different sizes. A) CCMV b) HSF c) DNA binding 
protein from starved cells (DPS). PDB: 1CWP, 2W0O, and 1DPS structure files were 
utilized for protein structure display. 
Over time, these, and many other proteins have been utilized as size-constrained 
reaction vessels or platforms to be chemically or physically modified at precisely known 
locations in order to generate libraries of protein cage architectures available for 
scientists.5 An understanding of the advantages provided by CLP’s is of primary 
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importance, because it enables one to correctly choose the appropriate building blocks 
or pathways for self-assembly of a desired CLP. 7 
1.1.1 Virus-like proteins 
Since their discovery virus-like proteins (VLP), derived from icosahedral viruses, 
have been studied for theoretical considerations on the principles of how these bio-
molecules aggregate.8 Furthermore, VLPs find applications outside their natural 
environment when they are devoid of their nucleic acid. This can be achieved via natural 
routes using recombinant DNA technology, to produce a non-infectious VLP, taking 
advantage of the biocompatibility of a multimeric ensemble to reduce the inherent 
toxicity.9 Many VLPs are of paramount importance because they have an increased ability 
to hold cargo, resist harsh conditions needed for inner or outer bioconjugation, have 
increased biocompatibility and in-vivo targeting and stability characteristics.9 Additional 
support has been given to VLPs because they have the potential to act as the protein 
shell for size- and shape-constrained reaction vessels, which can be used for chemical 
synthesis and catalysis (Figure 2).10 However, this is not the only type of use that they 
can be given. Numerous reports state that VLPs could be used as molecular containers, 
reaction vessels, nano templates and as synthetic platforms for nanoparticles.11 Hence 
the potential applications of these biomolecular vessels are of interest.9 
 4 
 
Figure 2. Cryo-electron micrograph reconstructions of several 
representative spherical viruses (T values between 3 and 25). Reproduced with 
permission from Johnson et al. 12 
It has been known for many years that VLPs are multimeric self-assembly-capable 
proteins that undergo dynamic structural transitions induced by defined chemical triggers, 
to provide unique gating mechanisms and control of the load-unload pathways of 
entrapped materials.10 Furthermore, VLPs can be assembled or disassembled from wild-
type or mutant subunits under in vitro conditions.12 However, it is of crucial importance to 
choose the best expression system for the desired VLP. It is vital to also consider the 
requirements for proper folding of the protein subunits and their possible requirement for 
post-translational modifications. Fuenmayor et al. presented a comprehensive review of 
the advantages and disadvantages of the different VLP production platforms, where the 
term “chimeric VLPs” is introduced to describe a hierarchical complex VLP that is 
composed of two different VLP.13  
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For example, examination of the structure of the CCMV capsid was carried out 
using x-ray crystallography and cryo-electron microscopy, which it revealed that the 
capsid was tied together via a carboxy-terminal extension of the subunit, residues 27 to 
35, and a hydrophobic intracapsomere contact amongst dimers resulting in a stable and 
modular arrangement of subunits.7 The CCMV’s outer diameter is 28 nm, with an inner 
diameter of 18 nm and is composed of an assembly of 180 identical subunits (19800 
Da;190 amino acids) which, as previously mentioned, renders an icosahedral lattice upon 
self-assembly.11 The virus subunit adopts a canonical virus β-barrel fold (Figure 3). 
Structurally, it has been reported by Johnson et al. that CCMV could have polymorphism, 
on which the structure can interchange between quasi-equivalent structures, where it has 
the potential to interchange between hexamers and pentamers in the presence of Ca2+ 
ions.12 Furthermore, CCMV possesses a desirable feature: It undergoes irreversible pH-
dependent swelling, which results in almost a 10% increase in its natural volume.10 
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Figure 3. Ribbon diagram showing the tertiary structure of the CCMV. 
Reproduced with permission from Speir et al.14  
The applications of VLPs are quite varied, for example: In the field of medicine, 
VLPs are devoid of any nucleic acid to produce vaccines that represent no danger of 
accidental infection for diseases such as hepatitis B, malaria, HPV, influenza virus A, HIV, 
human parvovirus and others.13 
1.1.2 Ferritins 
Iron is a ubiquitous and essential element for life that is involved in major biological 
functions, most of them crucial for organisms, such as DNA synthesis, nitrogen reduction, 
oxygen transport as found in hemoglobin, and redox reactions. The term “ferritins” was 
first used in 1937 by Laufberger to describe a family of iron-containing proteins.15 Ferritins 
are located, for the most part, inside cells, and their structure is highly preserved and 
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consists of an Fe3+-storage cavity surrounded by a protein capsid which mediates 
biological Fe2+ transport processes into the cavity with oxidative precipitation of iron(III) 
oxide. These storage proteins are present in almost all life forms such as eubacteria, 
archaea and eukaryotes.16 Interestingly, because they can come from different sources, 
there is structural variation among them. Examples of members of the ferritin superfamily 
are human heart ferritin, HSF, bacterioferritin (Bfr), DNA-binding protein from starved cells 
(DPS) and archaeoferritin, among others.17  
1.1.2.1 Ferritin Structure 
The basic building block from the ferritin family is the ferritin subunit, about 50 Å 
long and 25 Å wide, which may vary in size depending on the source of the subunit.18 
Furthermore, as shown on Figure 4, it is composed of a four-helix bundle with a C-terminal 
extension which lies at a 60° angle roughly perpendicular to that of the central axis of the 
four-helix bundle.19 Ferritins, for the most part, are hollow tetra-helical ensembles.20 In 
general, ferritins have 12-13 nm outer diameters, 7-8 nm inner diameters and molecular 
weights of approximately 450 kDa.21 However, there are different sized ferritins. First, 24-
subunit ferritins are present in plant and animal tissues. However, 12-subunit ferritins also 
exist and it is believed that their role is to protect DNA from oxidative damage.22 This 
difference between the two types of ferritin involve a change from a structure containing 
twenty-four, α-bundle subunits arranged in a 4-3-2 symmetry stable cage-like structure 
that can hold up 4000 ferric atoms in an inorganic ferric oxide-phosphate complex;22 to a 
twelve, α-bundle subunits in a 4-3-2 symmetry stable cage-like structure that can hold up 
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500 ferric atoms.13 Therefore, HSF and Bfr are termed Maxi-Ferritin, that is they possess 
a 24-subunit structure whereas DPS are termed a Mini-ferritin due to its 12-subunit 
structure.23  
It is also worthy to note that some ferritins can be composed of different subunits, 
and this is dependent on the particular tissue it is isolated from. For example, the 
mammalian ferritin cage may have two distinct types of subunits, which mainly differ in 
their amino acid sequences. First, there is the heavy ferritin chain subunit (H-chain) which 
is more predominant in the mammalian heart, and its main characteristic is the presence 
of a di-iron ferroxidase centre, which oxidizes cellular iron from Fe2+ to Fe3+. Secondly, 
there is the light ferritin chain subunit (L-chain), which is found predominantly in 
mammalian livers and is mainly involved in iron core nucleation processes.18 The H-chain 
(21 kDa) and the L-chain (19 kDa) lengths are 182 and 175 amino acids respectively, 
being 90% and 85% identical to human ferritin, respectively.24 Going further away from 
mammalian ferritins, less similarity is found amongst the subunits. Such is the example 
of the bacterioferritins, being only 22-24% identical to H-chain and 18-21% identical to L-
chains of mammals.21 Due to the multiple differences in the ferritin sequences, it is 
unlikely that ferritin subunits in mammals form homopolymeric structures. This results in 
a large number of isoferritins, that is composite ferritins, existing.15 To be more precise, 
some isoferritins may present the following combinations of H- and L-chain subunits: 
human placenta (∼ 20% H, 80% L), human spleen (∼ 10% H, 90% L), human liver (∼ 
50% H and , 50% L), horse spleen (∼ 8% H, 92% L), and rat liver (∼ 35% H, 65% L).25 
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As well, the most substantial difference between ferritins and bacterioferritins is the 
presence of 12 heme moieties which are present in the bacterioferritins.23 
 
Figure 4. The tertiary structure of recombinant horse L HSF subunit, PDB 
2v2i, and shown are four α-helices forming a bundle and a short C-terminal α-helix. 
Reproduced with permission from Crichton et al. 18 
1.1.2.2 Ferritin cage assembly 
The ferritin cage is a structure that undergoes self-assembly. However, 
understanding how the formation of the supramolecular complex occurs facilitates 
mechanistic insight. Gerl et al. reported the mechanism of how HSaF assembles using 
intrinsic fluorescence, far-UV circular dichroism and glutaraldehyde cross-linking 
experiments. The overall proposed scheme takes into consideration the steps of how the 
protomers assemble themselves to render the cage-like protein.23 
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The process starts with 24 unfolded ferritin subunits (24M1*) that fold themselves 
into the appropriate conformation, to then associate into eight monomers (8M1) and eight 
dimers (8M2). The next step is the formation of trimeric protomer (8M3) followed by the 
formation of four hexamers (4M6). The final two steps are the formation of two twelve-
mers (2M12) to associate on the protein cage (M24) finally. Several studies have been 
made to understand how the cage-like protein assembles. Sato et al. reported a time-
resolved small angle x-ray scattering study for E. coli ferritin A to verify what Gerl et al. 
reported, with the main difference that they were unable to discard the presence of 8-, 
10-, or 14-mers during the process of the formation of the cage-like protein. Their findings 
showed that the ferritin could dissociate and associate reversibly with no large aggregates 
being formed during the reassembly reaction.26  
In support of the disassembly/reassembly of the protein cage, it is well known that 
ferritin subunits in aqueous solutions are stable between pH 3-10 due to strong hydrogen 
bonding interactions at the intra- and inter-subunit contacts, as well as through 
hydrophobic interactions. In dilute salt buffers another interaction contributes, namely a 
salt bridge between K59 and E104, which is believed to further enhance quaternary 
structure stability.27 Ferritin oligomers further undergo a well-known dissociation process 
at pH below 3 and pH above 10. Below pH 3, ferritins suffer a stepwise disassembly that 
is not entirely reversible, causing ferrihydrite core aggregation at pH 2.10, followed by 
subunit aggregation at pH 0.80. It has been shown that dimers can be found between pH 
values of 3.4 and 0.8.27 However, further dissociation from dimeric ferritin subunits to 
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monomers is not possible (e.g. in strong acids or at high salt concentrations). As a result, 
a solution with a pH below 0.8 results in an inhomogeneous and polydispersed ferritin 
subunit solution.28 For basic pH values above 10.6, there is irreversible dissociation due 
to hydrolysis of some of the peptide bonds.29 In conclusion, it is of utmost importance to 
understand which are the essential elements that facilitate the mechanism of self-
assembly and disassembly of the CLP.  
 
1.1.2.3 Iron (II) intake and Iron (III) mineralization 
As previously mentioned, the assembled cage-like protein has a 4-fold, 3-fold and 
2-fold symmetry axis. The 4-fold axis renders a largely hydrophobic structure.4 In contrast, 
it is known that for higher organisms, hydrophilic residues such as three aspartate and 
three glutamates mainly compose the 3-fold axis. This trend is not seen for some 
invertebrate protein sequences, because this 3-fold axis also has some hydrophobic 
residues which, as a result, inhibit metal binding.21  
 
Figure 5. Depiction of the: (A) 4-fold and (B) 3-fold channels of human ferritin 
with the key amino acids that allow Fe(II) intake. Adapted with permission from 
Bou-Abdallah et al. Copyright 2017 American Chemical Society.25 
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Therefore, special attention should be given to the 3-fold axis for the mammalian H-chain 
ferritin subunit. It facilitates a channel that connects the outer with the inner environment, 
which has been proposed as the main route for iron transport across the protein shell to 
the site of Fe(II) oxidation.21  
In the early 1990s, studies conducted by Desideri et al. and Stefanini et al. 
concluded that Fe(II) enters the molecule through this threefold axis, and the iron is 
oxidized inside the cage’s hollow cavity.30 To support this statement, several studies 
attempting substitution of the carboxylate residues by other residues resulted in complete 
quenching of the iron uptake into the ferritin cage.31 Likewise, iron intake has been 
corroborated by X-ray crystallography studies using Cd2+, Zn2+, Tb3+ or Ca2+.31 
Nevertheless, the intake of iron(II), or other metals, can be quenched by high 
concentrations of chelators such as phosphate (PO43-) anions, since there is a binding 
preference for Fe2+ to PO43- ions rather than to ferritin cage structures.32 To further 
understand quenching studies, the interactions of [Cr(N(CH2CH2NH2)3(H2O)(OH)]2+, a 
Cr(III) amine complex (Cr(TREN)) and Tb(III) have been studied. It was found that 
Cr(TREN) inhibits the intake of iron(II) by obstructing the routes of metal uptake. Also, Tb 
(III) cannot interfere with Cr(TREN) binding, whereas the inverse interaction could 
occur.33  
As previously mentioned, ferritin cages facilitate iron intake through the 3-fold 
channel. However, the migration across the shell is the first step of the process for iron 
storage inside the ferritin cage. Several authors have reported that iron mineralization 
and iron ferroxidation, the other two key steps for iron storage inside the cage, take place 
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in the L-type subunits and at the ferroxidase centre of the H-type subunits, 
respectively.30,34,35 The steps of iron uptake, oxidation and core formation have been 
studied to understand the process of migration of the iron through the protein shell of 
several ferritins over time using specialized techniques such as time-resolved 
fluorescence,36 Fe Mössbauer spectroscopy,31 diferric transferrin formation 
spectroscopy,35 spectrophotometric assays, oximetry and elemental analysis,32 among 
other thechniques.  The ferroxidase centre, as depicted in Figure 6, is an iron binding and 
oxidation centre exclusively found within the four-helix bundle of H-type subunits. 
However, it is not entirely clear how this centre operates.37 Nevertheless, it has been 
shown that to facilitate the oxidation/mineralization process, a ratio of L-type and H-type 
subunits must be present, the optimal ratio being 30% H-type and 70% L-Type.25  
 
Figure 6. Schematic view of the di-iron ferroxidase centre on the four-helix 
of the H-chain Human Ferritin. Adapted with permission from Bou-Abdallah et al. 
Copyright 2017 American Chemical Society.25 
As a result, three reasonable models have been proposed: a ferroxidation model, 
a mineralization model, or a combination of both, as shown in Table 1.38 
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Table 1. Accepted mechanisms of iron (II) oxidation 
Mechanism Chemical Reaction 
Ferroxidation 2Fe2+ + O2 + 4H2O → 2FeOOHcore + H2O2 + 4H+ 
Mineralization 4Fe2+ + O2 + 6H2O → 4FeOOHcore + 8H+ 
Fe2+ + H2O2 detoxification 2Fe2+ + H2O2 + 2H2O → 2FeOOH(core) + 4H+ 
*Adapted from Bou-Abdallah et al.25 
The mechanism that takes place depends on the amount of iron present at specific 
times and the subunit composition. It has been reported that when a small number (~50 
atoms per addition) of iron (II) is present, the ferroxidation mechanism occurs whereby 
two iron (II) atoms are oxidized per O2 molecule. On the other hand, when large amounts 
(~1000 atoms per addition) are added, the dominant mechanism is mineralization, where 
four iron (II) atoms are oxidized per O2 molecule. When an intermediate quantity of iron 
(II) is added, the mechanism that takes over is the Fe2+ + H2O2 detoxification, where the 
H2O2 produced by the ferroxidase centre oxidizes more Fe(II) by the detoxification 
reaction.39 
The ferritin cage has been proven as an active site for iron mineralization, where 
it provides a microenvironment that can mineralize ferrihydrite (5Fe2O3·9H2O) cores with 
large surface to volume ratio, enabling the protein to be used as a nanoreactor. 31 
However, the properties of the ferritin ferrihydrite cores may vary depending on the ferritin 
source; some examples are shown in Table 2.  This behaviour allows the possibility to 
take advantage of these properties when other nanoparticle mineral cores of ferritin need 
to be synthesized. 
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Table 2. Properties of ferritin mineral cores from some species 
Ferritin Source 
Average no. 
Fe Atoms 
Mean Core 
Size (nm) 
Crystallinity 
Horse spleen 2000 - Good 
Bacterium (Pseudomonas aeroginosa) 800 6,0-6,5 Amorphous 
Mollusc (Acanthopleura hirtosa) 1500-2500 8,0-8,5 Limited 
Pea seed (Pisum sativum) 1800 5,2-6,5 Amorphous 
*Data points were taken from Chasteen et al.31 
1.1.3 Chaperonins 
The term chaperonin is used to describe a group of CLP that aid protein folding 
and protein stabilization inside a cell when it has been exposed to environmental or 
physiological stress.40 The first chaperonins reported were the E. coli chaperonins GroEL 
and the co-chaperonin GroES as proteins that facilitate unfolded or partially folded 
proteins to achieve their fully folded and active state.41 Their structure is mainly 
characterized by monomers of 60 kDa subunits of heat shock proteins that oligomerize 
into arrangements between 800-1000 kDa into two rings placed back to back that are not 
connected to each other as shown in Figure 7. 
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Figure 7. Structure of the GroEL–GroES–ADP7 complex. (a) Representation 
of the complex. (b) Representation of a cross-section of the complex. Reproduced 
with permission from Lund et al. 41 
Chaperonins have been classified into two groups according to their structure and 
origin. Group I chaperonins, found in eubacteria, mitochondria and chloroplasts, feature 
a detachable co-chaperonin as a lid that closes the cavity, whereas group II chaperonins, 
found in archaeal cytoplasm and eukaryotic cytosol, have proteinaceous lids built into 
their structure which gates the large pores.42 Chaperonins have found applications 
facilitating the functional expression of heterologous enzymes, where E. coli xylose 
isomerase (XI) and arabinose isomerase (AI) are being coexpressed with bacterial GroE 
in Saccharomyces cerevisiae to overcome the mismatch that occurs when bacterial 
proteins are overproduced in eukaryotic systems in the absence of HSP60.43 Equally 
important is that chaperonins have also found an application in the medical field, by 
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reducing amyloid formation in Alzheimer's disease by recognizing non-native protein 
molecules and facilitating their refolding.44  
1.2 Bioconjugation of proteins 
The functional and structural properties of proteins make them important scaffolds 
for medicine as well as materials science. Efficient strategies to covalently attach 
additional molecules to their surfaces is of importance.45 As a consequence, many 
strategies have been encompassed into a class of reactions addressed as 
bioconjugation, to introduce new chemical functionalities onto proteins by modifying 
endogenous amino acid residues through chemical or biochemical reactions, while 
maintaining functionality and structure.46 For instance, it is known that protein assemblies 
using disulfide bonds, flexible genetic linkers or protein-protein interactions deliver 
polydispersed materials.47 Therefore, bioconjugation has been used to reduce this effect, 
while exploiting its advantages such as increased availability to synthesize building blocks 
of advanced complexity, enhanced control over the assembly of the desired product, and 
accurate control over modularity for a single subunit of the construct.47  
Complex bioconjugation strategies can be utilized to modify proteins.45 An obstacle 
for bioconjugation is the need to be able to facilitate high selectivity within a complex 
substrate, such as a protein that contains many different amino acid side chains.48 
Therefore, to increase the production of the desired protein conjugate several factors 
need to be accounted for such as the abundance of the targeted endogenous amino acid 
residues, their surface exposure, and the selectivity of the modification reagent.49 As well, 
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the extent of labeling can be varied by controlling the concentration of the modification 
reagent; but excess reagent can result not only in over modification of the protein, but 
also in a reduction in regioselectivity.45 
1.2.1.1 Bioconjugation techniques 
As mentioned previously, multiple chemical reactions have been developed to 
covalently link synthetic molecules to natural proteins. The design of these reactions has 
allowed the study of the behaviour of these proteins. The most common approach is to 
use electrophilic reagents that interact with the nucleophilic amino acid side chains. 
Hence, peptide residues with a more significant nucleophilic behaviour such as aspartic 
acid, glutamic acid, lysine, arginine, cysteine, histidine and tyrosine in the unprotonated 
state are most likely to be modified (Figure 8).50  
Not only endogenous amino acids are targets for bioconjugation, but positions 
such as the N-terminus, natural amino acids (NAA) and non-natural amino acids (NNAA) 
that are exposed on the surface of the proteins also can be conjugated readily.51 A 
thorough review of all the available reactions for bioconjugation has been published by 
deGruyter et al.52  On the other hand, there is constant development of new 
bioconjugation and modification reactions, which can be put into play in the bioprinting 
process and can render materials suitable for a broader range of applications and 
processing routes that apply to 3D bioprinting.53 
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Figure 8. Average pKa value and abundance of bioconjugate groups on 
RNAse A (PDB ID: 2QCA). Reproduced with permission from Rosen et al. 54 
1.2.1.1.1 N-terminus modifications 
It has been reported that the N-terminus of a protein can be selectively modified 
with bioorthogonal functional groups via transamination reactions, pH-controlled N-
terminal selective acylations or oxidations and reductive alkylations, all of these being 
very selective and having minimal side reactions.55 Factors such as the loss of bioactivity, 
commercial availability, loss of charge at the N-terminus or the generation of unwanted 
derivatives, respectively, need to be weighed in to guarantee an adequate bioconjugation 
level.55 More so, the N-terminus is unique for protein chemical modification, being basic 
but charged at physiological pH. 
1.2.1.1.2 Exposed natural amino acid modification 
Creating a covalent link between molecules is the most common approach for 
conjugation; other approaches that bridge molecules without the need of a covalent link, 
employ affinity-based systems or protein co-factors.56 The available sites for modification 
can be determined by targeted amino acids, protein morphology, the electrostatic 
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environment, the accessibility of the substrate to the modification site, residue availability, 
and the pH at which the posttranslational modification is carried out.57 An overview of the 
major conjugation strategies is shown in Figure 9. 
 
Figure 9. Modification reactions for the bioconjugation of amino acids. (a) N-
terminus of Lysines: NHS ester conjugation. (b) Cysteines: thiol–maleimide or 
halogen-substituted acetamide coupling. (c) Glutamic and aspartic acid: EDC/NHS 
coupling. (d) Tyrosine: oxidative coupling of a phenylenediamine derivative, or 
oxidation through a diazonium coupling reaction. (e) Tryptophan and (f) para-
Amino-L-phenylalanine: oxidative coupling of a phenylenediamine derivative. (g) 
Homopropargylglycine and (h) Azidohomoalanine: click chemistry between the 
alkyne and an azide. Reproduced with permission from Rosen et al. 58  
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1.2.1.1.2.1  Lysine modification 
Primary amino groups are a major target for bioconjugation due to their frequent 
occurrence on the surface of proteins (up to ~6%), yet the selective modification of a 
specific lysine side chain can be difficult.57 Amino groups can be divided into two groups: 
the α-amino group, situated at the N-terminus of most polypeptide chains and the ε-amino 
group of a lysine residue, with pKa values of 8 and 10, respectively.59 These residues are 
often involved in vital structural and functional processes, intra-, interdomain, and 
interprotein interactions such as cation-π, hydrogen bonds, and salt bridges, for which a 
net charge is essential. Interestingly, available approaches historically used for side chain 
and amine tagging, such as activated esters (fluorophenyl esters, N-hydroxysuccinimides 
(NHS), sulfo-NHS, acyl azides), isothiocyanates, isocyanates, aldehydes, anhydrides, 
sulfonyl chlorides, carbonates, fluorobenzenes, epoxides and imidoesters, eliminate the 
native charge at the lysine.60 Instead, methods that employ reductive alkylation, using an 
aldehyde or ketone combined with a reducing agent such as sodium borohydride and 
sodium cyanoborohydride, have been proven to preserve the lysine charge.61 In general, 
deprotonated primary amines are one of the most reactive functional groups in proteins 
(cysteine thiol groups being more reactive), to maintain a deprotonated state; the pH 
needs to be adjusted in buffers, so that a free amine state is obtained for either α-amino-
, ε-amino- or both groups. Equally importantly, an adequate amine-slective reagent has 
to be selected, because it will react with nucleophilic surface residues. Despite selecting 
the right conditions for the reaction to be carried out, the reaction rates will be affected by 
depletion of the amine-reactive reagent due to hydrolysis in aqueous solutions.59 
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In terms of available strategies for lysine residue bioconjugation, the most used 
strategy is the use of activated esters, a strategy developed in 1963 by Anderson et al. to 
generate a peptide bond.52 The goal of this approach is to use a compound of 
intermediate stability that can be an acyl halide, azide or a mixed or symmetric anhydride, 
as shown in Figure 10, where the intermediate undergoes a process of aminolysis to 
generate a new peptide bond. 62 
 
Figure 10. Activated ester peptide bond formation. Reproduced with 
permission from El-Faham et al.62 
It has been reported that for activated esters, a high concentration of nucleophilic 
thiols need to be avoided because they increase the rate of degradation due to the 
formation of thioesters, which subsequently hydrolyze.59 The most frequent types of 
active esters used have been the ones derived from p-hydroxamic active esters such as 
o-phthalimido esters or the widely used, water soluble and easy to remove from solution, 
N-hydroxysuccinimide esters (NHS esters).62  
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1.2.1.1.2.2 Cysteine modification 
Solvent-exposed cysteine residues are easily modified due to the high 
nucleophilicity of their sulfhydryl side chain, and with high selectivity because of their low 
abundance in proteins.59 Likewise, at pH 9, cysteine resides react faster than lysine due 
to the higher nucleophilicity of thiols over lysines, resulting in a selective modification of 
cysteine over lysine residues.63 There are two well-known methods, such as maleimide-
thiol Michael additions and activation with halogen-substituted acetylamides.58 
Generating maleimide-thiol conjugates is one of the most commonly used methods 
for bioconjugation, on which a thiolate (RS-) undergoes Michael addition to the double 
bond of a maleimide to form a succinimidyl thioether. These reactions are desired due to 
their specificity to thiols, fast aqueous reaction kinetics, lack of byproducts, and the 
stability of the thioether addition product.64 In many cases, in the absence of excess thiols, 
retro-Michael additions revert the thioether adducts to the starting materials. However, in 
the presence of an excess of thiol (R’S-) new conjugates (RS-) are permanently 
substituted by (R’S-).This behaviour has been well characterized for antibody-drug 
conjugates, where the products are required to have a long shelf life.65 
Interestingly, maleimide reagents are not adequate solutions for applications 
where high stability and the size of the generated linkage is crucial. Instead, the use of 
haloacetyl-mediated conjugations are preferred with haloacids such as iodoacetate, 
bromoacetate, 3-bromopropionate, 2-bromopropionate and 2-bromobutyrate.59 It has 
been reported that with smaller halogens, fewer side reactions are present, such as when 
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chloroacetamide is used instead of iodoacetamide to reduce adduct formation in the 
alkylation of cysteine-containing peptides.64  
1.2.1.1.2.3 Glutamic and aspartic acid Modifications 
Carboxylic acids in aqueous solutions exhibit lower reactivity. These functionalities 
are found on the C-terminus of proteins, or as side chains in glutamic and aspartic acids 
located internally to the protein sequence.59  The modification is carried out in the 
presence of carbodiimides and primary amines, with the disadvantage of decreased site 
specificity due to the frequent presence of primary amines on proteins.58 Carbodiimides 
react with a carboxylic acid to generate a reactive species, an O-acylisourea that 
undergoes aminolysis in the presence of a nucleophilic component, a primary amine. A 
side reaction in these reactions is the formation of N-acyl urea byproducts, which can be 
avoided utilizing an excess of hydroxybenzotriazole. 63  
1.2.1.1.2.4 Tyrosine and tryptophan modifications 
In general, tyrosine residues are less frequently occurring protein residues, which 
can be introduced by site-directed mutagenesis without changing the electrostatic 
environment or redox sensitivity dramatically.66 Interestingly, it has been reported that 
tyrosine residues are often overrepresented on binding sites of proteins.67 For this reason, 
they can be used as a desirable residue to switch the protein target between its active 
and inactive states, using procedures such as the reversible addition of phosphate 
groups.68 Even though tyrosine residues are less reactive than aliphatic amines at neutral 
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pH, the pKa (4.75) difference between amine and phenolic groups can be exploited to 
allow tyrosine side chains to also react with amine-reactive reagents at lower pH.59  
Furthermore, the phenolic group of tyrosine provides a distinct reactivity, which 
can be utilized to modify the side chain via a palladium-catalyzed allylic alkylation using 
an electrophilic π-allyl intermediate in aqueous solution.69 Likewise, it can be modified at 
the ortho position using a myriad of reactions such as three-component Mannich 
reactions, diazonium salts bearing electron-withdrawing para substituents and oxidative 
coupling reactions using Ni(II), ceric ammonium molybdate (CeH8Mo3N2O12), and 
Ru(bpy)3 catalysts (Figure 11).66,67,70 Nonetheless, the modifications of tyrosine requires 
surface exposure and compete with both exposed tryptophan (Trp) residues and reduced 
disulfides.71 
 
Figure 11. Scheme for the modification of tyrosine: (a) reaction with 
diazonium salts, (b) three-component mannich reaction, (c) reaction with 
preformed imines, and (d) ene-type reaction with diazodicarboxylate reagents. 
Reproduced with permission under CC license from Boutureira et al.71s 
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In contrast, tryptophan, one of the least frequently present amino acids in proteins, 
provides a unique centre for specific bioconjugation reactions. It has been reported that 
a viable conjugation can be done through the in situ generation of a rhodium carbenoid 
reagent, which produces an alkylated indole. This reaction is possible since the reaction 
with tryptophan can outcompete hydrolysis of the rhodium reagent. However, this reaction 
requires a highly acidic pH (1.5-3.5), which could cause protein unfolding and 
denaturation.67,71 
1.3 Ferritin polymer-protein conjugates 
The ferritin family provides an versatile shell that can be used as a multivalent 
scaffold. To recapitulate, ferritins are a family of proteins that have been investigated for 
applications as nano-carriers for drug therapy, vaccine development, chemical catalyst 
and imaging surrogates, that minimize toxicity in the body while maximizing absorption.72–
74 Furthermore, ferritins, being proteins, can stabilize several particles inside their cavities, 
and are able to be engineered to prevent any immunogenic response towards many 
substances.72 Hence, the well-defined ferritin structure makes it an excellent particle for 
derivatization. It is possible to derivatize the protein shell by genetic, combinatorial or 
chemical methods, which will depend on the desired product.16   
Even the overall quaternary structure of ferritin itself can be controlled, as 
evidenced by multiple studies carried out on ferritins from different organisms. For 
example, for a genetic mutation of A. fulgidus ferritin (AfFtn), a tetrahedral ferritin, it was 
shown that a mutation at K150A and R151A was sufficient to shift the quaternary structure 
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from the tetrahedral to the canonical octahedral symmetry of the vertebrate and bacterial 
ferritin cage proteins. The reason for the morphological change was attributed to the loss 
of hydrogen bonding and a decrease in the positive electrostatic charge.75 In the same 
manner, DPS protein from Mycobacterium smegmatis (MsDps1) was mutated at an 
invariant residue F47 to E47 as described by Chowdhury et al., ultimately eliminating the 
formation of dodecamers in solution and increasing the flexibility at the AB α-helices loop. 
It was shown through X-ray crystallography that in the crystalline state, MsDps1 could 
undergo 24mer formation.76 
In terms of chemical derivatization of ferritins, the ability of ferritins to be grafted 
onto surfaces was explored. Such is the case reported by Dominguez-Vera et al., where 
HSF was grafted onto an N-succinimidyl-3-(2-pyridyldithio)propionate–modified gold 
surfaces.77 In a similar way, Halfer et al. modified alumina particles with -COOH moieties 
to use EDC/NHS ester and further graft HSF to them.78 These approaches can facilitate 
the control of the fraction of residues that can be modified while maintaining structural 
composition. Many reagents have been proven useful for protein functionalization. As 
previously mentioned, the most common residues are cysteine residues and lysine 
residues. Cysteine residues can also serve to employ click-type chemistry using azide-
alkyne Michael additions, whereas lysine residues are modified by taking advantage of 
their reactivity in alkaline media using NHS esters, NHS carbonates, NHS carbamates, 
thiazolidine-2-thiones, pentafluorophenyl esters, anhydrides, acid halogenides and 
amidination reagents.79  
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1.3.1 Ferritin polymer-protein conjugates by “Grafting-to” 
Lysine residues are one of the most common sites for the functionalization of 
ferritin. The labeling efficiency is defined by the surface exposure of the lysine side chains 
and their reactivity. For example, to graft to HSF, Gálvez et al. used NDB, a family of 
nitrobenzofurazans that react preferably with primary and secondary amino groups under 
alkaline conditions, to understand the labeling capacity of this protein.80 It was 
successfully shown that two out of three reactive lysines could be modified per subunit: 
the K83 and K97 sites, whereas the more hindered K104 remained unlabeled.  
Furthermore, ferritin-antibody conjugates have been synthesized by Kishida et al. 
reporting a comparison of the effectiveness of adding activated moieties to a ferritin 
subunit by reaction with a water-soluble carbodiimide and N-hydroxysuccinimide, or with 
an excess of glutaraldehyde.81 It was shown that EDC/NHS lysine residue modification 
resulted in ferritin-ferritin polymers, high hydrolysis rates of the activated ester at pH 8 
and a dependence of the reaction time. Likewise, glutaraldehyde and reactive amino 
groups formed ferritin-ferritin polymers by the linkages of the glutaraldehydes, the 
formation of stable Michael-type adducts or both.  Hu et al.  demonstrated grafting onto 
ferritin surfaces by NHS terminated methacryloyloxyethyl phosphorylcholine (MPC) and 
PEGMA monomers.82 It was shown that the reaction occurs within 1 hour, and more 
prolonged incubation times facilitated the aggregation of the conjugated samples. 
Furthermore, short polymer chains, such as NHS-polyPEGMA, are readily conjugated in 
comparison with NHS-polyMPC. This appears to demonstrate that molecular weight is a 
critical aspect that affects the reaction kinetics. 
 29 
To support this statement, Spa et al. derivatized HSF with NHS-fluorescent dyes 
(Cy3 and Cy5 dyes); however, low yields were achieved. Instead, the NHS moieties were 
exchanged for tetrafluorophenol esters (TFP) to reduce competitive hydrolysis, achieving 
11 and 15 molecules of Cy3 and Cy5, respectively, per ferritin cage.83 However, the 
functionalization of ferritins can also lead to shifting in the net charge of the resulting 
chemically-modified protein. Wonga et al. then synthesized a hydrophobic ferritin by EDC 
coupling with long chain (C9, C12, C14) primary amines.84 This reaction was carried out in 
conditions under which ferritins are usually unstable such as organic solvents (DCM, ethyl 
acetate, and toluene). Conjugation with long-chain alkyl amines led to a net positive 
charge, due to the excess of surface lysine and arginine residues that remained 
unaffected by the coupling reaction.  
Ferritins offer such a flexible platform that they have been used by Bhattacharyya 
et al. to synthesize a three-part complex system of protein-CNT-polymer conjugates.85 
The functionalization of multi-walled carbon nanotubes (MWCNT) was achieved by 
oxidation of the surface to provide –COOH moieties, which underwent reaction with the 
primary amines of ferritin once the EDC/O-acylisourea intermediate was formed. Once 
the modification was made, these adducts were used as additives for polymer 
strengthening, such as in the preparation of modified (polyvinyl alcohol) (PVA). 
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1.3.2 Ferritin polymer-protein conjugates by “Grafting-from” 
 A “grafting-from” approach has been reported vía an ATRP reaction combining a 
chain transfer agent (CTA), by attaching 2-bromo-isobutyric acid (BIBA) to the amino 
groups of the protein shell, and further copolymerization of thermoresponsive poly(N-
isopropyl acrylamide) (PNIPAAm) and photo-crosslinkable 2-(dimethyl maleinimido)-N-
ethyl acrylamide (DMIAAm) groups from the protein surface without any variation of the 
original protein dimensions to form an emulsion stabilizer.86 It was found that 
characterization of the products became more complex as the reaction was incubated for 
longer times, due to the modification of the protein quaternary structure and the high 
polydispersity of the protein-polymer product. However, it was also demonstrated that this 
bioapplication could be useful for the construction of polar-apolar interfaces by decreasing 
the interfacial tension due to the presence of hydrophobic/hydrophilic moieties. Likewise, 
Hu et al.  demonstrated that ATRP CTA agents could be grafted to ferritin (∼2 tertiary 
bromide initiators) by NHS ester chemistry in pH 9.0 PBS buffer (with 20% DMSO) at 4 
°C for 24 h, followed by a polymerization in aqueous solution with CuBr and 2,2′-bipyridine 
(bpy), using  MPC and PEGMA monomers. These monomers addressed the drawbacks 
of the addition of PEG has and supplies hydrophilic moieties with greater 
biocompatibility.82  
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1.3.3 Ferritin polymer-protein conjugates by “Grafting-through” 
 Danon et al. reported the preparation of a polycationic derivative using 
EDC/DMPA.87 Ferritin was derivatized under physiological conditions without a change in 
morphology of the native molecules. Furthermore, labeling was controlled by changing 
the surface charge, which could be adjusted according to the needs of a particular 
experiment. To further this discovery of a cationized ferritin, Mann et al. modified the 
external surface of ferritin by attaching DMPA to aspartic and glutamic acid residues using 
EDC chemistry, followed by the addition of an anionic polymeric surfactant C9H19-C6H4-
(OCH2CH2)20O(CH2)3SO3−, resulting in the formation of a solvent-free liquid protein 
nanoconstruct.88 Using this approach, it was possible to attach approximately 4 surfactant 
molecules per subunit, which was fouhd to be sufficient to increase protein stability by 
30%, and increase its decomposition temperature from 315°C to 405°C. 
Transmission electron microscopy (TEM) and dynamic light scattering (DLS) were 
used to study complex arrays of HSF polymers through channel-directed electrostatic 
interactions with poly(α, L-lysine) in the presence of urea.89,90 This system relied on the 
positive charge present on the side chain of the lysine residues and the head-to-tail 
orientation of the polymers, in contrast to the branched arrangement produced by most 
free radical polymerizations (FRP). 
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1.4 Protein-polymer conjugates for PEGDA-based hydrogels 
Natural polymers offer mild gelation properties and provide adequate 
environments for cell encapsulation under physiological conditions. However it is often 
necessary to add synthetic and photocrosslinkable reagents, such as the ones based on 
polyethylene glycol (PEG), to provide greater control over the final macroscopic hydrogel 
properties.91 PEGDA-based hydrogels have been used in bioprinting applications due to 
their hydrophilic, biocompatible and highly tunable nature.92 However, there have been 
developments on developing peptide-binding proteins in polymeric networks to use them 
as detection methods in complex mixtures.93 The crosslinking of PEGDA-based 
hydrogels are done preferably using water-soluble photoinitiators that are nontoxic. 
Multiple authors have used the photoinitiator Irgacure 2959 in low concentrations 
(~0.05%).94 It can be activated in the upper spectrum of the UV region (>350 nm). 
However, this wavelength has been reported to damage cells.95 As an alternative, the use 
of mild photoinitiators with the capacity to be photopolymerized at longer wavelengths 
(~400 nm), resulting in lower cytotoxicity and high cell survival (>95%), is desirable. 
Acylphosphine oxide photoinitiators have demonstrated these requirements while 
increasing the gelation rate up to ten times in contrast with the hydrogels obtained utilizing 
Irgacure 2959.96 
However, PEGDA hydrogels present drawbacks such as low mechanical strength 
and potentially rapid degradation of the photocrosslinkable polymers.97 Therefore, various 
approaches have been explored to improve the mechanical strength and structural 
stability of these PEG-based gels. The first approach is that of physical blending (i.e., 
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PEGDA/HEMA improves the viscosity of the hydrogel).98 Nonetheless, blended hydrogels 
are challenging in that is difficult to identify the contributions of the individual components 
to the overall physical properties of the gel. The second approach is to chemically or 
biochemically crosslink the polymer chains (i.e., molecular strands).98 The third approach 
allows one to independently tune the gel’s properties by using interpenetrating networks 
(IPN), the addition of a second polymer network entangled on the chains of the first 
polymer to reinforce the mechanical properties of hydrogels. This method has employed 
polysaccharides and PEGDA-based polymers (e.g., agarose-, xanthan gum-, and 
alginate-PEGDA).99–101  
1.4.1 PEGDA 
PEGDA is a reagent that is used extensively in the field of therapeutics, protein 
stabilization, and drug delivery. It was patented by Lee pharmaceuticals in 1973 as a 
composition of aromatic and alicyclic polyacrylates (~25-90% wt).102 They can be 
synthesized by addition of linear PEG polymer chains into a nonpolar solvent (e.g., DCM 
or toluene) containing acryloyl chloride. The reaction is followed by precipitation of the 
product polymers in cold diethyl ether (4°C).103 
In general, PEG-based polymers offer increased biocompatibility, low biofouling, 
and drug delivery capabilities. For PEGDA-based hydrogels, the hydrophobicity is closely 
correlated with the porosity of a sample. Also, as the wt % of PEGDA increases, the 
average mesh size decreases.104 PEGDA offers many attributes that are useful for 
bioprinting applications; however, as described by Mazzoccoli et al., PEGDA blends 
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require a combination of long and short chains to facilitate viscoelastic behavior. This is 
achieved by varying the processing conditions during polymerization or combining various 
polymers to manufacture a hydrogel with a desired set of mechanical characteristics.105 
Despite all the advantages, PEGDA ester linkages introduced upon acrylation of the PEG 
diol are susceptible to slow degradation in vivo by hydrolytic cleavage of the ester linkages 
(~ months to years).91 To reduce the degradation rate of PEGDA hydrogels, Browning et 
al. synthesized PEG diacrylamide (PEG-DAA).106 It was shown that the amide bond, 
instead of the hydrolytically degradable ester bond, changes the polymer’s structure; 
however, there is no significant change in the gel’s rheological properties. It was 
demonstrated that the elastic moduli increase with the decrease of the polymer chain 
polymerization and that swelling decreases with increasing PEG weight fraction. 
1.4.2  Thickening Agents (TA) 
Carboxymethylcellulose is a derivative of cellulose which is water soluble. It has 
been used it the production of bioinks for biomedical applications (Figure 12).  To obtain 
these hydrogels, chemical crosslinking is achieved by the use of bifunctional crosslinkers 
containing chemical groups such as aldehydes, dicarboxylic acids, and PEG.107 
Likewise, alginates are a naturally derived linear copolymer of 1,4 linked β-D-mannuronic 
acid and α-L-guluronic acid residues repeated at irregular intervals. These systems are 
called G-blocks.108 The formation of a hydrogel from these biomolecules will depend on 
the type of alginate used and the method of crosslinking. Traditionally, the alginates 
undergo physical crosslinking with divalent cations such as Ca2+ ions.109 It has been 
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reported that the resulting alginate-based gel has a structural conformation described by 
the egg-box model, which arise when Ca2+ ions are chelated by G blocks of greater than 
20 units.108 Furthermore, xanthan gum is a cellulose-based polymer, substituted on the 
O-3 of alternate backbone residues by charged trisaccharide side-chains of β-D-
mannose-1,4-β-D-GlcAp-1,2-α-D-mannopyranose to give a branched pentasaccharide 
repeating unit.110 It is a non-gelling biopolymer that exists in aqueous media with an 
ordered rigid chain conformation which is able to form highly viscous solutions even at 
low concentrations.111 Lastly, Pluronics F127 is a water soluble triblock copolymer formed 
by poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (PEO–PPO–PEO) 
which can exhibit a thermoreversible behavior.112 The gelation mechanism of these 
solutions is reported as a physical crosslinking, which is dominated by the PPO block, on 
which the solubility is decreased in aqueous solutions above 15 °C.113  Pluronics solutions 
are liquid before cross-linking and beyond the gelation point, a physical network is formed 
which continue to increase as the temperature is increased. Furthermore, this behavior is 
desired for the incorporation of drugs due to increased circulation time and enhanced 
metabolic stability.114 
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Figure 12. Repeating units of polysaccharides used as thickening agents: A) 
Xanthan Gum, B) Carboxymethylcellulose, and C) Sodium Alginate. 115 
1.5 3D molecular bioprinting 
3D Bioprinting technology, also referred to as Additive Manufacturing (AM), is a 
technology that facilitates the fabrication of complex constructs altogether instead of by 
the conventional predefined assembly of several pieces cast over predefined moulds. It 
was first introduced by Charles Hull in the early 1980’s, in response to extended 
fabrication processes and manufacturing imperfections in prototype development.116  
In general, the process for 3D bioprinting follows a set of predefined steps, which 
starts by creating the desired tridimensional model on any designated software with all 
the desired morphology. Secondly, the generated model is converted to the STL format 
that encompasses the geometry information of the model. Third, the model is processed 
using a 3D printer software, which slices the 3D model into an array of 2D layers stacked 
one on top of the other. Lastly, the model is bioprinted to generate the 3D object that was 
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designed. Once all the stages have been made, some post processing can be needed 
for the model to be ready to be used in the desired application.117 AM provides great 
flexibility and applicability, where it utilizes a layer-by-layer stepwise approach employing 
computer-aided design (CAD), allowing for rapid prototyping and the fabrication of custom 
parts. It has been used in many industrial applications such as in materials science, with 
the rapid production of microfluidic devices with complex geometric features; in 
biomedical engineering, for scaffold fabrication for cultivation of mesenchymal stem cells; 
and in nanotechnology, for the small-scale production of stretchable and flexible 
conductors, among others.118 
1.5.1 3D bioprinting 
3D Bioprinting is a methodology that physically deposits a biomaterial, using a 3D 
printer, which is further stabilized or immobilized by melt-cure, chemical or physical 
crosslinking. This approach can precisely deposit biomaterials such as bioactive 
molecules, biopolymers or even cells at specific spatial sites.119,120 3D bioprinting has an 
unprecedented advantage over conventional 2D strategies, providing biocompatible and 
biodegradable 3D scaffolds, namely extracellular matrices (ECMs), which can be 
classified into two main groups: scaffolds of complex geometries that are directly 
fabricated using biocompatible materials, which may or may not be seeded with cells, and 
artificial tissues that are directly fabricated with cells encapsulated during the bioprinting 
process.120–122  
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Currently, since there are no synthetic multicellular 3D structures that can mimic 
in vivo conditions, research is focused on the latter. As a result, new  biomaterials and 
desired substrates are being developed that facilitate cell positioning in a specific spatial 
arrangement capable of rendering specific physiological properties of the environment 
only biological structures can deliver.123 Furthermore, 3D bioprinting is a challenging task, 
since the physical properties of the desired biomaterial for bioprinting will define the 3D 
bioprinting technology needed. For that reason, desirable techniques that provide 
simultaneous material deposition, viable cell-laden constructs, unhindered cell-transport 
structures and post-seeding for multiple material types are constantly being developed.123  
1.5.1.1 Bioprinting methodologies 
Bioprinting, a methodology that arises at the intersection where engineering meets 
medicine and science, has been a tool employed for diverse applications from promoting 
self-repair of endogenous tissue to reconstruction using a biomimetic tissue.124 Formally 
it has been described as a process of bioprinting biological systems made of cells, growth 
factors, and biomaterial scaffolds.125 In the past, methods such as electrospinning, fibre 
deposition, freeze-drying, and gas foaming have been used, all of which lack the required 
control to synthesize an advanced scaffold.120  In general, the goal is to design novel 
bioinks that facilitate an adequate scaffold fabrication process that can grow and maintain 
a set of physiological functions. However, an adequate bioprinting process employs a 
suitable combination of a bioink with an adequate bioprinting methodology.126 Therefore, 
the development of techniques that can facilitate the complex production of multi 
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cellularized scaffolds has been of interest. Many authors have reviewed the available 
techniques and have agreed that the methods are grouped as stereolithography-based, 
laser-based, inkjet-based, and extrusion-based bioprinting (Figure 13).120,126–128 Less 
known classifications are either the direct-write or thermal-inkjet bioprinting methods.129 
For practical purposes, to address the different methodologies available, the descriptions 
are going to be made according to what most of the authors have agreed as relevant 
(Table 3). Despite the advantages of the 3D bioprinting methodologies, inaccuracies in 
resolution (~20 to 85 μm) and material mixing can lead to material variability and 
distribution of defects.130  
 
Figure 13. Representation of A) stereolithography-based, B) Laser-based, C) 
Inkjet-based, and D) Extrusion-based bioprinting methodologies. 
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A) Stereolithography-based approaches 
This methodology employs a laser source to solidify a photosensitive polymer in a 
selective layer-by-layer fashion. This technique delivers a high-resolution product. As a 
result, and taking advantage of the method’s flexibility, it has been used to create moulds 
and anatomical models for cell deposition.124  However, due to the nature of this 
bioprinting method, the application of live cell bioprinting is restricted.125 Several toxic 
materials such as acrylics and epoxies have been used to develop this model.127 To 
overcome the cellular toxicity of these resins, high molecular weight polymers which can 
hydrolyze in vitro and in vivo, such as D,L-lactide and poly(propylene) fumarate, have 
been used.  Likewise, polymers such as poly-(ethyleneglycol)-diacrylate (PEGDA) and 
poly-(ethyleneglycol)-metacrylate (PEGDMA) have been used to develop scaffolds using 
stereolithography-based bioprinting.125  
 
B) Laser-based approaches 
Laser-induced forward transfer (LIFT) is a technique that has been used due to its 
ability to deposit cells at a density of 108 cells/mL. It consists of three main parts: a pulsed 
laser source, a ribbon coated with a biomaterial that coats a metal film, and a receiving 
substrate.120  It operates by a pulsed beam that is focused on a designed area such as a 
glass absorbing layer.131  Once the pulsed beam hits the layer’s surface, it creates a high-
pressure bubble on the other side that propels cell-laden material onto a collector 
substrate that can be controlled using an elevator system.125 This methodology is 
convenient due to its accuracy, precision and reproducibility without the need of using a 
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nozzle. Furthermore, it avoids direct contact between the dispenser and the bioinks. As 
a result, it does not cause mechanical stress to the cells, which results in high cell viability 
(usually higher than 95%).132 However, the viability of the cells contained in the bioink can 
be compromised according to the intensity of the pulsed beam. In addition, the technique 
is time consuming.133 
 
 Figure 14. Graphical representation of laser-based bioprinting. Reproduced 
with permission from Malgorzata et al. 128  
C) Inkjet-based approaches 
Inkjet bioprinting is a technique that deposits droplets over a surface to produce 
2D and 3D structures.133 It is the most common type for biological and non-biological 
bioprinting application.134,135 Pragmatically, it is called “inkjet” bioprinting because the 
biomaterial is placed inside a cartridge altogether with other additives that allow the 
bioprinting process over an electronically controlled stage.133 The bioprinting process is 
activated by either a thermal or a piezoelectric drop-on-demand (DoD)  actuator that 
enables the flow of biomaterial from the cartridge to the platform.134 In the case of the 
thermal actuator, it uses heat to generate small air bubbles that collapse within the 
pinhead to provide pressure pulses that eject the bioink out of the nozzle. It generates  
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heat for about 2 µs, causing an overall temperature rise of 4–10 °C above ambient 
temperatures. It has been reported that the droplet size cannot be controlled (~ 10 to 150 
pL) as a result of the temperature gradient applied, the current pulse frequency, and the 
viscosity of the bioink itself. A common drawback is needle clogging due to material 
aggregation.125 On the contrary, the piezoelectric actuator, which does not use heat or 
cause needle clogging, uses high frequencies to propel the droplets from the needle. This 
allows for control of the direction and size of the droplets.120 However, some of their 
frequencies can cause cell damage and lysis. Therefore, the thermal actuator is preferred 
for bioprinting applications when an inkjet bioprinter is the desired method of printing.136 
Bioinks with lower viscosities must be used because higher viscosity bioinks are unable 
to form picoliter droplets to produce satisfactory deposition materials on any surface by 
this approach.133 Furthermore, inkjet bioprinters facilitate the integration of multiple 
bioprinting heads, which enables deposition of multiple cell types.136 This methodology 
offers advantages such as a reduced cost due to the similarity with other available 
printers, high cell viability (~80-90%) and relatively high bioprinting speed.132 However, 
the main restrictions are the low upper limit for the viscosity of the bioink (0.1 Pa s−1), 
making the deposition of highly viscous hydrogels and extracellular matrix (ECM) 
difficult.136  
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 Figure 15. A) Thermal- and B) Piezoelectric-based systems for inkjet 
bioprinting. Reproduced with permission from Malgorzata et al. 128  
D) Extrusion-based approaches 
Extrusion-based bioprinting is a technique to dispense bioinks using force to flow 
materials through an orifice. Materials such as solutions, pastes or dispersions are 
extruded using either a pneumatic- or mechanic-based system, as shown in Figure 16. 
120  Each method offers unique advantages. However, all use high shear and extensional 
forces or higher temperatures, which can compromise cell viability.124 
 
Figure 16. A) pneumatic-, B) mechanical- and C) solenoid-based systems for 
extrusion-based bioprinting. Reproduced with permission from Malgorzata et al. 128  
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Pneumatic-based systems offer considerable control over the amount of pressure 
applied to bioinks. However, when it comes to high viscosity bioinks, a different approach 
must be taken into consideration. Approaches such as a screw or piston driven 
mechanical approaches are also used. These actuators offer great spatial control and 
precision regarding the dispensing process of the bioinks. Nonetheless, they can 
generate higher pressures which may degrade the bioinks.137 As a rule, pneumatic 
systems are better for high viscosity materials, while mechanical systems outperform the 
latter on low viscosity materials.129 Also, the final product depends on the filament 
extruded, which, at the same time, is a function of needle diameter, material flow rate, 
bioprinted filament height and write speed.129 
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Table 3. Summary of the different bioprinting methodologies 
 Stereolithography 138,139 LIFT 126,140 
Inkjet bioprinting 
120,126,140 
Extrusion bioprinting 
126,140 
Viscosity 
bioink 
n.a. 1–300 mPa s <10 mPa s 30–6 × 107 mPa s 
Cell density Medium 107 cells/ml Medium (108 cells ml−1) Low <106 cells ml−1 High, cell spheroids 
Resolution 1.2–200 µm 10–100 μm 10–50 μm 200–1000 μm 
Single cell 
control 
High Medium Low Medium 
Fabrication 
speed 
Fast (<40,000 mm/s) Medium (200–1600 mm/s) Fast (100 000 droplets/s) 
Slow (700 mm/s –
10 μm/s) 
Cell viability >90 % >95% >85% 80%–90% 
Advantages 
 Complex internal 
features 
 Growth factors and 
cell loading possible 
 Supports vascular channels 
 Nozzle-free technology 
enables less cell damage 
 High precision 
(1cell/droplet) 
 low cost 
 high resolution 
 high printing 
speed 
 ability to introduce 
concentration gradients 
 Independent 
movement with high 
resolution 
 Support is not 
required 
Disadvantages 
 Toxic photoresins 
 Possible shrinking 
 Need of support 
structure 
 Expensive 
 Difficult to print multi 
cellularized cellular scaffolds 
 Limited commercial viability 
 Thermal and 
mechanical stress to cells 
 limited printable 
materials 
 Expensive 
 Optimization of 
bioink properties is 
crucial 
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1.5.1.2 Bioinks 
The bioprinting methods previously described provide a myriad of strategies for 
bioprinting applications. Moreover, the bioprinted product’s functionality will depend on 
the combination of a bioprinting method and an adequate bioink for the application. In 
general, each bioprinted construct will need a bioink that can successfully comply with 
the requirements of the needed geometry. As a result, the dependence on structural 
composition and functionality extends the need to develop novel bioinks further using 
nano-dimensional biomaterials such as proteins, polysaccharides, polymers and micelles 
to improve mechanical and chemical properties. 
Bioinks are usually classified into two main categories, depending on their 
bioprinted processes: (1) Scaffold-based bioinks, which are curable polymers that 
possess mechanically robust and durable materials and (2) scaffold-free bioinks, where 
soft materials, such as hydrogels, usually with a high water content, provide a viable 
environment for cell multiplication.131,141,142  While this classification is the most widely 
used, it is important to emphasize that point 1 comprises the type of bioinks used on “Top 
Down” approach, where the scaffolds are seeded with cells after bioprinting. In contrast, 
point 2 comprises the bioinks used in a “Bottom up” approach, where highly hydrated 
polymers are combined with cells prior to bioprinting.143 In general, a bioink’s potential to 
be used in the field will depend on the printability, crosslinking ability, mechanical 
properties, biocompatibility degradation controllability and formation of by-products after 
biodegradation occurs.125 
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1.5.1.3 Scaffold-based bioinks 
The scaffold-based bioprinting approach is the most widely used approach to date 
because it provides an area for cell adhesion and a biological cue for cell differentiation.142 
There are three categories that encompass the scaffold-based bioinks: hydrogels, 
decellularized extracelular matrices (dECM) and micro carriers. 
1.5.1.3.1 Hydrogels 
Attempts to work under physiological conditions have been satisfied using 
hydrogels. El-Sherbiny et al. define hydrogels as “three-dimensional networks composed 
of hydrophilic polymers crosslinked either through covalent bonds or held together via 
physical intramolecular and intermolecular attractions”.144 Hydrogels are desirable 
materials in bioprinting applications due to their ability to provide enhanced printability, 
cytocompatibility, address low biomaterial viability, provide homogenous distribution of 
substrates, and facilitate diffusion of molecular oxygen required for cell viability.145  These 
materials have a high content of hydrophilic moieties, provide fast gelation times and 
enhanced mechanical strength which can support 3D-structures.146,136 However, to 
provide a microenvironment with proper mechanical properties for cellular activities it is 
crucial to preserve the original 3D structure. Therefore, it is of utmost importance to select 
a crosslinking mechanism that does not have a negative impact on the desired structure. 
Various crosslinking processes have been developed for hydrogels, including thermal-, 
chemical-, and photo-crosslinking.147 
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Hydrogels used for bioprinting are usually classified with respect to whether they 
contain natural or synthetic polymers. Natural polymers are preferred over synthetic 
polymers because of cell affinity and resemblance to the ECM. However, natural 
polymers undergo uncontrollable degradation and possess poor mechanical stability.126 
In contrast synthetic polymers, provide relatively consistent chemical and mechanical 
properties that exceed the ones natural polymers can provide.125 Many authors have 
described the available bioinks extensively.131 However, some examples of frequently 
used bioinks are provided in Table 4. 
1.5.1.3.2 Decellularized ECM 
Novel research has been focused on developing naturally derived materials that 
overcome biocompatibility, cytocompatibility and diffusivity issues. As a result, dECM, a 
material that retains the components and complexity of natural ECM, has been used as 
a bioink. 125 dECM has been collected thoroughly from sources such as human skin, 
nerve, and demineralized bone.148  
To facilitate the use dECMs as a bioink, the chosen ECM needs to undergo 
minimal damage. There are two general approaches for isolating dECM and utilizing it as 
a biomaterial: a) organ decellularization and recellularization, and b) isolation and 
processing of tissue and organ-specific dECM into a separate, distinct, biomaterial form 
before utilization. The second approach is desirable because it can be fully recellularized 
with enhanced cell control to make a functional tissue, and does not require sufficiently 
functional organs before decellularization.148 Furthermore, it is of paramount importance 
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to remove residual DNA after decellularization (less than 50 ng dsDNA per mg dry weight 
and 200 base pair DNA fragment length) which, may cause an immune response.149 In 
most cases, the decellularization process is based on gentle methods that dissolve cell 
membranes which maintain the structural integrity of the monolayers. They involve the 
use NH4OH and Triton X-100 solutions in phosphate buffered saline (PBS).150 
Furthermore, Kim et al. reported a thorough review of ECM decellularization. 149 
1.5.1.4 Scaffold-free bioinks 
Scaffold-free bioinks have been used as a method to facilitate rapid fabrication of 
bio-mimetically developed tissues.151 It is a developing method which has been unable to 
provide a reliable and reproducible approach for the production of custom-shaped 
scaffolds while maintaining control of the brioprinted shape when multicellular constructs 
are needed.152 To our knowledge, there are three types of scaffold-free bioinks for 
extrusion bioprinting: tissue spheroids, cell pellets and tissue strands.142 
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Table 4. Summary of some properties of hydrogels with references on their use for bioprinting. 
Type of 
bioink 
Biomaterial Composition. 153 bioink composition 
Crosslinking 
method 
Applications Advantages Drawbacks 
Natural Alginate. 154 
Polyanionic copolymers derived 
from brown sea algae and 
comprising 1,4-linked B-D-
mannuronic (M) and a-L-guluronic 
acid (G) residues in varying 
proportion 
Alginate-TEMPO-
oxidized cellulose 
nanofibrils (TCNF)-
glycerin 
CaCl2  
Wearable 
sensors and 
drug releasing 
materials. 
Hydrogels without 
glycerin are stable 
at room 
temperature 
Instability under moist 
conditions for 
prolonged use 
Natural Agarose.155 
repeating units of alternating β-d-
galactopyranosil and 3,6-anhydro-
α-l-galactopyranosil groups 
3% agarose / 1:1:1 
(Agarose:Collagen:
Mesenchymal Stem 
Cells) 
Melt-cure 
Fabrication of 
bone, cartilage, 
fat, and 
capillaries. 
Higher 
proliferation rate 
of MSC's 
Limited applications 
because they force a 
physical and 
subsequent phenotypic 
cell 
Natural Collagen.156 
Component of the ECM found in 
all connective tissues 
0.12% Collagen 
Riboflavin 
crosslinking 
bovine 
chondrocytes 
differentiation 
Increased 
rheological 
properties on low 
collagen 
hydrogels. 
The crosslinking 
method affects the cell 
viability (~77%) 
Natural Chitosan. 157 
linear polysaccharide consisting of 
β-1,4 linked 2-acetamido-2-deoxy-
β-d-glucopyranose units and 2-
amino-2-deoxy-β-d-glucopyranose 
units 
2% Chitosan 
Solution 
Thermal cross-
linking reaction 
Bone tissue 
engineering 
pH dependent 
gelation 
Cells cannot be printed 
due to acidic 
environment 
Natural Fibrin.158 
A natural major protein component 
of blood clots 
0.25% Fibrinogen 
solution 
CaCl2 
In vitro-
engineered 
substitutes of 
human skin 
allow efficient 
production of 
collagen that allow 
efficient 
production of 
collagen 
Poor control on cell 
deposition. 
Natural Gelatin.159 
A mixture of peptides and proteins 
produced by partial hydrolysis of 
collagen 
Gelatin/hepatocyte 
2.5% 
glutaraldehyde 
solution 
Large scale-up 
hepatic tissues 
Provide nutrients 
and space for cell 
growth and 
aggregation 
Necrosis occurred 
during the whole culture 
period 
Natural 
Hyaluronic 
Acid.160 
A linear anionic polysaccharide 
comprising [α-1,4-D-glucuronic 
acid-β-1,3-N-acetyl-D-
glucosamine]n, a naturally 
occurring high molecular weight 
hydrophilic glycosaminoglycan 
1%-3% Methacrylate 
Hyaluronic Acid 
UV-cross-linked 
Osteogenic 
differentiation 
Excellent 
spontaneous 
osteogenic 
differentiation 
Low cell viability 
(~65%) 
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Type of 
bioink 
Biomaterial Composition. 153 bioink composition 
Crosslinking 
method 
Applications Advantages Drawbacks 
Natural Matrigel.161 
A gelatinous protein mixture 
derived from mouse sarcoma 
1:1 Matrigel:Cells 
solution 
Thermal cross-
linking reaction 
at 4°C 
radiation testing 
Facilitates the 
creation a new 
sensor 
Limited cell type 
applications 
Synthetic 
Pluronics  
F127.162  
PEO–PPO–PEO tri-block 
copolymers 
15-40%w/v 
Pluronics F127 
Thermal cross-
linking reaction 
at 37°C 
support 
materials 
(Fugitive Inks) 
fast gelation in 
physiological 
conditions 
Limited gelation 
integrity 
Synthetic 
Methacrylated 
Gelatin.163 
Methacrylated peptides and 
proteins from partial hydrolysis of 
collagen 
5-15% GelMA 
macromers 
UV-cross-linked 
3D drug 
discovery 
platform 
High cell viability 
(80%) 
Does not allow for 
dispensing of 
continuous fibers 
Synthetic 
Poly(ethyleneg
lycol).164 
non-ionic polyester PEG diol with 
two hydroxyl end groups 
3-20% PEGDA UV-cross-linked 
Cell 
encapsulation 
studies 
Ease for 
functionalization 
Lack of protein binding 
sites and low 
degradability. 
Synthetic 
poly-lactic 
acid. 165,166 
Thermoplastic aliphatic polyester 
with a starting compound of lactic 
acid. 
100% Poly-lactic 
acid 
UV-cross-linked 
fetal femur-
derived cells 
differentiation 
Increased 
interconnectivity 
Not applicable for direct 
write applications 
 
poly(lactic-co-
glycolic 
acid).167 
biodegradable synthetic copolymer 
of Poly-(glycolic acid) (PGA) and 
poly-(lactic acid) (PLA) 
PLGA 97%-3% 
Alginate 
Melt-cure 140°C 
Cell 
encapsulation 
studies 
Able to print with 
other blends 
Not applicable for direct 
write applications 
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1.6 Summary and research objectives 
The role of CLP has been established in the Honek laboratory through the study 
of several interactions both outside and inside the quaternary structures.  
The host-guest encapsulation properties of bacterial ferritin (Bfr), a HSF analogue, 
was studied by generating a protein which had a poly histidine amino acid sequence (His6-
tag) presented on the internal surface of the Bfr cage. Once the Bfr His6-tag was prepared, 
it was used to investigate strategies to encapsulate a range of guest molecules 
(fluorescent dyes, intact proteins and gold nanoparticles) linked to the Ni2+-nitrilotriacetic 
acid (NTA) functionality. The investigations confirmed that successful encapsulation of a 
guest molecule(s) within the cavity of an engineered Bfr depends strongly on the 
multisubunit structure of Bfr, and slight variations can cause a decrease on the 
encapsulation success.24 Furthermore, the factors that controlled the host-guest 
capabilities were studied using fluorescence quenching experiments and transmission 
electron microscopy (TEM). Analyses of TEM data obtained on several host-guest 
systems verified encapsulation of the above guest molecules.168  
Additionally, the Bfr outer surface has also been engineered by utilizing 
recombinant DNA techniques and carrying out enzymatic surface modifications. 
Furthermore, large centimeter-sized macro porous ferritin gels reported by Kumari et al. 
has been synthesized.169 These results were obtained by forming a cross-linked network 
of poly (ethylene glycol)-diglycidyl ether and HSF, which formed a gel-like material that 
could be used as a nanoreactor for chemical reactions. 
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The purpose of the research was to design a biocompatible HSF-based bioink 
system, capable of photo-polymerizing, which presented host-guest interaction 
capabilities to release a cargo of interest, that was suitable for direct extrusion from a 3D 
bioprinter. 
To do so, HSF was functionalized on the surface with NHS esters via controlled 
modification of primary amines. The reaction conditions such as protein concentration, 
pH levels and bioconjugation degree on HSF were studied to verify the impact on the 
protein solution when high levels of bioconjugation were achieved.  
The functionalized HSF was mixed with a biocompatible prepolymer, such as 
PEGDA to generate a bioink, in different ratios to gather relevant data on the printing 
capabilities. Furthermore, a rheological investigation of the prepolymer mix was made to 
understand the printability of the material. This investigation demonstrated the need to 
increase the viscosity of the solution by the addition of additives that allow direct writing 
from the designated bioprinter. As a result, three polysaccharides, known for their 
biocompatibility were considered: sodium alginate, carboxymethylcellulose and xanthan 
gum.  To gather relevant data on these systems, a rheological assessment was done 
considering the linear viscoelastic region, apparent viscosity, loss and storage moduli of 
each sample. The results confirmed successful viscosity ranges for direct-write of the 
bioink on a surface. 
Once the rheological assessment was carried out, the hydrogel constructs’ 
physical properties such as sol-gel fraction, porosity, swelling capacity, host-guest 
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capabilities were evaluated by leaching studies, SEM, thermal gravimetric analysis 
(TGA), and transmission electron microscopy (TEM) respectively.  
Once the hydrogel constructs were characterized appropriately, E. coli cells 
expressing green fluorescent protein were blended with the bioinks. These bioinks were 
bioprinted using the BioBots 1 printer. In order to evaluate the impact of the bioprinting 
process, quantitative assessment of the hydrogels using confocal microscopy techniques 
were used. The investigations confirmed that successful cell viability depends on the 
porosity of the materials that facilitate the nutrient migration on the hydrogel construct. 
Further variations of the bioconjugation modifications on guest-containing CLP were 
explored to optimize the position and release characteristics of molecular cargo after 
incorporation into 3D bioprinted structures.  
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Chapter 2 Protein Scaffold Engineering 
2.1 Introduction 
Proteins play an essential role in biomedical research due to their biological activity 
and specificity.170 However, there are shortcomings associated with the use of proteins 
for therapeutic use, such as short in vivo half-life, poor stability in humans and possibly 
low solubility.171 Protein structure and stability can also be affected by pH, ionic strength, 
temperature, and solvent additives.171 Variants of a protein can be made by genetic 
manipulation of the protein residues (e.g., site directed mutagenesis) or by chemical 
modification of residues such as the ones described in section 1.2.1.1. 
Polymer-protein conjugates have been the focus of  interest by many researchers 
since these conjugates provide the ability to incorporate a variety of properties to the 
protein, and are produced by coupling reactive moieties to protein residues.172 Polymer-
protein conjugates have been successfully synthesized using either (1) grafting-to, (2) 
grafting-from, or (3) grafting-through approaches. The approach to be selected will 
depend on the application of the material and the precision needed for the desired 
synthesis ( 
Figure 17).173 For 1, a pre-formed reactive polymer is conjugated to a protein; 2, a 
polymer chain is grown from a protein macro initiator; and 3, protein reactive groups are 
incorporated in a polymer which can react with the proteins after polymerization.172,174 In 
terms of advantages from these methods we could describe that grafting-from enables a 
high degree of protein modification and the advantage of natural purification of the product 
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by dialysis.173 Nonetheless, this process is challenging due to the difficulty in preserving 
protein structure while attaching long polymer chains.175 In contrast, grafting-to 
approaches facilitate the control of the polydispersity and the chemical structure. 
However, the resulting grafting density is strongly dependent on the molar mass of the 
polymer chains.176 For the grafting through approach, there is no guarantee that only one 
reactive moiety will react with exclusively one group of the desired peptide, a situation 
which increases the complexity of the product.79 
 
Figure 17. Polymer-protein conjugates approaches (1) grafting-to, (2) 
grafting-from, or (3) grafting-through. Based from Grover et al.177  
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To control the polymerization degree in grafting-from methods, reversible-
deactivation radical polymerization (RDRP) techniques have been developed with the 
objective to facilitate the formation of a product with a well-defined composition, site-
specific functionalities and controlled architecture.178 The three most common methods 
employed in RDRP reactions are methods such as reversible addition–fragmentation 
chain transfer polymerization (RAFT), atom transfer radical polymerization (ATRP) and 
nitroxide mediated polymerization (NMP).175 Likewise, for grafting-to methods, click-type 
reactions are preferred, on which a cysteine or an unnatural amino acid with an alkynyl 
residue can undergo active-ester-mediated amide couplings, thiol-maleimide Michael 
additions, or copper-catalyzed and strain-promoted 1,3-dipolar azide-alkyne 
cycloadditions.179 
 
2.2 Modification of HSF at the ɛ-amine of lysine residues 
 This chapter will outline and discuss the methods for the preparation and the 
characterization of a HSF-based protein-polymer conjugate and its properties. This 
protein will be studied initially by the modification of the HSF at the ɛ-amino group of lysine 
residues using three different reagents: N-acrylosuccinimide ester (NAS), methacrylic 
acid N-hydroxysuccinimide ester (MMA) and glycidyl methacrylate (GMA). In order to 
verify successful bioconjugation, a range of biophysical techniques such as proton 
nuclear magnetic resonance (1H-NMR) and matrix assisted laser desorption ionization 
(MALDI) mass spectrometry were utilized. Furthermore, Fourier-transform infrared 
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spectroscopy (FTIR) was used to corroborate the presence of acrylic moieties provided 
by the derivatization reaction. Dynamic light scattering (DLS) was used to determine the 
aggregation degree and hydrodynamic radius increase (RH) with increasing 
functionalization of the protein. To further understand the behavior of mHSF with 
increased bioconjugation, transmission electron microscopy (TEM) was employed to 
analyze large structural changes that might result from these approaches. 
2.3 Materials and methods 
2.3.1 Materials 
HSF, bovine serum albumin (BSA), lithium bromide (LiBr), 2-butanone (MEK), 
dimethyl formamide (DMF), dimethyl sulfoxide (DMSO), sodium chloride (NaCl), sodium 
bicarbonate (NaH2CO3), sodium carbonate (Na3CO3), PEGDA (Mn: 700,2000,6000), 
uranyl acetate, molybdic acid, ammonium persulphate (APS), N,N,N',N'-
tetramethylethylenediamine (TMEDA), 2,4,6-trinitrobenzenesulfonic acid (TNBS), 
deuterium oxide (D2O), N-acrylosuccinimide ester (NAS), methacrylic acid N-
hydroxysuccinimide ester (MMA) and glycidyl methacrylate (GMA) were purchased from 
Aldrich (Milwaukee, USA) and used without further purification. MILLI-Q water was 
prepared freshly by reverse osmosis. Lithium acyl phosphinate (LAP), ethyl (2,4,6-
trimethyl benzoyl) phenylphosphinate (CAS: 84434-11-7) was purchased from AK 
Scientific (Union City, CA; USA) and used without any further purification. Copper grids 
(300 mesh) with a carbon-formvar coating were purchased from CANEMCO-MARIVAC 
(QC, Canada). Standard regenerated cellulose (RC) membrane dry spectra/por®4 
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Dialysis Tubing 12-14 kDa MWCO was purchased from Spectrum Labs (Rancho 
Dominguez, CA, USA). Horse spleen apoferritin (HSaF) was prepared following the 
procedure described by Wonga et al.84 
2.3.1.1  Safety Statement 
All uranyl acetate used with TEM was disposed of properly through the waste 
management facility.  
2.3.2 Instrumentation 
2.3.2.1 DLS 
DLS spectra was recorded employing Malvern Instrument Zetasizer Nano ZS at a 
173° (back angle) scattering angle, using a quartz cuvette Spectrosil Precision Cell QS 
3.0 mm (Thermal Syndicate LTD, Northumberland, USA). Ten series of 10-second 
experiments were averaged for the acquisition of the correlation function.  
2.3.2.2 NMR Spectra 
Proton (1H) NMR (600 MHz) spectra were recorded in 10% D2O on a 600 MHz 
High-resolution UltraShieldTM Bruker spectrometer (Bruker Daltonics Inc. Billerica, MA, 
USA). For a 7” tube (NE-HL5-7”) 1.00 mL of sample is prepared according to the following 
procedure. Typical concentrations are: 10-mg (1H) or 50 mg (13C) for 300 MHz, 5 mg (1H) 
20 mg (13C) for 400 MHz. 
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2.3.2.3 FTIR Studies 
Samples were analyzed by ATR-FTIR using a Bruker Tensor 37 FTIR unit 
equipped with a BioATR II cell. All protein concentrations were adjusted to a concentration 
of 2 mg/mL in MQ water. The analysis was made at room temperature, controlled by a 
water bath.  All the samples were run on a window from 800 to 4000 cm-1 through 512 
scans to increase the signal to noise ratio. 
2.3.2.4 MALDI  
An AutoFlex Speed MALDI-TOF/TOF (Bruker Daltonics Inc. Billerica, MA, USA) 
was utilized for mass spectrometric analysis. The data analysis was performed using 
FlexAnalysis software (Bruker Daltonics Inc.). A saturated solution of sinapinic acid was 
prepared in TA30 solvent (30:70 [v/v] acetonitrile: 0.1% TFA in water). All samples were 
desalted using a C-18 ZipTip activating them with 3 washes of 10  μL 100% acetonitrile,  
3 washes of 10 μL 0.1% formic acid , 10 washes of 10 μL of the sample, the sample was 
further cleaned with 6 washes of 10 μL 0.1% formic acid, and then the analyte was eluted 
them with 10 washes of 60% acetonitrile/40% 0.1% formic acid. The samples were mixed 
in a ratio of 1:2.5 with the matrix solution and 1 μL was spotted on the plate. A protein 
solution was used as an internal standard that was composed of cytochrome c (12360 
Da), Protein A (22307 Da) and trypsinogen (23982 Da).  
2.3.2.5 Electrospray Ionization 
All protein samples were buffer exchanged for water using Pall Nanosep® 10 kDa 
cut-off spin columns and then diluted to a final concentration of 3-10 μM in a 50 μL solution 
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of 1:1 water:MeCN with 0.2% formic acid. Protein samples were run on a Q-Exactive 
hybrid quadrupole-Orbitrap™ detection mass spectrometer (Thermo Scientific, Waltham, 
MA, USA). Spectra were collected between 600-1500 m/z. 
2.3.2.6 UV/Vis absorption spectra  
SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA) equipped with 
SoftMax® Pro Enterprise software was utilized to record UV/vis absorption spectra. 
2.3.2.7 Lyophilization 
A FreeZone 4.5 Liter Benchtop Freeze Dry System (Labconco Corporation, 
Kansas City, MO, USA) was utilized. 
2.3.2.8 TEM 
 TEM was performed on a CM10 Philips microscope modified with an Advanced 
Microscopy Techniques image capturing CCD camera. The accelerating potential was 
set to 100 keV for imaging in bright field mode. 
2.3.2.9 Size Exclusion Chromatography 
BioRad DuoFlow (Hercules, California, USA) equipped with GE Sephacryl™ S-300 
HR column was utilized to undertake protein purifications. 
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2.3.3 Methods 
2.3.3.1 Bioconjugation studies 
To study the effect of increasing acryloylated lysines on the surface of the protein, 
three different acryloylation reagents were used: NAS and MMA as proposed by 
Hermanson et al., and GMA proposed by Xu et al.50,180 All the protein concentrations were 
measured using Bradford Assay.181 
 
 
 
Figure 18. Strategy for the synthesis of a ferritin-conjugated monomer 
2.3.3.2 Optimal parameter determination 
The procedure proposed by Hermanson et al. was followed to evaluate the impact 
of changing the solvent percentage on the bioconjugation of the protein with either MMA 
or NAS. One mEq HSF solution was mixed with 7200 mEq of bioconjugation reagent 
(MMA and NAS) varying the concentration of solvent from 0.00%, 7.50%, 10.00% and 
20.00% (v/v) topped to 1 mL with a PBS buffer pH 7.8. The effect of the molar excess 
concentration on the bioconjugation was also evaluated using the procedure proposed by 
Hermanson et al. changing the molar excess on the bioconjugation of either MMA or NAS 
on the protein. HSF (1 mEq) solutions were mixed with 100, 500, 1000, 2500, 5000 or 
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7200 mEq of bioconjugation reagent (MMA and NAS) in a 7.50% DMF topped to 1.00 mL 
with PBS buffer pH 7.8. Furthermore, the optimization parameters were evaluated using 
other solvents such as DMSO instead of DMF. The acryloylated protein solutions were 
dialyzed (15 mM NaCl, pH 7.0) for 4 hours twice at 4 °C. MALDI analysis was employed 
to verify the number of lysine residues covalently modified on the surface of each cage-
like protein. 
2.3.3.3 Primary amine determination: TNBS Assay 
To measure the bioconjugation degree, a colorimetric assay that measured the N-
trinitrophenylation of primary amines was used.182 A 0.01% TNBS in NaH2CO3 buffer (0.1 
M, pH 8.5), 1.00 M HCl, and 10% SDS solutions were prepared. To verify assay validity, 
several primary amine standards at a concentrations of 20-200 µg/mL (large proteins) or 
of 2-20 µg/mL for small molecule (amino acids) were prepared. A 1 mg/mL lysine solution, 
5 mg/mL HSaF solution and 5 mg/mL BSA solution were utilized. A 6 point standard 
calibration point was made by adding from 0.00 µL to 60 µL in 10 µL increments,  30 µL 
for the unknown samples, 250 µL of the TNBS solution and bringing the solution to a 
volume of 625 µL with a NaH2CO3 buffer (0.1M, pH 8.5) followed by 2 hours of incubation 
at 37.0°C. Then, 250 µL of the SDS solution and 125 µL of the HCl was added to stop 
the reaction. The measurements were made at a wavelength of 345 nm. 
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2.3.3.4 Acryloylation of HSF for TNBS Analysis 
1. MMA and NAS 
The bioconjugation reactions using either NAS or MMA as described by 
Hermanson et al.1 were carried out using 7200 mEq of a NAS-DMF (0.091 g of reagent 
in 0.9558 g of solvent) and added to 1 eq. (1 mL) of the HSF solution (45 mg/mL HSF) 
and the mixture was incubated at room temperature with stirring for 12 hours. Each hour, 
a sample of 50 µL was taken to measure acrylates using the primary amine TNBS 
analysis described in section 2.3.3.3.  
2. GMA 
The bioconjugation using GMA proposed by Xu et al. 2 was carried using a sodium 
bicarbonate buffer at pH 9.5, 0.100 M. In order to carry out the bioconjugation, 100 µL of 
a GMA-DMF solution (0.1109 g of acryloylation reagent in 0.954 g of solvent) to make up 
for 7200 mEq, was added to 1 mL of the HSF solution (45 mg/mL HSF) and the mixture 
was incubated at 35 °C with stirring for two hours. The bioconjugation was followed using 
the primary amine TNBS analysis described in section 2.3.3.3 which involved extracting 
a 50 µL every hour to measure acryloylation. The acrylated protein solution was dialyzed 
against phosphate buffer (100 mM, pH 7.4) at 4°C overnight before TNBS analysis was 
undertaken. 
2.3.3.5 Acryloylation of HSF using NAS or MMA 
HSF (200 µL of a 53 mg/mL solution pure HSF) was combined a sodium phosphate 
buffer (800 µL, 500 mM NaH2PO4, pH 8.01) to produce a 10 mg/mL HSF solution. This 
solution was chemically acryloylated employing ~7200 mEq (60 µL of acryloylation 
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reagent (NAS or MMA; 100 mg/mL in DMF)) which was slowly added (30 µL every hour) 
and incubated for 2 h at 4°C, finally producing acryloylated HSF (aHSF). The unreacted 
acryloylation reagent was eliminated by dialysis in sodium phosphate buffer (2 L, 15 mM 
NaH2PO4, pH 7.41) and incubated for 4 h at 4 °C, followed by a second dialysis in four 
hours at 4 °C. 
2.3.3.6 Acryloylation effects of using molar excess on bioconjugation reactions 
To study the effects of increasing acryloylated lysines on the surface of the protein, 
three different acryloylation reagents were used: GMA, NAS and MMA as proposed by 
Xu et al. and Hermanson et al. respectively. Initially, 100 mg/mL stock solutions were 
prepared from each of the bioconjugation reagents in DMF. Seven samples per 
bioconjugation reagent were prepared using 0.5 mL of a 20 mg/mL of HSF (2.2x10-8 
mEq), followed by cooling the sample down to 4 °C with constant stirring. The samples 
were prepared by adding between 25 µL up to 175 µL of the bioconjugation reagent (e.g., 
25 µL, 50 µL or 75 µL) in 25 µL increments. Each increment was slowly added (25 µL 
every 2 hours) to the protein solution, and the mixture was incubated for 14 h at 4 °C. The 
protein solution was topped up to 1 mL with sodium carbonate buffer (0.1M, pH 9.5) or 
sodium carbonate buffer (0.1 M, pH 8) for GMA or NHS activated esters respectively. The 
acryloylated protein solution was then dialyzed (15 mM NaCl, pH 7.0) twice, for 4 h each 
time, at 4 °C. MALDI analyses were made to verify the number of lysine residues 
covalently modified on the surface of each CLP. 
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2.3.3.7 Acryloylation density studies to evaluate protein diameter change 
To study the effect of increasing acryloylated lysines on the surface of the protein, 
two different acryloylation reagents were used: NAS and MMA as proposed by 
Hermanson et al.1 Two conditions were tested: the effect of a) bioconjugation at room 
temperature and b) bioconjugation at 4 °C. First, 100 mg/mL bioconjugation solutions of 
NAS and MMA were prepared in DMF. Likewise, an HSF solution (12.6 mg/mL measured 
by the Bradford assay) was prepared by diluting one mL of a stock solution of HSF (50 
mg/mL) to 4 mL using a 500 mM phosphate buffer pH 8 solution. To carry the 
bioconjugation studies, four 200 µL HSF samples per treatment were prepared, for a 
total of 16 samples. The samples were reacted with either one, three, five or seven 
aliquots of 20 µL of the corresponding bioconjugation reagent every 45 minutes, 
respectively. To keep the volume constant, once the desired amount of bioconjugation 
reagent aliquot was added, 20 µL aliquots of DMF was added to the solution to complete 
to add up to a total of 140 µL in the mixture. The samples were later purified using Amicon 
Ultra 0.5 mL MWCO 10K spin column (Millipore,  Billerica, MA, USA) doing four 500 µL 
interchanges at 10,000g for 10 minutes. Finally, both, the filtrate and the unfiltered 
solution were characterized using MALDI analysis and DLS studies. 
2.3.3.8 Surface bioconjugation studies 
Kinetics of the reactions were followed by high resolution 600 MHz 1H NMR. 
Spectra (64 scans with 120 s delay) were recorded in 10% D2O on a 600 MHz Bruker 
spectrometer as described by Imani et al. The reagents were screened before the 
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reaction to verify the signals. The observed changes in the intensity of the vinyl protons 
were determined as a function of time. All runs were performed at room temperature. One 
mL of 4.0 mM of TMEDA and 10 mg/mL of protein conjugate was poured into a 7 mm 
diameter NMR tube. An aliquot of 50 µL of a 125 mM APS was added to initiate the 
polymerization, and immediately the tube was transferred to the NMR instrument.  
2.3.3.9 DSC studies of modified proteins 
Differential scanning calorimetry studies were carried out according to what is 
described by Zhang et al.183 The samples prepared in section 2.3.3.6 were analyzed using 
a VP-DSC micro calorimeter equipped with degassing equipment. The samples were 
dialyzed three times with 50 mM NaH2PO4, pH 7.2, prior to analysis. Then, each sample 
was degassed for 5 minutes. The operating conditions were optimized for 30 scans for a 
temperature range from 20 to 110 °C on a scan rate of 90 °C/h. The Post-cycle thermostat 
threshold was set to 25 °C, and the pre- and post-scan thermostat times were set to 15 
and 0 minutes respectively. 
2.3.3.10 TEM studies of modified proteins 
Preparation of samples for TEM were performed using 300 mesh copper grids with 
a carbon-formvar coating. Molybdic acid ((NH4)6Mo7O24), and Uranyl acetate 
(UO2(CH3COO)2) stains were prepared and used as both 0.7 % and 0.5 % solutions. Both 
stains were used to determine which gave better resolution. The protein samples were 
prepared to a concentration of approximately 1.0 mg/mL, and buffer exchanged using 
dialysis tubes in Milli-Q water. Grids were prepared by placing a 10 μL sample droplet, 
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two 10 μL droplets of water and one droplet of stain on Parafilm®. The sample droplet 
was placed on top of the grid to form a layer of solution on the grid. The samples were 
washed by placing the grid on the water droplet while waiting a minute at a time. The grid 
was placed onto the stain solution for 10 seconds followed by blotting the grid on the filter 
paper. The final step was to wash the sample on the water droplets for 10 seconds 
followed by dabbing the grid on the filter paper. Each grid was left, covered, at room 
temperature to dry for 24 hours. 
2.3.3.11 SEC purification of labeled HSF 
The separation of the labeled HSF samples was made using GE SephacrylTM S-
300 HR resin.  The running solution was 100 mM potassium phosphate dibasic buffer at 
pH 8.0. AHSF was added in 500 μL injection volumes and run at a flow rate of 40 ml/hr 
with a collection of 8 mL fractions. The first eluted peak was collected and used directly 
for further experiments. 
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2.4 Results and Discussion 
2.4.1 Bioconjugation Effects 
The scope of the project was to bioconjugate the HSF to introduce reactive 
moieties that could undergo a grafting mechanism that could be subsequently 
incorporated into a hydrogel network. Initially, two vinyl-based NHS esters were chosen: 
NAS and MMA. There are four reasons why acrylate-based monomers were chosen for 
HSF bioconjugation: 1) the ability to undergo radical polymerization, 2) low cost, 3) good 
aqueous solubility, and 4) potentially adjustable hydrogel properties which could be 
adjusted by the monomer concentration used and which could lead to interesting physical 
properties (e.g., transparency and glass transition temperature).184  
It has been challenging to identify the chemoselectivity of the NHS esters for HSF. 
For example, it was first reported that HSF had approximately 3.3±0.3 surface lysine 
residues per subunit that are chemically addressable and that can be used for 
bioconjugation.185 However, to prove accurate reactivity of lysine groups, Zeng et al. 
modified a HSF analogue with 5-carboxyfluorescein NHS followed by tryptic digestion of 
HSaF. Analysis of the results of these experiments indicated that K97, K83, K104, K67 
and K143 residues are actually modified per lysine subunit.186  
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Figure 19. X-ray structural diagram of HSF with subunits presented in HSF 
and the indication of a HSF subunit with all the exposed lysines according to Zhen 
et al. Reproduced with permission from Zhen et al.  186 
It was shown that once the lysines are modified with a CTA, and soluble PEGMA 
was added by ATRP, an amphiphilic hydrogel resulted; showing that by controlling the 
chemoselectivity of derivatization it is possible to affect the particle’s surface affinity 
towards a specific moiety. To further the studies of lysine modification, Zeng et al. 
derivatized apo-HSF employing a 200-fold excess of 5-(propargylamino)-5-oxopentanoic 
acid NHS ester (200-fold excess) in a phosphate buffer (0.1 M, pH 7.8) and DMSO, at a 
4:1 (v/v) ratio, for 24 h. Analysis of the combination of MALDI studies with trypsin and V8 
protease digestion showed that there are five addressable lysines per subunit instead of 
the previously reported four: K97, K83, K104, K67 and K143 on apo-HSF (L-chain). 
Furthermore, it has been demonstrated that as bioconjugate steric hindrance increases, 
a decrease in the number of labeled lysines results.187 This chemoselectivity on lysine 
residues results in versatile methods to alter the properties of HSaF particles, which can 
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be extended to other protein nanoparticles. On average, this result gave perspective on 
the number of lysine residues that could be modified on the ferritin surface by using 
different bioconjugation reagents under different conditions. 
Our first approach to bioconjugate HSF was made following the procedure 
describe by Böker et al.86 Commercially-available equine ferritin was purified by size-
exclusion chromatography (SEC) to isolate non-aggregated ferritin. Subsequently, the 
non-aggregated ferritin was reacted with a NHS ester at 500-fold excess with respect to 
the addressable amino groups per ferritin cage (3 residues on the surface per subunit 
and 24 subunits per HSF) and left to react for 24 h at 4 °C in a 1:5 (v/v) DMF:PBS buffer 
(0.1 M, pH 8). The final step was to dialyze the mixture in PBS buffer (0.1 M, pH 7.4) to 
remove any non-reacted NHS ester. This resulted in the formation of protein precipitates 
that were not possible to resolubilize even after extensive dialysis. The aggregation could 
have been prevented adding a stabilizing osmolyte or a non-denaturing detergent. 
However, because the bioconjugation of the HSF was critical to introduce reactive 
moieties that could undergo a grafting mechanism in one-step.  It was desired to optimize 
the reaction conditions in order to reduce aggregation while facilitating a successful 
bioconjugation by varying the solvent used to solubilize the NHS ester, the buffer pH, the 
reagent concentration (both NHS ester and protein concentration), and reaction times.  
 To assess the impact of solvent volume percent, DMF and DMSO were selected 
because NHS esters have high solubility in non-aqueous solvents. Furthermore, DMSO 
was selected due to the lack of nucleophilic groups that might react with the NHS esters. 
Although DMF is generally an unreactive solvent, a frequently present impurity in 
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commercial DMF is dimethylamine, which is reactive towards NHS esters. Therefore, 
fresh DMF was needed to do carry out the reaction. Concentrations ranging from 0-20% 
of organic solvent (DMF or DMSO) were used to verify the maximum amount of solvent 
tolerated by the reaction while keeping constant the other conditions (25 mg/mL (0.05 
mM) HSF, pH 8, 500-fold excess, 4 °C and 24 h reaction time). Our findings demonstrated 
that the presence of DMSO did not improve the bioconjugation process, and possibly 
increased the aggregation of HSF in comparison with DMF. In addition, it was evident 
that extended periods (>12 h) in contact with these solvents completely precipitated the 
protein from solution even at 4 °C, an observation also described by others.50  
The buffer pH was evaluated, as there is a correlation of the pH and the NHS 
esters hydrolysis rates in aqueous media. The half-life of NHS esters decrease from 4-5 
hours to under 10 minutes as the pH is increased from 7.0 to 8.6. It was reported that at 
pH 8 the t1/2 is roughly 1 hour. 51 From this, an assumption that at pH 9, NHS-activated 
esters have a t1/2 of only a few minutes made it evident that the incubation had to be done 
at the lower pH and lower temperature. As a result, multiple buffers were tested to regulate 
the pH at which the reaction was carried: acetate buffer (1 M, pH 7.88), sodium 
bicarbonate buffer (0.1 M, pH 8.5) and phosphate buffer (0.5 M, pH 8). Sodium phosphate 
buffer (0.5 M, pH 8) was chosen because it assists in protein stabilization and free Fe2+ 
complexation.188 Moreover, successful bioconjugation has been reported using (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) and (3-(N-
morpholino)propanesulfonic acid) (MOPS) for bioconjugation of some proteins.189 
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Furthermore, a buffer with reactive primary amines, such as TRIS (0.1 M, pH 8), was used 
to quench the labeling reaction.  
To gain more insight concerning the HSF bioconjugation procedure, variation of 
the molar ratios of acryloylation reagents:protein were tested starting from 5:1, 10:1, 25:1, 
50:1, and 500:1. To verify the protein bioconjugation, the different assays were first 
purified using Nanosep® Spin Columns MWCO: 10 kDA. The purification was carried out 
with bioconjugated and non-bioconjugated protein using a phosphate buffer (50 mM, pH 
7.4, 15 mM NaCl). The use of ultracentrifugation procedures resulted in high aggregation 
rates and difficulty in resolubilization as well. It is known that ultracentrifugation will result 
in a higher local protein concentration, facilitating precipitation, which could lead to 
unfolding and an increase in non-specific protein-protein and protein-membrane 
interactions, ultimately causing a blockage in the membrane, increasing the ultrafiltration 
times. To reduce the nonspecific binding, 50 µM of Tween 20 was added.190 However, 
the presence of detergents is detrimental for MS analysis, resulting in low sensitivity of 
the protein analyte.191 As an alternative method, dialysis in phosphate buffer (50 mM, pH 
7.4, 15 mM NaCl) was chosen using two exchanges of 4 hours and one final exchange 
overnight. Neither of these procedures gave positive results for the bioconjugation 
process, instead, it favored an increased reagent waste at the beginning of the synthesis.  
Initial analysis of the samples was carried using the Thermo Scientific Q-
ExactiveTM Orbitrap mass spectrometer using positive ion mode (spectrum scan range 
was collected between 650-2500 m/z for 2 minutes at 17500 MHz resolution) which gave 
unsuccessful results. The ESI-MS spectra showed a large distribution of ions 
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corresponding to a high distribution of molecular weights from the bioconjugated HSF 
(Figure 20). The reason supporting this behavior is the composition of HSF that has two 
different subunits (L- and H-chain). In addition, bioconjugated HSF led to inhomogeneous 
modified ɛ-lysine residues. As a result, multiple charged species were identified when 
analyzed using ESI-MS. At first, this variation was attributed to the source of the protein, 
which may be glycosylated as reported in the literature.192 To discard this possibility, 
HSaF was acquired from another commercial source (EMD Millipore Inc.) with a stated 
protein purity of ≥ 90%. This protein led to the same result of multiple charged ions with 
similar charges, making it impossible to deconvolute the ESI-MS spectra. It was 
hypothesized that L- and H-chain would ionize to the same degree, because of the protein 
similarities, making ESI an inadequate method to analyze reaction completion. 
Furthermore, it has been reported, that the molecular characterization of the polymer–
ferritin conjugates imposes many challenges because of their high molecular weights.86 
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Figure 20. Mass spectra from HSaF using ESI mass spectrometry. 
Due to the difficulties found with the NAS and MMA, other alternatives were 
explored. Xu et al. introduced the use of GMA as an alternative to acryloylated proteins.180 
However, GMA can undergo self-hydrolysis under basic conditions.193 Furthermore, when 
GMA in DMF (100 mg/mL solution) was added to the protein solution, two phases were 
formed due to low solubility of GMA in water, requiring the use of an increased amount of 
solvent for the bioconjugation reaction.  
The bioconjugated proteins modified with NAS, MMA and GMA were first studied 
by the use of the well-known TNBS colorimetric assay (see section 2.3.3.3).180 This assay 
addressed the detection and quantitation of unreacted terminal amines on the ferritin 
shell. This was accomplished employing HSF and BSA as a control proteins. BSA 
contains 60 addressable lysine residues, while HSF has an average of 55 and up to 72 
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addressable lysine residues on the exterior of HSF that where modified by NHS-
ester/GMA acylation.194 GMA bioconjugation was studied first by adding 100-fold excess 
towards HSF lysine residues. BSA showed an enhanced bioconjugation capability using 
the bioconjugation approach because all the lysine residues are somewhat exposed to 
the solution environment.195 According to the experimental results, 13 out of 60 lysine 
residues can be acryloylated under 2 hours for BSA. In comparison, only 3 out of 7 lysine 
residues of the HSF can be acryloylated. The reaction was carried out over 18 hours. It 
was found that 32.6 (~50%) of the available lysine residues of BSA react, while only 10 
(~14%) lysine residues are bioconjugated. Likewise, NAS was evaluated to show that 59 
of BSA and 40 of HSF lysine residues can be modified under 14 hours. This difference 
can be attributed to the lower reactivity of GMA in comparison with NAS. This 
demonstrated that the nucleophilic substitution is favored with NHS esters in comparison 
with the ring opening that the glycidyl group undergoes. However, the modification of the 
protein with GMA allow the reaction of the glycidyl group with the ɛ-primary amine while 
preserving the net charge of the protein, favoring its stability and keeping the isoelectric 
point constant.194 Thus, decreasing aggregation. The TNBS analysis was accurate as a 
tool to determine the amount of bioconjugated lysine residues, however, it was a time 
consuming technique. During the development of the project, the chemistry department 
at the University of Waterloo acquired an Ultraflex, MALDI mass spectrometer. This 
technique can be used for high throughput analysis for proteomics at a low cost. As a 
result, TNBS analysis was no longer pursued.  
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A set of bioconjugation reactions utilizing NAS, MMA and GMA were proposed to 
understand the influence of the bioconjugation reagent over a time span of 14 hours. The 
experiment was carried out by adding (15 µmol, 25 µL of 100 mg/mL solution) of 
bioconjugation reagent into the protein solution every two hours to study how many lysine 
residues could be modified (1200 mEq excess towards total lysine residues per aliquot). 
This experiment was studied using MALDI, as shown in Figure 21. 
After 14 hours GMA (142.15 g/mol) MMA (183.16 g/mol) and NAS (169.13 g/mol) 
could modify an average of 1.41±0.50, 2.28±0.38 and 3.86±1.20 lysine residues per 
ferritin subunit respectively. It was demonstrated that two aliquots of the bioconjugation 
reagent were enough to achieve more than 60% of the maximum lysine bioconjugation 
that could be achieved with each of the bioconjugation reagents. As a result, a minimum 
of two aliquots (3000 mEq, 50 µL of 100 mg/mL solution) spaced by 45 minutes was 
required to produce an acceptable bioconjugated protein. Although the GMA was 
correctly quantified, the use of the GMA reagent for further experiments was not pursued 
because of the low number of bioconjugated lysine residues achieved after 14 hours of 
reaction.  
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 Figure 21 Acryloylated lysine residue yield employing increasing 
concentrations of different bioconjugation reagents (NAS, MMA and GMA) where 
the mass difference is evaluated from the WT-HSF average MW = 20000 Da to the 
highest frequency point on the weight distribution. 
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2.4.2 Temperature effect 
 Amidation reactions have been reported to be made under room temperature and 
at 4 °C.196 It is expected that a decrease in temperature will reduce the hydrolysis of the 
ester group. However, the reaction rate decreased as well,  it was expected that the rate 
was going to be sufficient enough to improve the efficiency of the coupling chemistry and 
increasing the degree of bioconjugation.197 Figure 22 showed that lower temperatures 
produce lower bioconjugation, which showed that it was needed to determine the effect 
of the decreased hydrolysis rate on the bioconjugation studies. Despite this, it was clear 
that there is a linear relationship between the aliquots added to the mixture and the degree 
of labeling. It was desirable to explore the effectiveness of this reaction under various 
experimental conditions. To do so, a few researchers have proposed that the 
determination of free NHS by UV absorbance at 260 nm is a powerful method to follow 
the reaction.198 This monitoring technique was unsuccessful to probe the presence of free 
NHS esters within the reaction to help verify the optimal time interval to carry out the 
reaction. After many failed measuring trials, a heuristic approach was made and 
reconfirmed that to make a successful labeling reaction the optimal time interval between 
aliquots was 45 minutes. 
 As previously mentioned, there is an evident increase on the labeling of the HSF 
when using NAS instead of MMA. This behavior may be attributed to the methyl group, 
which causes a decrease in the reactivity in comparison with the NAS reagent. However, 
this behavior is desirable because it facilitates a repeatable method to control the amount 
of lysine groups that can be modified on the ferritin shell.  
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Figure 22. Effect of number of aliquots (~1500 mEq/aliquot) effect of 
bioconjugation reagent on modified HSF at 4 °C and 23 °C. 
In addition to the temperature conditions explored above, it was necessary to gain 
further insight into the aggregation profile using DLS. The hydrodynamic radius (RH) is 
affected by the bioconjugation of the HSF (Figure 23). It is important to note that HSF and 
HSAF have the same hydrodynamic radius.199 However, it is shown that the greatest 
increase in the hydrodynamic radius was achieved using NAS as a bioconjugation 
reagent, which is in accordance with the fact that NAS is the reagent that covalently 
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modified the most acrylates on the ferritin surface. A trend was observed; MMA 
bioconjugation rendered a higher value of polydispersity index (PDI) of hydrodynamic 
radius for the modified ferritin compared to NAS, this will affect the cross-linking density 
of the hydrogel once the bioink has been polymerized. 
 Surface labeling of HSF had been achieved in the past.200 The labeling of charged 
groups of the HSF causes an irreversible change of their charge. In this case, due to the 
loss of primary amine moieties at physiological pH, the modified protein’s pI will be 
decreased. Additionally, when there is a high degree of labeling, an increase in the 
polydispersity of the modified proteins will result. This in turn would make it more difficult 
to purify to homogeneity a unique protein with only one molecular weight. As mentioned 
above, the increase in temperature will have an effect on the extent of labeling. 
Furthermore, an increase of the temperature of the reaction will also affect the amount of 
protein aggregation over the amount of added aliquots to the reaction. 
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 Figure 23. DLS determinations of the temperature effect on aggregation on 
modified HSF by the addition of aliquots of bioconjugation reagent (1500 
mEq/aliquot) shown as A) Z-average and B) polydispersity index. 
It was assumed that CLP conformation is preserved after the protein labeling; 
nonetheless, it is not guaranteed that the cage-like structure prevails for most subunits. 
To determine the integrity of the CLP, SEC of protein structure was utilized. More 
importantly, the intact 24-mer of the HSF CLP will had a retention time similar to WT-HSF. 
This finding suggested that the structure prevailed after surface functionalization. 
However, it was necessary to correlate the aggregation with the intact structure by 
evaluating the HSF with a series of molar blending ratios of 1 through 7 aliquots (1500 
mEq per aliquot) in increasing concentration steps of acryloylation reagents (MMA and 
NAS). The NHS labeled proteins were then screened by employing TEM. This technique 
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had been successfully utilized to visualize encapsulated guest molecules within 
Bacterioferritin.168 Two TEM stains were used: uranyl acetate and molybdic acid, to 
determine the structure and the aggregation profile of the modified HSF. It was expected 
that the modified HSF appeared as a shell because the stains can penetrate all the protein 
channels (eight 3-fold and six 4-fold) by connecting the inner cavity to the solution with 
pore sizes between 0.3 and 0.4 nm.90 After a few trials, uranyl acetate was discarded, 
and molybdic acid was selected as the method to use for TEM screening. Instead, as 
shown on panel A of Figure 24, commercial HSaF showed stain penetration within the 
inside of the capsule protein. The penetration of stain confirmed that single atom stains 
were small enough to transit across the native pores. In addition, the negative stain 
facilitates the determination that the protein shell remains intact through the labeling 
process, regardless of the amount of lysine residues being modified. For example, panels 
B and D show NAS and MMA modified proteins that had approximately 2.1 and 2.8 lysine 
residues modified respectively. However, there are distinct protein shells that are 
observable. In contrast, at higher labeling, there are no single protein shells that are 
observable, suggesting that aggregation is likely when higher labeling is achieved. These 
TEM studies showed that the cage-like structure is likely preserved (Figure 24).  
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Figure 24. TEM studies for the evaluation of quaternary structure 
preservation as a result of bioconjugation with A) 1500 mEq of NAS, B) 10500 mEq 
of NAS, C)1500 mEq of MMA, and D) 10500 mEq of MMA. 
Further information from the bioconjugated protein was needed, as a result, SDS-
page analyses were made on MMA-, NAS-bioconjugated and self-cross-linked HSaF 
using LAP. This experiment was done to confirm that bioconjugation was successful, and 
to explore the capabilities of the ferritin to undergo self-polymerization once it is exposed 
to FRP conditions. It can be interpreted from Figure 25 that not only the acryloylated 
ferritins (N026A, M026A) showed an increased molecular weight due to the addition of 
several acrylate groups, but also when the acryloylated ferritins were exposed to UV-light 
(406nm) under the presence of LAP, they may undergo self-polymerization. This theory 
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was supported by analyzing the gel band where polymerized N026A and M026A 
occurred. That is, there was a decreased intensity of the band near the trypsin inhibitor 
at 20,100 Da, whereas on the top of the well there was observed a broadening of the 
band, which had the same concentration as the acryloylated ferritins that were not 
exposed to the UV light. This suggested that a polymer with much larger molecular weight 
was not able to penetrate into the acrylamide gel. 
 
Figure 25. SDS-Page gel with WT-, acryloylated and polymerized ferritins. 
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2.4.3 Verification of vinylic moieties on HSF quaternary structure 
NAS- and MMA-NHS esters were chosen to label HSF due to their capabilities to 
provide vinylic moieties that function as anchoring points for a free radical polymerization 
(FRP) with other vinylic moieties or Michael additions with thiol moieties. This stage was 
relevant because it defined the cross-linking density and the intermolecular hindrance of 
the modified proteins. At first, it was presumed that a simple method such as the use of 
a 5% KMnO4 aqueous solution to screen for the oxidation of the vinyl moieties was 
sufficient.201 However, the maroon protein solution of labeled HSF protein made it difficult 
to confirm if the vinylic moieties were present, or if they had undergone self-
polymerization.  
Furthermore, to analyze protein structural changes, DSC studies were carried out 
on the modified proteins (1-7 aliquots) as described in section 2.3.3.9. The proteins were 
purified using SEC as shown in section 2.3.2.9. However, unrepeatable results were 
achieved for these multiple runs. Therefore, the DSC evaluation of modified HSF was 
abandoned as a suitable mechanism to provide insights on the protein stability due to the 
acryloylation of the exterior of the protein cage. Instead, an instrumental approach was 
followed using ATR-FTIR and 1H-NMR to verify if the labeled proteins had reactive vinylic 
moieties available to be further cross-linked in a second step. 
 It was possible to characterize the acryloylated ferritins by FTIR. This method 
monitors the formation of the C=C band 1380–1420 cm−1 vibration band due to symmetric 
bond stretching. 
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Figure 26. ATR-FTIR for the evaluation of the presence of vinyl moieties 
produced by of bioconjugation. 
Supporting evidence for a successful bioconjugation was achieved through the 
analysis of 1H-NMR, where acrylic protons are shown near the 6 ppm range 1H-NMR. 
The signals are very distinct for each of the reagents. MMA-HSF [1H-NMR (600MHz, D2O) 
δ 6.25 (d, 2H), 5.85 (d, 2H), 4.10 (m, 3H)], and NAS-HSF [1H-NMR (600MHz, D2O) δ 6.40 
(d, 2H), 6.20 (m, 2H), 6.02 (m, 2H), 5.85 (m, 2H)], show the presence of vinylic moieties, 
excluding the signals that come from the pure NAS and MMA which have been identified 
in Figure 27 in accordance to literature.202,203 
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 Furthermore, a 13C-NMR analysis was attempted in a solution for 5 mg/mL of 
modified protein. After 7 hours of analysis, using 13C proton-decoupled NMR, no 
observable resonances were present. This was likely due to the much lower abundance 
of the 13C nucleus present in the sample, and much longer NMR experiments would have 
been required. These were not pursued. 
 
Figure 27. 1H-NMR evaluation of the presence of vinyl moieties because of 
bioconjugation with NAS and MMA. 
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2.5 Conclusions 
Here it has been shown that lysine residues of HSF can be chemically modified 
with different bioconjugation reagents (MMA, NAS and GMA), two of which gave high 
bioconjugation yields. The resulting modified capsule was a mixture of different modified 
lysine residues. It was shown that there was undesired aggregation effect as the 
bioconjugation degree (Addition of aliquots) was increased or as the reaction temperature 
was increased. Furthermore, it was discovered that the use of high levels of 
bioconjugation reagent led to irreversible aggregation and precipitation of the protein, 
which made it unsuitable for long-term storage. In addition, it was shown that vinylic 
moieties do not undergo Michael addition and remain available to undergo 
polymerization. The product synthesis was evaluated with TEM, FTIR and later by 1H-
NMR to demonstrate that the protein quaternary structure remains unchanged, but with 
the presence of acrylic moieties on the surface. The bioconjugation of the HSF was critical 
to introduce reactive moieties that could undergo a grafting mechanism. MMA was 
selected as the most suitable bioconjugation reagent for the introduction of acrylic 
moieties, because it provides much more control of bioconjugation with 2.28±0.38 
modified lysine residues per subunit (~ 55 modified lysine residues per cage), which is in 
agreement with the literature.  
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Chapter 3 Rheological properties of polysaccharide-polymer blends 
3.1 Introduction 
The viscoelastic behavior of proteins originates by a combination of weak 
intermolecular forces (Appendix A). Therefore, the resulting interactions are not 
permanent.204 Functionalization of hydrogels has been of interest for biomaterial 
applications. By doing so, a protein polymer conjugate might have a change in the storage 
modulus (G’), thermosensitivity and softening properties.205 Protein-polymer blends are 
difficult to characterize. Usually, they behave as non-Newtonian fluids, making the ηapp a 
function of many other factors, that have not been mentioned before such as gelling 
mechanisms, polymer molecular weight, polymer concentration, temperature, cross-
linker activity, and humidity.129 Furthermore, Lawrence et al. demonstrated that there is a 
relationship between protein sequence and the macroscopic properties of protein 
networks in terms of rheological behavior.206 In addition, relaxation mechanics could be 
controlled by altering the protein sequence if the percentage of protein content is 
approximately above 10% of a polymer-protein melt.204,206 
As previously mentioned, PEGDA is frequently employed as a crosslinking agent 
because of the non-toxicity of PEG itself and this reagent can be readily chemically 
modified; however, it is not suitable for bioprinting because of its relatively low viscosity. 
However, many PEGDA-based hydrogels have emerged.207 Kraut et al. successfully 
characterized PEGDA-Poloxamer 407 blends using the power law method, correlating 
apparent viscosity with shear rate.207 Furthermore, it was confirmed that PEDGA-based 
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hydrogels suffer from shear thinning behavior, which favors the formation of smooth 
hydrogel strands, facilitating the 3D bioprinting of constructs that are viable up to 180 
minutes. While not characterizing the same type of system, Patel et al. indicated that as 
PEGDA content increases; hydrogels become firmer due to the higher number of polymer 
chains and behave more elastically.208 More so, the use of a synthetic crosslinker with a 
polysaccharide can improve the gel state properties, while reducing the degree of 
polysaccharide degradation when exposed to high shearing/high-pressure conditions.209 
To gain further insight into the unique properties of the polymer-polysaccharide 
blend, numerous rheological studies were undertaken in this thesis research. Particular 
attention to the rheological properties of the prepolymer, preparation, and characterization 
of the 60 bioinks were made (varying their weight percentages of PEGDA and TA) with 
appropriate concentrations for bioprinting without the bioconjugated protein. The purpose 
of the chosen TA was to identify the optimal concentration at which each component 
delivers the fastest bioprinting, the highest bioprinting resolution, the lowest pressure 
required for bioprinting, and the extent of its facilitation of gel swelling.  
To do this, small strain oscillatory flow measurements were carried out for each 
prepolymer as a function of the thickening agent’s weight percent to determine the change 
of the viscoelastic properties as a function of PEGDA weight percent. All the 
measurements were adjusted to the Ostwald-de Waele approximation to determine the 
behavior of the viscosity as a function of the strain rate. Furthermore, the materials were 
classified according to their mechanical loss angle (tan δ), into viscoelastic or non-elastic 
bioinks. The last step was to analyze, by the use of image recognition software such as 
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FUJI, the best performing bioinks on which they bioprinted to analyze the deviation in the 
dimensions (width, height, and length) in order to determine the resolution of the 
bioprinted construct.  
The results of these rheological analyses provide extensive details regarding the 
optimal composition of the desired bioink and offer a fascinating insight into the 
mechanisms that are involved in the gelation of the desired construct. 
3.2 Materials and Methods 
3.2.1 Materials 
Sodium alginate (Alg), sodium carboxymethylcellulose (CMC), xanthan gum (XG), 
Pluronics F127 (PL), PEGDA 700, 2000, 6000, NAS and MMA were purchased from 
Aldrich (Milwaukee, USA) and used without further purification. Ethyl (2,4,6-trimethyl 
benzoyl)phenylphosphinate (CAS: 84434-11-7)  was purchased from AK Scientific (Union 
City, CA; USA) and used without any further purification. Standard Regenerated Cellulose 
(RC) Membrane Dry Spectra/Por®4 Dialysis Tubing 12-14 kDa MWCO was purchased 
from Spectrum Labs (Rancho Dominguez, CA, USA). 
3.2.2 Instrumentation 
3.2.2.1 Rheometry measurements  
The viscosity of the polymer solutions without UV polymerization was measured 
on a Bohlin CVO 100 digital rheometer (Viscometry mode, 4° cone/plate geometry, gap 
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= 150 μm). Dynamic viscosity measurements were conducted at 25 °C and in controlled 
shear rate (100–400 s−1). 
3.2.2.2 BioBots 1 Bioprinter 
The bioprinting was carried out using a Biobots 1 3D bioprinter (Allevi, CA, USA) 
equipped with a single extruder system powered with a pneumatic air compressor system 
capable of providing 0-100 PSI (Figure 28). The bioprinter onset polymerization was 
carried out with a visible blue light lamp mounted on the lower section of the extruder 
cartridge [405 nm wavelength (λ) lamp (Light power = 10%, I0= 10 mW/cm2)] to cure 
biomaterials. The cartridge was set-up with a ten mL Luer-Lok syringe with a 1/4” straight 
cannula blunt end tip gauge either 30 or 32 from Fisnar (Germantown, Wisconsin, USA).  
 
Figure 28. BioBots 1 bioprinter used for the studies of the aHSF-PEGDA-TF 
based bioinks. 
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3.2.3 Methods 
3.2.3.1 Reagent synthesis 
The initiator LAP was synthesized following the process described by Majima et 
al. via the Michaelis–Arbuzov reaction (Figure 29).210,211 Consequently, the synthesis 
begins with the addition of LiBr (2.482 g, 0.0285 mol; 4 eq) to 2-butanone (0.060 L) into 
a round bottomed flask with a magnetic stirrer. The resulting mixture was heated to 60 
°C, and followed by the slow addition of ethyl (2,4,6-trimethyl benzoyl)phenylphosphinate 
(2.260 g, 0.0071 mol; 1 eq) to the mixture. The reaction was carried for 20 minutes and 
then cooled down for 2 hours without stirring. After the reaction reached room 
temperature, the precipitate was filtered using a 20 μm mesh size filter paper (Whatman, 
Maidstone, United Kingdom) protecting it from light during the ﬁltration. The precipitate 
was washed twice with 2-butanone (0.050 L) and dried under vacuum at room 
temperature for 16 h to remove excess solvent.  
Synthesis of the desired compound was verified using 1H-NMR (300MHz, D2O) δ 
7.65 (m, 2H), 7.45 (m, 1H), 7.35 (m, 2H), 6.80 (s, 2H), 2.20 (s, 3H), 1.90 (s, 6H). These 
results are consistent with the information reported by Fairbanks et al.96 
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Figure 29. Synthesis proposed by Majima et al. to yield lithium acyl 
phosphinate from ethyl (2,4,6-trimethylbenzoyl)phenylphosphinate (P-1).210 
3.2.3.2 Study of bioinks without thickening agent 
To determine the behavior of the bioink inside the bioprinter cartridge, a 
preparation varying the aHSF at a fixed concentration of the PEGDA was made. The 
photoinitiator, 0.17 mM lithium acylphosphinate, a reagent proposed by the manufacturer 
of the bioprinter, and 50% (v/v) PEGDA and aHSF (0.1 %, 1.20×10-4 mmol, 72 modified 
lysine residues per cage) stock solutions were made. Then, three separate bioinks with 
a fixed PEGDA concentration at 35% but varying the concentration of the aHSF (1.20×10-
5, 1.80×10-5, 2.20×10-5 mmol) were prepared. Each bioink was exposed to 405 nm 
wavelenght where the concentration of the photoinitiator was varied from 0.0017 M 
(0.05% v/v) to 0.17 M (5.00% v/v) in the following steps 1.72 mM, 3.44 mM, 17.22 mM, 
34.44 mM, 86.10 mM and 172.20 mM. The characterization of the polymerization was 
made visually to determine if the polymerization had taken place. 
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3.2.3.3 Wetting agents for reduction of surface tension 
To reduce the contact angle that occurs between the drop of bioink and the cannula 
of the printer syringe, wetting agents described by Moghimipour et al. such as glycerin, 
polysorbate 80 and Pluronics F-127 were evaluated.212 Stock solutions of the wetting 
agents were prepared at 20% weight/volume. Later, 1.50 mL of bioink was prepared 
containing either 0.50%, 2.50%, and 5.00% Pluronics F 127 (PL); 0.20%, 1.00% and 
2.00% glycerin; or 0.10%, 0.25% and 0.50% of polysorbate 80. Then 1.00 mL from each 
bioink was placed inside the printer cartridge to assess further if the mixture of the wetting 
agents with the bioink was suitable for direct bioprinting using either 30 gauge 1/8” blunt 
end tips, or 100 µm Micron-S Micro Bore (Fisnar, USA) tips. 
3.2.3.4 Thickening agent and pressure dependence 
To assist in printability and resolution, thickening agents (TA) such as Alg, XG, 
CMC and PLwere evaluated. Recommended values reported in the literature indicate that 
for increased viscosity, ranges between 1%-7% for Alg, 1.00%-5.00% for XG, 0.50%-
3.00% for CMC and 10.00-20.00% for PL are recommended.207 Stock solutions of the TA 
of the highest value for the latter range were prepared. Then, preliminary blends were 
prepared to evaluate the pressure needed for bioink bioprinting as shown in Table 5. 
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Table 5. Preliminary evaluation of bioink printability at different pneumatic 
pressures 
TA Percentage PEGDA LAP psi 
ALG 6.03% 10.78% 0.06% 20 
CMC 2.35% 16.35% 0.14% 15 
CMC 2.59% 10.78% 0.06% 15 
Pluronics 16.53% 13.79% 0.06% 18 
XG 4.13% 13.79% 0.06% 5 
XG 3.82% 19.10% 0.05% 5 
XG 4.27% 10.69% 0.12% 25 
 
3.2.3.5 TA-PEGDA bioink formulations 
To determine the subset of bioinks with desirable features for extrusion bioprinting, 
60 bioinks, with a volume of 10 mL each were prepared.  To evaluate a representative 
spectrum of bioinks, the concentration of crosslinking and TA were varied according to 
Table 6. The range over which the crosslinking reagent was varied comprised four 
different weight/volume percentages (8, 12, 15, and 20%). Likewise, four different TA 
such as alginate (A), carboxymethylcellulose (CMC), xanthan gum (XG), and a triblock 
copolymer, Pluronics F127 (PL) were evaluated. The weight/volume percentages 
employed were Alg: (3, 5, 7, and 9%), CMC: (6, 8, 10, and 12%), XG: (2, 4, and 6%) and 
PL: (12, 14, 16, and 18%).  
To guarantee the preparation of the bioinks, the liquid components were added 
first. That is, 10 mL of the PEGDA solution was added into a Corning® 15 mL centrifuge 
tube. Then, the thickening agent was quickly added followed by a thorough shaking 
process. Each bioink was allowed to rest 30 minutes on the bench to guarantee hydration 
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of the thickening agent before mechanical stirring with a spatula. To homogenize the 
bioink and remove the trapped air, two centrifugation steps at 5400 rpm (clinical 
centrifuge) were made. Each bioink was labeled and stored at 4°C for further evaluation. 
Table 6. Composition of the initially tested bioinks for rheological studies 
8%P 12%P 15%P 20%P
3%A 1 2 3 4
5%A 5 6 7 8
7%A 9 10 11 12
9%A 13 14 15 16
6%CMC 17 18 19 20
8%CMC 21 22 23 24
10%CMC 25 26 27 28
12%CMC 29 30 31 32
2%XG 33 34 35 36
4%XG 37 38 39 40
6%XG 41 42 43 44
12%PL 45 46 47 48
14%PL 49 50 51 52
16%PL 53 54 55 56
18%PL 57 58 59 60
Poly (ethylene glycol) diacrylate (P)
Alginate (A)
Carboxy Methyl 
Cellulose (CMC)
Xanthan Gum (XG)
Pluronics F 127 (PL)
 
 
3.2.3.6 Linear Viscoelastic region determination 
The linear viscoelastic region (LVR) was determined using stress sweep rheometry 
measurements on each set of bioinks. To perform LVR measurements, the bioinks that 
are at the extreme values in Table 6 were selected. Furthermore, two of the middle bioinks 
were measured for each set to confirm the trend. Given this, the LVR was measured for 
XG samples: 33, 36, 38, 41, and 44; CMC samples: 17, 20, 23, 26, 29, and 32; PL 
samples: 45, 48, 50, 55, 57, and 60. Lastly, measured Alg samples were: 1, 3, 7 10, and 
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15. To categorize the bioink’s properties, an empirical classification was made based on 
their flow capacity. 
This division of liquid and gels/solids was justified based on the concept that 
depending on the viscosity of the bioink, the defined maximum stress values will vary as 
shown in Table 7. Furthermore, all samples were measured using a CP4/40 LS cone-
shaped plate spaced 150 µm from the sensing plate. Measurements were conducted at 
room temperature with a 5-second delay between measurements. All measurements 
were performed using stress sweep mode. In total, 30 steps were taken in-between the 
ranges of the frequency with an up/down frequency sweep.  
Table 7. Settings for the Bholin Rheometer to measure the respective 
bioink’s LVR 
Material Frequency Range Stress Range(Pa) Max Strain(Pa) 
Alginate 3% 0.05-1 Hz 0.5-90 150 
Alginate 5% 0.05-1 Hz 0.5-90 150 
Alginate 7% 0.5-5 Hz 0.5-300 15 
Alginate 9% 0.5-5 Hz 0.5-300 15 
CMC 6% 0.05-1 Hz 0.5-90 150 
CMC 8% 0.05-1 Hz 0.5-90 150 
CMC 10% 0.5-5 Hz 0.5-300 15 
CMC 12% 0.5-5 Hz 0.5-300 15 
Pluronics F-127 12% 0.05-0.5 Hz 0.5-30 150 
Pluronics F-127 14% 0.05-0.5 Hz 0.5-30 150 
Pluronics F-127 16% 0.05-0.5 Hz 0.5-30 150 
Pluronics F-127 18% 0.05-0.5 Hz 0.5-30 150 
Xanthan Gum 2% 0.05-1 Hz 0.5-90 150 
Xanthan Gum 4% 0.05-1 Hz 0.5-90 150 
Xanthan Gum 6% 0.05-1 Hz 0.5-90 150 
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To determine the LVR of the different bioinks, a script in R was developed. The 
code was developed to scan each sample’s measurements and determine the LVR, 
where there is a change in 10% of the slope from the relationship between G’ concerning 
the logarithm of the stress. These results determined the adequate regions on which the 
oscillation sweeps could be made. 
3.2.3.7 Oscillation sweeps determination 
Oscillation sweeps were performed for all the bioinks described in Table 6 to 
determine their viscosity as a function of the strain rate, and relative position of the storage 
and loss modulus as a function of the strain rate. To perform these oscillation 
measurements, all materials were measured at room temperature using a CP4/40 LS 
cone plate. Furthermore, measurements were performed using oscillation mode. To do 
so, the rheometry was set for a continuous oscillation. In total, 15 frequencies were 
selected between the ranges of the frequency with an up/down frequency sweep. An 
interval of 10 seconds was given in-between measurements. Based on the LVR 
measurements, the maximum stress used for each sample is given in Table 8.  
Table 8. Frequency range and Maximum Stress Values for Oscillation 
Experiments 
Thickening Agent Frequency Range Max Stress(Pa) 
Alginate 3% 0.1-1.5 Hz 1 
Alginate 5% 0.1-1.5 Hz 1 
Alginate 7% 0.1-5 Hz 10 
Alginate 9% 0.1-5 Hz 10 
CMC 6% 0.1-1.5 Hz 1 
CMC 8% 0.1-1.5 Hz 1 
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Thickening Agent Frequency Range Max Stress(Pa) 
CMC 10% 0.1-5 Hz 10 
CMC 12% 0.1-5 Hz 10 
Pluronics F-127 12% 0.05-0.5 Hz 0.4 
Pluronics F-127 14% 0.05-0.5 Hz 0.4 
Pluronics F-127 16% 0.05-0.5 Hz 0.4 
Pluronics F-127 18% 0.05-0.5 Hz 0.4 
Xanthan Gum 2% 0.1-1.5 Hz 1 
Xanthan Gum 4% 0.1-1.5 Hz 10 
Xanthan Gum 6% 0.1-1.5 Hz 10 
 
 The viscosity was plotted as a function of the frequency on a log scale for all 
samples. The equation of a line was fitted to each plot, and the slope of the line was 
recorded.  
3.2.3.8 Bioprinting resolution experiments 
Bioinks 6, 11, 14, 22, 26, 30, 34, 38, and 42 were selected for bioprinting based 
on the oscillation and linear viscoelasticity region measurements data. Furthermore, 1.72 
mM of LAP was added to each bioink for the polymerization of the PEGDA as studied in 
section 3.2.3.1. Bioprinting conditions, as demonstrated in Appendix C, were set based 
on previous experiments and fixed for all samples. To bioprint with the selected bioinks, 
the air compressor pressure was adjusted to maintain a constant filament radius 
depending on the bioink at hand. To bioprint successfully, 5 psi, 15 psi, 25 psi and 40 psi 
were selected for XG, Alg, CMC and PL, respectively. To examine bioprinting resolution, 
a three-dimensional model, as shown in Figure 30, was bioprinted. It consists of an array 
of rectilinear objects varying in size and height. The exact dimension of each of the objects 
will depend on some layers that are stacked one on top of each other. The first layer 
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height is 0.150 mm and each extra layer adds 0.120 mm to the model. Also, the models 
side are for light blue: 0.250 cm, orange: 0.500 cm, green: 0.750 cm and purple: 1.00 cm. 
Following bioprinting, images of the model were taken and analyzed using the ImageJ 
software. Here, the sides and height of each object were measured and compared to their 
expected value. Furthermore, the radius of curvature for each of the corners was 
measured and averaged for each object. This value provided the metric for determining 
the angular sharpness of each object.  
 
Figure 30. Schematic of bioprinting models used for testing resolution 
capabilities of the BioBots 1 bioprinter 
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3.3 Results and discussion 
3.3.1 Linear dynamic viscoelastic properties 
The purpose of this chapter was to analyze the rheological properties of the bioinks 
to be used in the extrusion-based bioprinting process. This analysis was explored first by 
a student under my supervision, Matthew Nguyen. To successfully bioprint any material, 
an initial screening of the bioprinter parameters was made (Appendix C). Initially, the 
bioinks were supposed to be a mixture of two components: a) aHSF, and b) PEGDA of 
different molecular weights (Mwaverage=250, 700, 2000, and 6000). However, it was 
noticed during the initial bioprinting evaluations (section 3.2.3.1) that PEGDA bioinks were 
difficult to bioprint using extrusion systems. The reason was attributed to low viscosity 
from the solutions that could not withstand elongation forces needed for bioprinting. 
The introduction of wetting agents that reduced the bioink viscosity, decreased 
surface tension and improved the flowability, was a solution to the difficulties encountered 
with the continuous bioprinting stream (section 3.2.3.3). The purpose was to reduce the 
behavior of the bioink droplet to stick to the side of the needle before touching the 
bioprinting platform surface. However, the addition of these agents not only did not 
facilitate the bioink bioprinting but also increased the spread on the solid bioprinting 
platform surface, decreasing the fidelity of the bioprinting. To allow this approach to work 
a hydrophilic surface to attract the droplet was needed instead of flat glass.213 As a result, 
the research was focused on how to increase the bioink rheological properties. 
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A critical component to bioprint a bioink, as stated by Marques et al., is the use of 
materials that increase the rheological properties of the PEGDA based prepolymer to be 
bioprinted.209 From here on, these materials are going to be addressed as TA. The 
purpose of the TA is to facilitate a mechanism to control the rheological properties of a 
given bioink. Furthermore, these materials need to allow the flow of the desired ink while 
reducing the spread of a given solution once is deposited on a surface of set inside a 
cartridge where shear stress was applied onto the bioink. To do so, the research was 
limited to investigation of the effect of three biodegradable polysaccharides and a 
synthetic triblock copolymer carboxymethylcellulose, alginate, xanthan gum and 
Poloxamer 407 (Pluronics F127), respectively (Figure 12). An initial screening of the 
adequate TA concentration was made (section 3.2.3.4). After this screening, the selection 
of 0.05% of initiator was made.94 
To further optimize the bioink composition, a set of 60 bioinks was prepared by 
varying the ratio between TA and PEGDA, which were the major components of the bioink 
(section 3.2.3.5). This was to optimize the bioprinting conditions, trading off over three 
variables: printability, viscosity, and pressure. The PEGDA percent range 8%-20% was 
chosen to maintain a suitable network pore size and matrix density reported by other 
authors.214–217 
 
 105 
3.3.1.1 Linear viscoelastic region determination 
It was necessary to analyze the bioinks and to determine their LVR (Appendix A). 
To determine the LVR, the rheometer was used in stress sweep mode, which applied a 
fix strain rate to the bioink. In return, the plate measured the stress, G’ and G’’ as a 
function of the total strain.  All parameters were measured in a range of strain frequencies 
up to a user-specified maximum. The LVR was identified as the point where a deflection 
of 10% from a flat line was shown by plotting Log (G’’) versus Log (Stress) (Figure 31). 
The deflection of this flat region corresponded to the end of the LVR. However, the flat 
region of the G’’ measure for the viscosity of the non-sheared sample. The analysis of the 
LVR at all frequencies was time-consuming (20-40 minutes depending on the sample), 
therefore, only a representative set of the bioinks was analyzed, as specified in section 
3.2.3.6. The extreme values of the set of TA were selected (e.g., highest [PEGDA] and 
[CMC], lowest [PEGDA] and [CMC]). The reasons are that it is expected that the LVR 
range should vary proportionally as a function of the [TA]/[PEGDA] weight percentage. 
By determining the LVR at the limiting values, we expected to obtain the LVR within the 
selected range. During the analysis of the bioinks, it was noted that the LVR is dependent 
on the [PEGDA] at low [TA], however, as [TA] increased, the contribution of [PEGDA] in 
the LVR decreased significantly. To demonstrate this, the two extremes of the PEGDA 
were also analyzed. Furthermore, the two middle elements of each set of bioinks were 
analyzed. This was to ensure that there was no local maximum/minimum when the LVR 
was varied as functions of both the thickening agent weight percent and the PEGDA.  
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Figure 31. Log scale plot of the loss modulus as a function of the stress for 
a) XG and b) CMC at a range of frequencies 0.05-5.00[Hz], the LVR is indicated here. 
It was noted that testing a less viscous sample using the high-frequency screening 
parameters might cause the liquid sample to burst from the equipment. Therefore, it was 
necessary to adjust the values of maximum stress value to guarantee that the analysis 
made was going to be representative depending on the viscosity behavior of the TAs. 
Once the LVRs, using stress sweep measurements, were performed the lowest value of 
all the LVR cutoffs was selected for each TA to guarantee that all the bioink mixtures kept 
their linear response and consolidated in Table 8 of section 3.2.3.7. Furthermore, the 
bioprinter, by design operated in the non-linear region of the LVR for the selected TAs. 
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3.3.1.2 Dynamic Oscillation Measurements 
 Dynamic Oscillation experiments involved applying a sinusoidal strain to the 
sample at varying frequencies. This frequency is proportional to the shear rate. The 
maximum stress value was set such that all samples were measured within the LVR. The 
purpose of oscillation measurements was to determine the dynamic properties of each 
material such as the loss (G’’) and storage (G’) moduli, which describe the viscoelastic 
properties of the material. Furthermore, similar information can be empirically determined 
from the phase shift between the applied oscillations of the plate to the oscillation in the 
material. This phase shift is referred to as the mechanical loss angle (δ), which is a 
relationship of the loss and storage moduli as tan δ ≡G″/G′. It is confined 
to 0≤δ≤π/2rad where 0 corresponds to the behavior of purely elastic, and π/2rad, to the 
behavior of a purely viscous material. This is the cyclic integral of the shear stress 
response to small amplitude oscillatory shear, and concerns the shear strain.218 
Therefore, this measurement can be used to demonstrate how a bioink will behave, by 
comparing G’, G’’ and δ. Specifically, these measurements provide information on the 
ease at which a bioink will flow once pressure is applied during bioprinting, and how 
quickly the network recover after the bioink has left the nozzle. To determine which of 
these events leads to the shear thinning or thickening, dynamic tests were conducted to 
determine the viscoelastic behavior of the material. 
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3.3.1.2.1 Viscosity Studies 
The 60 bioink blends were analyzed to understand how the percentage of TA 
influences the viscosity of the bioinks. Analyses of the apparent viscosity of the bioink 
blends as a function of shear rate showed that all samples exhibited a high shear thinning 
behavior regardless of the TA and its concentration (Figure 32). Due to the sensitivity 
limits of the rheometer at low shear rates, the apparent viscosity of the TA-PEGDA bioinks 
were evaluated at shear rates above 0.1 Hz. To obtain relevant data, the viscosity and 
shear rate is usually plotted on a log scale; however, Cox and Merz, while doing a 
rheological analysis of polysaccharides, reported that the curve of apparent viscosity 
versus shear rate was very similar to the curve of complex viscosity versus frequency.219 
The Cox and Merz rule is not obeyed in semi dilute solutions and at lower frequencies 
and shear rates. Therefore it was essential to have concentration values above 1% of 
TA.220 
First, as the frequency increases, some of the forces holding the gel structure 
together may weaken and as a result, decrease the viscosity of the hydrogel. The shear-
thinning viscosity of the bioinks results from disaggregation of the network formed by the 
polysaccharide particles and PEGDA particles and the alignment of individual molecules 
in the direction of the flow.221 Unfortunately, a zero shear viscosity was not determined to 
verify weight in the viscosity contribution of every component in the mixture. However, it 
was shown that the slopes of the plots became nearly proportional. This suggested that 
the polysaccharide content mainly dominated the intermolecular interactions that 
determine the viscosity from the TA network structure. A steeper slope was identified with 
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xanthan gum than with any other TA. It has been reported that the chain-chain association 
in xanthan gels can be modulated by salt content and temperature.205 Furthermore, it is 
widely known that for solutions with increased viscoelasticity, quick thinning due to a more 
particulate structure of dissolved xanthan will result. The reason is attributed to the large 
size of individual xanthan molecules (length ∼1 μm) and a change in the density of 
junction zones of the elastic network formed by side-by-side associations.220,221 
 
Figure 32. Log scale plot of the viscosity as a function of the frequency of 
the TA. 
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Determination of the viscoelasticity of Pluronics F127 could not be characterized 
at the frequency range previously mentioned. At 25 °C, the solutions underwent a 
crystalline transition. It has been reported that the rheological behavior of highly 
concentrated solutions in the crystalline phase of PEO–PPO–PEO are unsuccessful 
because of the presence of nonlinear viscoelastic regions. Hence the viscoelastic 
properties also change.112 
It was found that the viscosity of neat PEGDA was independent of the applied 
frequency, whereas all TA-PEGDA dispersions exhibited notable shear thinning behavior, 
in agreement to what has been reported in the literature.221 It was anticipated that varying 
the PEGDA concentration in the bioinks would result in a characteristic change of the 
rheological properties.222 The applications of the viscosity determination were to allow us 
to customize the viscosity when the pneumatic compressor exerts pressure into the 
syringe. These measurements could be critical to the successful reduction of the printing 
pressure and to maximize the resolution of the bioprinting procedure. For example, 
bioinks with low viscosity could not sustain the pressing force and would extrude faster, 
while suspensions with very high viscosity could not be extruded easily. Therefore, 
adjusting the bioink viscosity to a proper range is an important step to achieving 
continuous extrusion. Typically, the viscosity (η) of the non-Newtonian fluids passing 
through a capillary can be adjusted by shear rate (γ˙), and many authors have studied 
this. For this case, the power law method was selected (Appendix A). 
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3.3.1.2.2 Power Law Determination 
The Power Law Model, also known as the Ostwald de Waele Model, is used to 
express a linear region over which apparent viscosity is plotted against shear stress over 
a logarithmic scale. In general, two useful values were acquired with this model: 
consistency (k) and power law index (n). These two values can be utilized to relate the 
shear rate at which a material is being exposed to the apparent viscosity at which the 
material will be sheared. The range at which these values oscillate will describe the 
rheological behavior of the blend. The value n <1 as shear thinning, n>1 as shear 
thickening and n=1 will be used to characterize a Newtonian fluid. With the known values 
of other parameters, the viscosity can be estimated at any shear rate within the shear-
thinning region. Nevertheless, the equation should not be used outside of the measured 
range of shear rates due to the possibility of the presence of Newtonian regions on either 
side of the measurement region, depending on the material being tested. 
The slopes and intercepts of the plot of the viscosity as a function of the frequency 
for the TA from Figure 32 were acquired as a function of PEGDA weight percentage. It 
was desirable to adjust the acquired values to a predictive model that could be used to 
determine the change of k and n as a function of the percentage of thickening agent for 
each PEGDA weight percentage. Once these values were plotted, it was observed that 
the values followed a logarithmic trend, which could be adjusted to a linear model. More 
so, the values showed that the variation due to the PEGDA concentration was negligible. 
To support this statement a one-way ANOVA was conducted to compare the variation of 
the data among PEGDA concentrations for every TA. Normality checks and Levene’s test 
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were carried out, and the assumptions met. There was no significant difference among 
the PEGDA concentrations for alginate, CMC or XG (p-value>0.05 and F>Fcrit). As 
expected, the variation of Pluronics was representative due to the difficulty in the 
reproducibility of the results (p-value 0.05). 
Table 9. One Way ANOVA results for the variation of the linear regression for 
consistency as a function of TA percentage over a range of PEGDA concentrations 
 
F(3,12) p-value 
Alginate 0.067 0.9759 
CMC 0.044 0.9871 
XG 0.06679 0.976 
Pluronics F127 3.0079 0.06841 
Fcrit(3,12)= 5.212 
 
Post hoc comparisons using the Tukey test were carried out. There was no 
significant difference between the PEGDA concentrations over the range of 8% to 20% 
on the k or n values. As a result, it is expected that the concentration of the PEGDA 
minimally affects the rheometry measurements, namely the viscosity, as these properties 
vary mainly as functions of the percentage of thickening agent. Using the n and k over 
the range of TA percentages provides us with an efficient way to control the viscosity of 
the bioinks suitable for bioprinting by adjusting the nozzle diameter and extrusion rate as 
shown in Figure 33 for k values.221  
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Figure 33. Dependency of Power Law model constants on thickening agent 
concentration. 
 
As shown in Table 10 the n value for Alginate = 0.773±0.025, CMC = 0.728±0.077, 
Pluronics F 127 = 1.254±0.174, and XG = 0.23±0.024. Analyses of this data indicated 
that XG is the material that presents the highest shear thinning behavior, CMC and Alg 
behave similary to each other, and PL would be a shear thickening material. It has been 
reported that polymer solutions with chains larger than the molecular entanglement 
weight would behave as a pseudo-plastic fluid because of the chain entanglement.221 
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Zhang et al. developed a 3D bioprinting system to optimize the flow and the 
porosity of scaffolds at the 100 µm resolution scale. To do so, they used a model shown 
in Equation 1 and Equation 2 to hypothetically determine the flow (Q) of a bioink based 
on their k and n values of a viscoelastic material. Furthermore, the experimental values 
were determined to show that the error between the experimental and the theoretical 
value is roughly 4%.223 
 𝑄 = 𝑎(∆𝑃)𝑏 Equation 1 
 𝑎 =  
𝑛
3𝑛 + 1
𝜋 (
1
2𝑘𝐿
)
1
𝑛
𝑅
3𝑛+1
𝑛 , 𝑏 =  
1
𝑛
 Equation 2 
The Zhang research group found that for 3% alginate solutions, employing an 
internal nozzle diameter of 0.25-0.41 mm and a pressure difference (ΔP) up to 1.5 bar, 
the flow of the bioink will not exceed 50 µL/s. Also, it was shown that for ΔP =1 Bar the 
flow of the bioink would be roughly 10 µL/s. Our findings show for this scenario in Table 
10, the flow would be almost five times larger for a 0.15 mm ID nozzle (48,6 µL/s). This 
can be explained by the fact that the PEGDA concentration disrupts the entanglements 
among the bioink’s polysaccharide network, causing a reduction in viscosity, and 
therefore increases the flow. Therefore, the nozzle extrusion pressure is proportional to 
the thickening agent concentration. As a result, too large of a TA concentration would 
exert excessive shear stresses on the cells inside. In contrast, if the thickening agent 
concentration was too low, the viscosity would also be too small resulting in a loss of 
bioprinting resolution. 
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Table 10. Power law model values for the determination of the viscosity as a function of shear stress 
Type Percentage (%) ΔP(Bar) Consistency (k) Index (n) a150 a110 µL/s150 µL/s110 
Alginate 
3 1 0.246±0.022 
0.773±0.025 
4.86E-05 1.28E-05 48.609 12.834 
5 1 1.293±0.281 5.68E-06 1.50E-06 5.681 1.500 
7 1 3.729±0.531 1.44E-06 3.81E-07 1.443 0.381 
9 1 18.681±12.224 1.79E-07 4.74E-08 0.179 0.047 
Carboxymethylcellulose 
6 2 0.299±0.033 
0.728±0.077 
2.86E-05 7.37E-06 74.192 19.109 
8 2 0.820±0.13 7.16E-06 1.84E-06 18.557 4.780 
10 2 1.548±0.169 2.99E-06 7.71E-07 7.753 1.997 
12 2 3.23±0.251 1.09E-06 2.81E-07 2.823 0.727 
Pluronics F127 
12 1.5 0.047±0.024 
1.254±0.174 
5.82E-03 1.79E-03 8044.258 2477.280 
14 1.5 0.060±0.022 7.64E-04 2.35E-04 1055.518 325.054 
16 1.5 0.054±0.002 8.31E-04 2.56E-04 1148.035 353.545 
18 1.5 0.055±0.006 8.19E-04 2.52E-04 1131.358 348.409 
Xanthan Gum 
2 0.5 1.361±0.158 
0.23±0.024 
1.57E-12 1.61E-13 7.71E-08 7.89E-09 
4 0.5 2.687±0.299 8.16E-14 8.35E-15 4.01E-09 4.10E-10 
6 0.5 4.257±0.176 1.10E-14 1.13E-15 5.42E-10 5.55E-11 
Flow rates calculated for R= 0.150 and 0.110 mm ID and L=3.175 mm
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3.3.1.2.3 G’, G’’, G* Dependence on the thickening agent 
Measurements of G’ and G’’ in frequency-dependent dynamic oscillatory 
experiments were used to examine the stability of bioink mixtures. It is possible to quantify 
the predominance of the solid or liquid character of a sample through these 
measurements.224 In general, a G’ above G’’ means that the elasticity is dominant, which 
suggests that a gelation process is prevailing. In contrast, G’’ above G’ represents a 
viscosity dominated solution-like material.221 Polysaccharides are a highly polymeric 
material; therefore, we studied the G' and G′′ of four TA in relation to frequency (0.1-5 Hz) 
at 2% strain to quantify viscoelasticity of the samples. Analysis of the plotted results of G’ 
and G’’ as a function of frequency on a logarithmic scale (Figure 34) indicated that the 
modulus G' and G′′ values of all samples were increasing with increasing frequency. 
These results indicated that the four sets of bioinks were viscoelastic materials.  
Analysis of dynamic testing indicated that at low frequency, the XG was 
predominantly a viscoelastic solid (G’>G’’). This finding is in agreement with what Ki-
Wong reported for xanthan gum solutions.111 Where, over a whole range of angular 
frequencies, the linear viscoelastic functions exhibit an essentially similar behavior in both 
the G’ and G’’; and these values are gradually increased with an increase in polymer 
concentration. However, they demonstrated that a stable gel could not be obtained by 
just increasing the xanthan gum concentration.111 
 Furthermore, alginate and CMC bioinks behave as viscoelastic fluids (G’’>G’).  
This was shown with a flat dependency of G’ and G’’ on frequency (f) ranging from about 
10-2 to 102 with G' one or two orders of magnitude greater than G’’.109 Even though the 
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study of the Pluronics-based bioinks provided inconclusive data, it appears that both 
curves G’’ and G’ intersect when the frequency reaches a certain value. This intersection 
is defined as a cross-over frequency; at this point, the bioink behaves more like a gel than 
a viscous liquid.224 
For these bioinks, at the same TA weight concentration, both the G’ and G’’ moduli 
increase as the frequency increases. Nonetheless, as the TA weight % was increased, 
the rate at which G’ rises was faster in comparison to G’’. This is indicative that more 
entanglements are being formed due to the presence of more hydrated polysaccharides. 
These trends indicate that the hydrogel is becoming firmer as the frequency is increased. 
Furthermore, as the bioink deforms, the polymer chains may begin to suffer from some 
anisotropy; however this is somewhat countered by overlapping chain entanglement.208 
For bioprinting purposes it is desirable for the material to behave like a gel while resting 
in a cartridge to minimize the flow of the bioink, prevent flocculation and other forms of 
aggregation once it is blended with the materials of interest. However, it is also desirable 
that this bioink have a rapid shear thinning and a crossover transition at low frequencies 
(or shear strains) to facilitate the deposition of the bioink. In addition to this, a fast network 
recovery is desired in order to facilitate resolution and bioprinting fidelity.  
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Figure 34. Evaluation of the viscoelastic properties G’ and G’’ for A) xanthan gum, B) alginate, C) Pluronics 
F127 and D) carboxymethylcellulose.
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3.3.2 Bioprinting Fidelity 
To assess the bioprinting fidelity and resolution of the bioinks, a student under my 
supervision, Matthew Nguyen evaluated a set of 9 bioinks according to section 3.2.3.8. 
The bioinks for bioprinting were selected with consistency values K > 0.3. Furthermore, 
the concentration chosen for PEGDA evaluation was 12%. The reason for this was 
twofold:  attempt to increase the rheological properties of the hydrogels while maintaining 
cell viability and exploit the gel strengthening benefits of a PEGDA-TA based blend.216,225 
The hydrogels were to be formed from the bioink by UV photopolymerization. The 
rate of the FRP is expected to be dependent upon the formation of free radicals generated 
by photochemical reaction of LAP. LAP underwent a photofragmentation process to yield 
highly reactive aryl radicals, which initiated the polymerization by attacking the vinylic 
groups present in the PEGDA. This reaction resulted in the formation of two cross-linked 
patterns: linear chain formation and cross-linked structures, yielding a three-dimensional 
insoluble polymer network.226 In general, all the bioinks showed a transition shift, from a 
transparent-like blend in the viscous state to an opaque three-dimensional network. This 
behavior is attributed to the aggregation of the polymer strands in a disordered manner.204 
The bioprinting conditions are given in Appendix C and the results are given in 
Table 11 and Table 12. Table 11 gives the measured side lengths of objects (4, 8, 12 
layers) and Table 12 lists the heights measured for objects of decreasing height (12, 9, 
6, 3. layers) according to the template shown in Figure 30. The percent deviations from 
the expected value are shown for each measured property.  
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A template was bioprinted and imaged (Figure 35) to evaluate the bioprinting 
fidelity. Furthermore, the images were analyzed using ImageJ to validate side and length 
deviations based on the desired dimensions. Also, the results for the highest alginate and 
CMC values (12P9A and 12P12CMC) are absent because they required more than 70 
psi to bioprint, which exceeded the bioprinter limit. It is shown in Table 11 that for any 
given object series, as the object’s theoretical side length decreases the deviation of the 
side increases. It was hypothesized that the trend is a result of increased evaporation 
rates and limitations of the bioprinter. As the object size decreases, the amount of water 
absorbed in the hydrogel structure decreases, enabling the shrinking processes that a 
specific object underwent. A similar trend was observed for the object height. It was 
expected that as we increase TA weight percent, the deviation of the object dimensions 
would decrease as a result of the increase of cross-linking density and enhancement of 
the mechanical properties. However, this was not what was found.  
Regarding printability, as the TA weight percentage was increased, the deviation 
of the layer height increased as well. This behavior was the result of the varying extrusion 
pressures between bioinks. The starting bioprinting pressures are shown in Table 10, 
where 4% XG bioprinting pressure was 0.5 Bar in contrast for 6% XG an initial bioprinting 
pressure of 0.5 Bar was applied, but during the bioprinting process, it had to be increased 
to 1.0 Bar. This bioprinting pressure had to be progressively increased during the run to 
compensate for the clogging of the needle. The need to increase the pressure was to 
maintain the velocity profile at which the bioprinting was taking place. However, the 
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clogging of the needle was a phenomenon caused by the curing of the bioink in a layer-
by-layer fashion inside the bioprinting needle. If the velocity profile was decreased, there 
was a more significant probability of polymerization within the tip at these regions caused 
by the UV-light. It was also noticed that the TA concentration influenced the clogging of 
the needle. More specifically, an increase of viscosity caused a decrease of the velocity 
profile inside the needle; therefore, the effective nozzle radius decreases as a function of 
time. Simultaneously, the extrusion filament width would also decrease as a function of 
time. Increasing the pressure aided in maintaining the same fluid flow rate, but not the 
filament width; hence lower resolution was the result.  
  
Figure 35. Images of A) top view and B) side view used to analyze the 
bioprinting fidelity of a 12% PEGDA and 4% XG gel using ImageJ. 
From these nine bioink samples, 12P4XG and 12P10CMC were selected to be the 
best performing based on having the sharpest hydrogel constructs. It was noted that the 
highest thickening agent weight percent samples were unusable due to their extrusion 
pressure exceeding 3 bar. Comparing the remaining bioinks, we found that 12P4XG and 
 122 
12P10CMC had similar deviations in their three-dimensional bioprinting resolutions. 
However, if we include the length and height deviations, then 12P4XG is preferred over 
12P10CMC due to a smaller total sum of the errors. That is, the total error in the height 
and length measurements for 12P10CMC exceeded 12P4XG by 1.31 times. Furthermore, 
the total radius of curvature of 12P10CMC exceeded 12P4XG by 1.57 times.  
Table 11.Length measurements for bioprinted features 
Sample Name Largest Side 
Length [cm] (% 
Deviation) 
Middle Side 
Length  
[cm] (% Deviation) 
Smallest Side 
Length  
[cm] (% Deviation) 
12P2XG 0.814 (1.75%) 0.657 (9.50%) 0.343 (14.25%) 
12P4XG 0.712 (11.00%) 0.485 (19.16%) 0.318 (20.50%) 
12P6XG 0.716 (10.50%) 0.522 (13.00%) 0.388 (3.00%) 
12P5A 0.710 (11.25%) 0.522 (13.00%) 0.217 (45.75%) 
15P7A 0.743 (7.10%) 0.500 (16.66%) 0.227 (43.25%) 
12P9A - - - 
12P8CMC 0.690 (13.75%) 0.451 (24.83%) 0.211 (47.25%) 
12P10CMC 0.725 (9.375%) 0.522 (13.00%) 0.275 (31.25%) 
12P12CMC - - - 
 
Table 12.Height Measurements for bioprinted Features 
Sample 
Name 
Object 12 Height 
[cm] (% Deviation) 
Object 9 Height 
[cm] (% Deviation) 
Object 6 Height  
[cm] (% Deviation) 
Object 3 Height 
[cm] (% Deviation) 
12P2XG 0.447 (10.60%) 0.236 (37.89%) 0.212 (15.20%) 0.035 (70.83%) 
12P4XG 0.413 (17.40%) 0.269 (29.20%) 0.183 (26.80%) 0.134 (11.66%) 
12P6XG - 0.211 (44.50%) 0.084 (66.40%) 0.042 (65.00%) 
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Sample 
Name 
Object 12 Height 
[cm] (% Deviation) 
Object 9 Height 
[cm] (% Deviation) 
Object 6 Height  
[cm] (% Deviation) 
Object 3 Height 
[cm] (% Deviation) 
12P5A - - - - 
15P7A 0.410 (18.0%) 0.325 (14.50%) 0.193 (22.80%) 0.036 (70.00%) 
12P9A - - - - 
12P8CMC 0.477 (4.60%) 
 
0.350 (7.8947%) 0.198 (20.80%) 0.116 (3.33%) 
12P10CMC 0.440 (12.00%) 0.288 (24.20%) 0.152 (39.20%) 0.061 (49.16%) 
12P12CMC - - - - 
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3.4 Conclusions 
Here, it has been shown that bioink blends can be rheologically characterized to 
determine their adequacy for bioprinting applications. It was determined experimentally 
that concentration ranges of PEGDA between 8 to 20% presented little influence on the 
rheological properties for the extrusion-based bioprinting process. Therefore, it is 
expected that the bioprinting properties are dominated by the weight fraction of the TA, 
as explained in the rheological properties chapter, such as xanthan gum, alginate, and 
carboxymethylcellulose. Furthermore, it was experimentally determined that to have a 
satisfactory bioprinting material, the values of consistency (K) and the power law index 
(n) should be above 0.3 and ideally below 0.5, respectively. To facilitate the bioprinting of 
these materials, it is crucial to select shear thinning materials, that dramatically decrease 
their apparent viscosity inside the nozzle as the material is being bioprinted. Also, it was 
shown that there is a negative impact on the bioink bioprinting when high concentrations 
of TA are used due to low flowability. To prevent needle clogging, the use of a nozzle that 
requires less pressure and can withstand constant velocity profile of the bioink is advised. 
To finalize, it was demonstrated that the best bioink to be used for bioprinting is the 12% 
PEGDA with 4% xanthan gum because it exhibited the best resolution with 1.3x less error 
in length and height deviation and a 1.57x corner sharpness. However, 12% PEGDA and 
10% CMC or 7% alginate can also be considered as bioink blends that will give 
satisfactory bioprinting.  
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Chapter 4 Bioprinting of bacterial cells on aHSF-based PEG hydrogels 
4.1 Introduction 
Current research on the development of bioinks are centered on tissue engineering 
applications, and focused on cell-seeded scaffolds for in vitro generation and posterior 
implantation.97 As a result, it is desirable to fabricate mechanically robust 3D ECM’s that 
can withstand these required applications.101 Traditionally, hydrogels have been used to 
fabricate these ECM due to their already diverse biomedical applications ranging from 
tissue engineering, drug delivery, and cell culture.227 However, the hydrogels require 
chemical modifications to fulfill a particular purpose. To expand the functionalities of the 
desired ECM and provide the biological functions, there has been an increased interest 
in attaching peptides and proteins to the gels themselves.228   
There are multiple hydrogel modification techniques such as NHS ester activation, 
click chemistry, enzymatic ligation, and affinity binding for transient immobilization.228  
Click chemistry has great attraction due to high yields, few byproducts, and the main 
advantage that this chemistry can be conducted under ambient conditions.229 In general, 
for protein and peptide attachment, the main advantage is that the thiol–ene coupling 
reaction is bioorthogonal with olefins on the surface directed to react specifically and 
exclusively with the thiols on the protein (cysteines).230 However, thiols can be 
problematic for conjugation chemistry because of their propensity to oxidize and form 
unreactive disulfide bridges, sulfones or sulfoxides.228   
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It is important to emphasize that ECMs cannot replicate the intricate architecture 
and arrangement of human native tissues and organs composed of multiple cell types. 
Therefore, a strategy to successfully organize the materials is to use dECMs. It has been 
considered a suitable strategy because the dECMs preserve a complex of functional and 
structural proteins from bioactive materials that are embedded in the natural ECMs while 
maintaining tissue homeostasis and promote the regeneration process needed to 
replicate a natural ECM.149 To further the bioprinting requirements, cells are encapsulated 
in hydrogels or dECMs; therefore, for cell bioprinting, the choice of bioink is crucial and 
limited by the conditions on which the material is being bioprinted. Hospodiuk et al. 
presented a comprehensive review of most of the bioinks used for bioprinting.141 This 
review presents the myriad of approaches that can be made towards generating ECM. In 
general, a good bioink will provide customizable control to promote cellular behavior by 
modulating the stiffness, added functional groups, and surface morphology.231  
4.1.1 Bacterial cell bioprinting 
The objective of a scaffold preparation was to develop a functional 3D structure 
using a bioink that will facilitate a cell bioprinting process with suitable rheological 
properties and have rapid crosslinking capabilities, without any additional steps required 
post/printing. To achieve this, our bioink, composed of a polysaccharide (10% 
carboxymethylcellulose, 7% alginate or 4% xanthan gum) was crosslinked with <1% of 
modified aHSF, in the presence of different ratios of PEGDA (Mw=700) under visible light 
(416 nm). The objective was to evaluate how the different crosslinking ratios would affect 
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the physical properties of the hydrogel construct such as protein declustering, diffusion of 
a substrate through the ferritin channels, the polymer network, swelling capacity, sol-gel 
partition, and scaffold porosity. 
Furthermore, the bioprinting of Eschericia coli in hydrogel constructs has gained 
publicity lately due to its development into advanced applications such as pressure 
sensitive circuits and shape engineered 3D constructs.232,233 For example, Conell et al. 
demonstrated by using multibacterial colonies that it is possible to analyze the dynamics 
of the environmental conditions of a specific construct.105 To fabricate these 
multicelllularized scaffolds, gelatin-based microcontainers filled with S. aureus  and P. 
aeruginosa at high cell density were fabricated using multi-photon lithography (MPL), a 
technique that allows one to bioprint an unlimited assortment of geometries. This 
approach facilitates micro positioning of desired bacterial colonies into a desired 
construct. However, using MPL is a costly and time consuming approach. As an 
alternative, Lehner et al. used E. coli as a rapid and inexpensive approach to assess an 
cell viability on bioprinted alginate-based bioinks.234 The incubated and bioprinted 
constructs were used to determine optimal conditions for bacterial colony growth. It was 
shown that within 48 hours incubated cells in non-bioprinted, liquid bioink reduced the 
viability of E. coli by approximately 50%, due to nutrient limitation. Bacterial cell loaded 
bioink extruded from a bioprinter increased the cell viability up to 200% due to the higher 
nutrient incorporation and lower bacterial density after bioprinting.  
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To verify cell viability, the most common method is to use the live/dead assay which 
is carried out by capturing images of cell-encapsulated mesh patterns right after 
bioprinting. This test is based on a fluorescence bioassay consisting of calcein AM to 
track living cells, and ethidium homodimer-1 to track dead cells which fluoresce in distinct 
wavelegths using confocal microscopy.105  
In this bioprinting study, E. coli spheroids were bioprinted in combination with the 
HSF-PEGDA-TA bioink selected previously as outlined in Chapter 3 to characterize the 
growth profile of E. coli containing a mutant form of the green fluorescent protein (GFP), 
specifically the His-tag GFP-S65T variant. There was an interest to understand the impact 
of seeding cells in incubated environments in comparison with bioprinted environments.  
  
4.1.2 Hydrogel scaffold properties 
4.1.2.1 Swelling experiments of HSF based hydrogels 
4.1.2.1.1 Sol-gel 
The sol-gel fraction was measured once the hydrogel was polymerized. This 
approach was undertaken to understand the influence of the PEGDA molar fraction on 
the modified ferritin cross-linking capacity. Xuzhen et al. used simple gravimetric analysis 
to characterize the sol-gel fraction in PEGDA hydrogels by merely leaching the unreacted 
fraction. 235 The method is to quantify the weight difference between a dry sample (mdry) 
just polymerized and a dry sample that was leached during at least 48 hours in a PBS 
solution (m’dry) and using the Equation 3. 
 129 
 𝑾𝒈𝒆𝒍(%) = (
𝒎𝒅𝒓𝒚
𝒎′𝒅𝒓𝒚
) ∗ 𝟏𝟎𝟎. Equation 4 
4.1.2.1.2 Swelling capacity of hydrogels 
Many authors have measured the swelling capacity of hydrogels.103,226,236  The 
equilibrium-swelling ratio can be calculated using Equation 5. 
 
𝑸 =
𝑴𝑺 − 𝑴𝒅
𝑴𝒅
 Equation 5 
where Q is the equilibrium swelling ratio, and Ms and Md are the masses in a 
swollen state and dried state, respectively.  Swelling and hydration of the gels were 
measured by increasing the PEGDA concentration. It is expected that the polymers 
become more highly crosslinked and less flexible under increasing PEGDA 
concentrations. Mellot et al. carried out an experiment with a PEGDA- pentaerythritol 
triacrylate (PETA) system by varying the mole fraction of the constituents to confirm there 
was a two-fold decrease in the final volume change once the mole fraction of PETA is 
1:1, reaching swelling equilibrium after approximately 20 minutes.226 To measure the 
sample weight equilibrium must be achieved, followed by blotting of the sample to remove 
any solution. To finalize the measurements, the dried sample weight was acquired by 
drying the sample under vacuum for 24 h and weighted again.237 
4.1.2.2 Declustering of cross-linked protein cages for cargo release 
Suttisansanee et al. studied the declustering mechanisms of HSF. Regarding 
stability, denaturation does not alter the shape and size of the 24mer significantly but 
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exposes protein chemical groups that were not exposed previously. It was reported that 
the cage structure is not stable under (I) protein concentrations <0.1 mg/mL; (II) pH<2 
and pH>10.6; (III) presence of denaturants such as 9 M urea or 6 M guanidinium-
hydrochloride solutions; (IV) temperature conditions above 93 °C, and (V) ionic strength 
<0.06 M NaCl.24 Furthermore, Chen et al. reported a novel human ferritin nanocage which 
can undergo disassembly at pH 4 and reassembly at pH 7.5 by cleaving the last 23 amino 
acids of the protein amino acid sequence. 238  This was accomplished by the complete 
removal of the E helix and the DE helix turn, sections which have no participation in the 
cage self-assembly process of HuFT and have no effect on the temperature stability.  
4.1.2.3 Diffusion of cargo through the HSF channels 
 The diffusion of various proteins inside PEGDA hydrogels has been studied 
previously.94,239 At first, Cruise et al. reported that PEGDA hydrogels of molecular weights 
ranging from 2000 to 8000 (mesh size 15-35 Å)  can only permeate proteins that are 
below 22 kDa, and PEGDA 20000 (mesh size 45-70 Å) can permeate proteins that are 
up to 45 kDa with concentrations ranging from 10% to 30% w/w.239 This approach 
employed the hydrogels as a membrane in between a solution that contained protein and 
a solution that was protein free. In contrast, Lee et al. evaluated diffusion by the Fickian 
diffusion model (Equation 6) by pre-making hydrogel disks, which were soaked in a 
protein solution (BSA, 4 mg mL-1) for 15 hours to understand the behavior of protein 
unloading from PEGDA hydrogels (2000 to 10000 Da).94 Zustiak et al. also followed the 
Fickian diffusion model in 4-arm-PEG polymers with Lysozyme, BSA, and Ig.240 
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 𝑴𝒕
𝑴∞
= 𝟒 (
𝑫𝒕
𝝅𝒂𝟐
)
𝟏
𝟐
 Equation 6 
For the diffusion determination, the formula used is useful only for short release 
times, to the extent of ~70% of total release. Mt is the accumulated protein release up to 
the time point t; M∞ is the accumulated protein release at the infinite time, which was 
determined by the protein accumulation; the fickian diffusion coefficient (D) of the BSA 
within the gel; and a is the gel diameter, and l is the gel thickness). It was shown that 
accepted values for the diffusion of proteins under 65 kDa in PEG-based hydrogels are 
in the range of (1.0–2.5 × 10−7 cm2 s−1).94,240 
In our studies, one approach that was taken was to determine the kinetics of the 
release of iron from the aHSF system by using ascorbic acid as a reducing agent. Jones 
et al. reported that the release of iron using ascorbate followed a zero order reaction rate 
for iron-loaded ferritins. The explanation of the phenomena based on the complexation of 
the iron (III) by the 1,10-o-phenanthroline and the photo reduction of the iron (III) to the 
iron (II) complex.237 Furthermore, Sakuari et al. reported that to facilitate this reaction, 
ascorbate could reductively release ferritin iron only at high concentration and at pH 5 or 
below. In addition to iron extraction, the iron needs to be removed successfully from 
solution by the addition of PBS, pH 7.4, containing 10 mM disodium EDTA for 1 h at 4 °C. 
This was followed ollowed by a second dialysis after incubation in PBS without disodium 
EDTA for a further 3 h.241 Therefore, D could be measured using an ascorbate solution, 
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followed by the O-phenanthroline reagent in combination with Fick’s law for short times 
(under 180 minutes). 
4.1.2.4 Porosity studies 
An essential aspect of hydrogel matrices is the accessibility to the internal sites of 
the hydrogel. A method used to increase the accessibility of the hydrogel matrix is to add 
a porogen during the polymerization. Methods to create pores within hydrogels during 
polymerization include the use of salts, organic solvents, and inert molecules.242 Another 
approach to increase the pore distribution, size and accessibility to the matrix could be by 
introducing co-polymers during polymerization. Liljeström et al. proposed the use of 
dendrimers as a co-polymer to increase the pore size with the advantage that they can 
be functionalized with a terminal amine.243 The applications of this reagents relied on 
utilizing the dendrimer’s terminal amine group for chemical modification. The main 
advantage of this reagent is the similarity with a cage-like protein, where it resembled the 
diameter of the ferritin with a different profile of releasing potential. Likewise, Zustiak et 
al. used PEG derivatives (4-Arm PEG-VS) and employed click-chemistry (Michael-
addition), and presented an elegant way of decreasing the cross-linking density and 
increasing the pore diameter at the microscopic level.237 
Traditionally, to study porosity features, two accepted techniques have been used: 
Scanning electron Microscopy (SEM) and nitrogen Brunauer–Emmett–Teller (N2 BET) 
isotherm analysis. HSF-based hydrogels have been studied by SEM studying the 
dependence of the crosslinking density on the porosity profile of the hydrogels.244 To 
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explore the morphology adequately, SEM studies of wet hydrogels are carried out using 
the backscattered electron detection (BSED) or the environmental scanning electron 
microscope (ESEM) at 10 kV.245 Furthermore, low pressure, a controlled low-temperature 
stage, and water vapor are needed to minimize the sublimation of the sample and sustain 
shape fidelity.246  Another acceptable method for porosity analysis is the freeze-drying of 
gels. However, is difficult to guarantee that these methods precisely tune the pore size. 
Instead, freeze-drying a sample often results in the formation of a surface skin because 
the matrix may collapse at the scaffold–air interface due to the interfacial tension caused 
by solvent evaporation.247 Once the images have been acquired, an acceptable method 
is to analyze the samples using an imaging processing software package such as ImageJ 
on which it is possible to develop an algorithm to perform automated and high-throughput 
analysis of SEM images with quantification of fiber diameter, pore size, and fiber 
alignment of hydrogels.248 
4.2 Materials and methods 
4.2.1 Materials 
Calcium chloride (CaCl2), sodium chloride (NaCl), magnesium (II) sulfate (MgSO4), 
monopotassium phosphate (KH2PO4), dipotassium phosphate (K2HPO4), ammonium 
chloride (NH4Cl),  disodium hydrogen phosphate heptahydrate (Na2HPO4 7H2O), sodium 
hydroxide (NaOH), glucose, bacto-tryptone, yeast extract, Alg, XG, CMC, PL, PEGDA 
(Mn: 700), NAS, MMA, and 1.5 cover glass were purchased from Aldrich (Milwaukee, 
USA), and used without further purification. CultureWell16 chambered cover glass was 
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purchased from Grace BioLabs (Oregon, USA). Blunt end tips (30” and 32”) and Micron-
S Micro Bore Dispensing Tips (150 and 50 µm) were purchased from Fisnar (WI, USA). 
Lithium acyl phosphinate was synthesized as described on section 3.2.3.1 and used 
without any further purification. E. coli (BL-21 cell line) containing the DNA coding for the 
variant His-tag GFP-S65T was expressed from a pET plasmid using isopropyl-beta-
thiogalactopyranoside (IPTG) induction and was kindly provided by Dr. Jeanne Hardy 
(University of Massachusetts, Amherst). 
4.2.1.1 Safety Statement 
All bacterial samples were handled in accordance to level 1-safety laboratory 
facilities. After use, all bacterial samples were bleached or autoclaved to sterilize the 
media before disposal.  
4.2.2 Instrumentation 
4.2.2.1 Bioprinting Equipment 
The equipment used for bioprinting is described in section 3.2.2.2 
4.2.2.2 Thermogravimetric Analyzer 
TGA was carried using a SDT Q600 (TA Instruments, PA, USA) in Thermal 
analysis mode using a 90 µL open ceramic cup.  
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4.2.2.3 Fluorescence Microscope 
OMAX 40X-2500X Lab EPI-Fluorescence Trinocular Compound Microscope 
equipped with 14MP CMOS Camera Model A35100U (Omax Microscopes, Kitchener, 
ON, Canada) was employed. Image analysis was made using ToupView. Excitation 
wavelength 475 nm and emission wavelength at 509 nm was employed. 
4.2.2.4 Confocal Microscope 
Confocal images were obtained on a Zeiss Personal LSM 700 confocal 
microscope equipped with 405, 488, 555, and 639 nm lasers (Carl Zeiss MicroImaging 
GmbH, Germany). 
4.2.3 Methods 
4.2.3.1 Bioink stock formulations 
To characterize the aHSF hydrogels, stock blends of TA-PEGDA were prepared. 
The bioinks were prepared by blending polysaccharide concentrations that delivered the 
optimal bioprinting conditions (0% thickening agent, 4% xanthan gum, 7% alginate and 
10% carboxymethylcellulose), selected edge values of PEGDA (8% and 14%) and 0.05% 
LAP as shown on Table 13. This was followed by the addition of an aliquot of 0.200 mL 
of aHSF (25 mg/mL) and 0.005 mL of the E. coli bacterial cell solution (OD600=0.8).  
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Table 13. Stock formulations for the hydrogel constructs to be analyzed. 
Repetition 
Thickening Agent 
Thickening Agent 
Percentage 
PEGDA 
Percentage 
Protein 
Percentage 
Ampicillin (µg/mL) LAP Cells 
1 None 0.00% 8.00% 20.00% 60 0.05% 5.00% 
2 Xanthan Gum 4.00% 8.00% 20.00% 60 0.05% 5.00% 
3 Alginate 7.00% 8.00% 20.00% 60 0.05% 5.00% 
4 Carboxymethylcellulose 10.00% 8.00% 20.00% 60 0.05% 5.00% 
5 None 0.00% 14.00% 20.00% 60 0.05% 5.00% 
6 Xanthan Gum 4.00% 14.00% 20.00% 60 0.05% 5.00% 
7 Alginate 7.00% 14.00% 20.00% 60 0.05% 5.00% 
8 Carboxymethylcellulose 10.00% 14.00% 20.00% 60 0.05% 5.00% 
 
4.2.3.2 HSF based PEG hydrogel properties 
4.2.3.2.1 Network composition of hydrogels determined by TGA 
TGA was performed to obtain information on the composition of the HSF-based 
hydrogel scaffold. Methods used to determine the quantity of water that is being held by 
a hydrogel scaffold has been described before.249 However, we purposely used TGA to 
determine matrix composition and total amount of water in the sample. The sample was 
blotted over a tissue paper, followed by the extraction of a piece that was going to be 
placed in the sample cup. The average mass of the sample was 15 mg. Each sample was 
heated from 30-600 °C at a rate of 5 °C min-1 under a 50 mL min-1 N2 flow. The final 
temperature was held for 20 minutes to guarantee that the sample had been fully 
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degraded. Subsequently, the first derivative of the network percentage with respect to the 
temperature was plotted using a spline-smoothing algorithm. To identify the peaks of the 
spectrum, the “peakfinder” function from Pracma, an R Studio package from CRAN was 
used to determine the amount of bound water (findpeaks(Dataset,npeaks=6, 
minpeakheight = 0.0002, sortstr=TRUE, minpeakdistance = 500)). 
4.2.3.2.2 Swelling and Sol-gel studies 
The swelling studies were carried out employing an approach previously described 
by Chavda et al.236 This strategy used dried hydrogels to determine their equilibrium-
swelling ratio in distilled water. To obtain Md, the hydrogel was lyophilized during 24 hours. 
Once dry, the weight was recorded. Then, it was immersed in excess of distilled water for 
swelling during 24 hours to guarantee hydration. The swollen hydrogel was put on an in 
lab designed grid, allowing a simple handling of the hydrogels in water while not altering 
the mechanical integrity. The hydrogel was removed from water; blotted using a tissue 
paper to remove the excess water and then weighed to record Ms. To analyze the 
variation of the swelling capacity, a spectrum of hydrogels encompassing a range of 
PEGDA concentrations of 8%,10%,12%, and 14% and an increasing amount of protein 
concentrations, 0, 5, 12.5, 20 mg/mL (Table 14) were weighed. 
 
 
 
 
 138 
Table 14. Prepared HSF-based hydrogels for swelling studies. 
 Amount of aHSF (mg/mL) 
PEGDA 
(%) 
0 mg/mL 5 mg/mL 12.5 mg/mL 20 mg/mL 
8% 1 2 3 4 
10% 5 6 7 8 
12% 9 10 11 12 
14% 13 14 15 16 
 
Hydrogel swelling studies were carried out to have a better understanding of the 
physical properties of the HSF-based hydrogels. To accomplish this, a 9-well plate was 
used to guarantee that all the hydrogels would have the same size and exposure to the 
UV-light. 
 
Figure 36. Designed nine plate well to guarantee gels with 12 mm wide, 12 
mm long and 2 mm thick using the blender 2.76 program. 
 
 
 139 
4.2.3.2.3 Cargo release through the HSF channels 
The aHSF-based hydrogels were evaluated by measuring the rate at which ferritin 
subunits released their cargo through the inter-subunit channels. Two conditions were 
evaluated. First, the protein concentration was evaluated by testing a range of modified-
HSF concentrations (0-20 mg/mL) at different ranges of PEGDA concentrations (8%-
14%). Secondly, the effect of the polysaccharides was evaluated by fixing the modified-
HSF concentration at 20 mg/mL, changing hydrogel composition (0% TA, 4% XG, 7% 
alginate and 10% CMC) at different PEGDA concentrations (8%-14%). To do so, 0.200 
mL of each bioink was polymerized under UV light to generate the hydrogel constructs. 
The release of Fe2+ through the protein channels followed a procedure described by 
Jones et al. using ascorbic acid to facilitate the entry through the hydrophilic channels, 
followed by reduction of the Fe3+ core.237 Fe2+ was released from the cage protein by 
immersing the hydrogel scaffolds in an ascorbic acid solution (1.5 mM in 0.1 M citric acid 
buffer, pH 3), then a 50 µL aliquot was extracted every hour for 8 hours. During these 
experiments, the gels were placed in a shaker. The rate of diffusion was monitored using 
a spectrophotometer which was employed to detect the o-phenanthroline Fe2+complex at 
510 nm, as described by Vogel et al., and then, this data was correlated to the initial 
ferritin concentration.250  
A Sohxlet extraction apparatus was used during 48 hours to remove unbound 
ferritin from the hydrogel network (condenser temperature: 5 °C, evaporation 
temperature: 50 °C, and vacuum).  
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4.2.3.2.4 Cargo release by declustering of the HSF cage protein 
The declustering potential of the HSF-based hydrogels was evaluated by 
measuring the rate at which ferritin subunits released their cargo under declustering 
conditions. A sample (0.200 mL) of each bioink was polymerized to generate the hydrogel 
constructs (~4 mg of modified protein). The declustering potential was studied in two 
stages. During the first stage, six 0.200 mL samples of HSF-based bioink (20 mg/mL of 
a 2 modified lysine per HSF, 20% PEGDA, 0.05% LAP) were polymerized under UV light 
to fabricate the hydrogel scaffolds. In addition, each scaffold was later immersed into one 
of the following declustering/denaturing conditions: a) 2% SDS, 6 M guanidine HCl and 9 
M urea in 1 M acetate buffer pH 3 pH;  b) 50% DMF, c) 100 °C, and d) extreme pH, with 
HCl (1 M).251 The second stage was used to analyze the influence of PEGDA 
concentration on the declustering capacity. Samples (0.200 mL) of the aHSF-based 
bioink (20 mg/mL 2 acrylated lysine residues per HSF, 0.05% LAP) ranging between 8%-
14% PEGDA were evaluated under a) 1 M acetate buffer pH 3,  b) 100 °C, c) HCl (0.1 M) 
and d) HCl (0.01 M). A control gel was set for each stage to analyze the maximum amount 
of Fe+2 stored in a sample. One HSF-based construct was immersed into 2 mL of an iron 
reducing solution (1% NH₂OH, 1 M acetate buffer, pH 3) for 24 h. Later, an aliquot of 50 
µL from the leachate was mixed with 50 µL of NH₂OH, 400 µL of an acetate buffer (1 M, 
pH 3) and 500 µL of O-phenanthroline solution (1% in ethanol) and measured. 
A Sohxlet extraction apparatus was used during 48 hours to remove unbound 
ferritin from the hydrogel network (condenser temperature: 5 °C, evaporation 
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temperature: 50 °C, and vacuum). The rate of declustering was measured by the release 
of Fe3+ ions every 60 minutes for 8 hours at 510 nm. The samples were stirred before 
sampling to homogenize the solutions (Fe3+ ions) and monitored using o-phenanthroline, 
as described by Vogel et al., and then, this data was correlated to the initial ferritin 
concentration.250  
4.2.3.2.5 SEM studies 
The porosity and the structure of the hydrogels were analyzed by SEM in order to 
ensure that hydrogels retain their structure. aHSF-based hydrogels were prepared by the 
photopolymerization of aqueous mixtures of 700 Da PEGDA and varying levels of TA (7% 
alginate, 10% carboxymethylcellulose, 4% xanthan gum and no thickening agent). Four 
distinct precursor solutions were prepared in dIH2O, each containing 8 or 14 wt % total of 
polymer (PEGDA). A photoinitiator consisting of a 0.5 wt % solution of LAP was added to 
each precursor solution at 10 μL/mL. All samples were polymerized by 6 minute exposure 
to longwave UV light (≈1 mW/cm2, 405 nm). The samples were pre-frozen a -20°C using 
dry ice and then they were cut to expose their inner structure. They were then placed on 
the SEM chamber and analyzed using low vaccum mode, 30 kV electron beam, 3.0 spot 
size, using 2.0 mbar. The porosity was evaluated by processing captured images and 
analyzing them by Image J software using particle count values. The script is provided in 
Appendix I.  
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4.2.3.3 Cell growth conditions 
Cell cultures were grown in Luria-Bertani (LB) broth (1% w/v tryptone, 0.5% yeast 
extract, 0.5% NaCl, pH 7.4 with NaOH), supplemented with ampicillin at a concentration 
of 100 µg/mL. To express the E. coli mutant His-tag GFP-S65T a starter culture was 
inoculated and left shaking at 37 °C overnight. When the OD600 reached 1.0 O.D. the 
samples were taken and used for the hydrogel constructs. 
4.2.3.4 Evaluation of the effect of growth media on E. coli casted bioink scaffolds 
The efficiency of the bacterial growth was measured for bioinks described in 
section 4.2.3.1 by casting 200 µL of each bioink into a CultureWell16 chambered cover 
glass and copolymerized for 10 minutes at 25 °C by exposure with a 405 nm wavelength 
(λ) lamp (Light power = 10%, I0= 10mW/cm2). The samples sets (n=4) in a CultureWell 
were supplemented with 200 µL of a different growth media (two growth media: LB and 
M9; two levels: with or without 0.5 mM of  IPTG). Each sample was measured by confocal 
microscopy at 3, 76 and 178 hours as described in section 4.2.3.6. 
4.2.3.5 Casted and bio bioprinted scaffold effects on E. coli growth 
The difference between bacterial growth on casted versus bioprinted scaffolds was 
measured for the bioinks described in section 4.2.3.1. For the casting hydrogel scaffolds, 
the procedure described in section 4.2.3.4 for LB was measured. For the bioprinted 
scaffolds, the bioprinter was placed in a type II laminar flow hood and sterilized using a 
UV light overnight. The bioink (1 mL) was loaded into a 10 mL Luer-Lok syringe and 
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placed in the bioprinter for the scaffold fabrication. The pressure was adjusted according 
to Table 10 and the model was bioprinted (13 layers, 0.8x0.8x0.2 cm3) for each sample 
on a 1.5 cover glass and copolymerized for the duration of the bioprinting at 25 °C. The 
scaffolds were placed in a 4 mL Petri dish with 2 mL of LB media. Each sample was 
blotted with a Kimwipe (Kimberly-Clark, Dallas, TX), placed on a clean 1.5 cover glass 
and read by confocal microscopy at 3, 76 and 178 hours as described in section 4.2.3.6. 
4.2.3.6 Cell-laden hydrogel imaging acquisition 
A z-stack of images (n = 15 per sample for a 50 µm cross-section), standardized 
to image through the entire thickness of the sample, was captured through the 
microscope slides using a resolution of 512 × 512 pixels via a 20× Dry lens, 1% laser 
output using the 488 nm and a pinhole of 1 AU. 
4.2.3.7 Cell-laden hydrogel imaging processing 
 Images were processed using ImageJ software using the script shown in 
Appendix J, where Z-stacks were compressed into one image using maximum intensity 
and subsequently subtracting the background. Later, images were converted to RGB 
using the ImageJ Cell Counter plugin and a scale was added. Viability was determined 
by counting the number of live cells determined by the presence of mutant-GFP cells. 
4.2.3.8 Statistical Analysis 
Comparisons between multiple samples were performed with single factor analysis 
of variance (ANOVA) with post hoc Tukey analysis was performed to determine statistical 
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significance in declustering experiments between Iron concentration vs PEGDA 
concentration (Appendix E). It was also used to determine statistical significance between 
groups in the bacterial cell viability data. All data are shown as mean ± SEM, with n = 4 
for declustering experiments and n = 3 for cell viability data. All graphs were plotted using 
R studio software. A p-value of less than 0.05 was considered statistically significant. 
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4.3 Results and Discussion 
4.3.1 aHSF Hydrogel Properties 
4.3.1.1 Network composition of the aHSF hydrogels 
The thermal stability of the hydrogels and starting materials were characterized by 
TGA to determine the effect of aHSF concentration on the hydrogel networks (Figure 37). 
For the hydrogel formation the aHSF was subjected to PEGylation, in order to investigate 
the development of these biopolymers as interesting materials.252 To establish a chemical 
fingerprint, the thermo-gravimetric transitions of the raw materials were measured. A 
narrow transition peak was found for Alginate (230 °C), xanthan gum (300 °C), and 
carboxymethylcellulose (320 °C); nonetheless, aHSF showed a broad distribution with a 
maximum at 380 °C. Furthermore, the PEGDA thermal transition is a two-peak signal in 
the range of 360-480 °C.  
Likewise, the influence of the PEGDA ratio with the TA was investigated by 
comparing the thermal stability of the hydrogels having different molar ratios of PEGDA 
to TA. To elucidate the influence of the PEGDA, the thermal stabilities of hydrogels 
containing only PEGDA as the synthetic polymer were also studied and compared with 
the thermal stability of the hydrogels with different ratios of PEGDA/TA (7% Alginate, 4% 
XG and 10% CMC). The evaluated samples showed a rapid weight loss below 180°. This 
first degradation process could be assigned to the bound and unbound water that is held 
inside the hydrogel network (90 %, Appendix G). Subsequent weight loss is observed 
between 180 °C and 360 °C due to the decomposition of the TA matrix. It was intended 
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to use TGA analysis to quantify the amount of aHSF that was bound to the hydrogel after 
extensive washing of the hydrogel scaffold. However, the signal that was expected at 380 
°C for aHSF was overlapped by the degradation of the PEG matrix. Hence, it was possible 
to use this analysis to show the stability of the polymeric matrix up to 280 ºC, but it was 
not useful to determine the aHSF concentration. Furthermore, the last step in the 
degradation profile for each sample is most distinct in higher concentrations of PEGDA. 
Understanding the impact of PEGDA concentration on these melts is beneficial because 
Mazzoccoli et al. reported a negative correlation between PEGDA weight percent in a 
hydrogel with cell viability when the PEGDA concentration surpassed 20% w/v .105 
Furthermore, it has been reported also that an increment of the PEGDA chain length will 
favor an increase in the network stability due to an increase in crosslinking density.253 The 
analysis of the melt gave a residual mass at 600 °C of 1.3 %, which corresponded to the 
iron oxide cores of the protein. The melt decomposed at 430 °C, compared with aHSF. 
Perryman et al. previously reported that aHSF-based hydrogels decompose, leaving 
behind 1% of inorganic matter.88  
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Figure 37. Thermo-gravimetric profile of PEGDA Mn 700 variation in aHSF-
PEGDA hydrogels prepared with different TA. 
4.3.1.2 Swelling potential of aHSF-based hydrogels 
The swelling ratio of hydrogels is a property that defines the amount of water that 
a scaffold can hold, therefore it is linked to the ability of a scaffold to foster cell viability. 
Effects of the protein concentration on the aHSF constructs were studied by swelling 
cycles as described in section 4.2.3.2.1. The measurement of the swelling was made 
immediately after the polymerization was carried out, then it was followed by freeze-drying 
at -40 °C to calculate the degree of swelling using the equation in section Equation 4. 
Swelling tests showed an inverse correlation between increasing the amount of aHSF 
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and the amount of swelling capacity that the aHSF-based hydrogel has (72 lysine 
residues per subunit). A possible explanation could be that the modified ferritin has a 
lower cross-linking density than a pure PEGDA hydrogel. In addition, a protein-based 
hydrogel would have no ether groups but amino acids with negatively charged 
carboxylate groups such as Glu and Asp, at pH 7.4, which should increase the amount of 
water that could be absorbed by the hydrogel.254  
 
Figure 38. Protein concentration effect on aHSF-based hydrogels. 
The characterization of the swelling behavior as a function of the concentration of 
aHSF in the hydrogels with no TA (Figure 38) showed that at low aHSF concentration the 
swelling potential of hydrogels remained similar. However, the method itself presented 
some variations that accounted for the large error for each measurement. In general, the 
samples were blotted over a tissue paper, which might account for those differences. 
Instead, the samples were measured using TGA as described on section 4.2.3.2.1, which 
gave a repeatable result for swelling. For the TGA analysis, the samples were equilibrated 
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for 24 hours in PBS buffer (0.1 M, pH 7.4) to guarantee that the samples were fully 
hydrated. This represented an increase of 10% for water an aHSF hydrogel can hold. 
Furthermore, two trends may be observed. First, an increase in the amount of PEGDA in 
the hydrogels, results in a decrease of the bound water to the aHSF-PEGDA scaffold. 
Second, TA hydrogels have an increased swelling ratio. This behavior is more prone on 
CMC-based networks perhaps due to the fact that CMC has a large electronic repulsion 
of carboxyl groups within the polysaccharide network.255 It was also shown that XG 
presents a large variation on the swelling ratio. This can be explained by the tangling 
between the PEGDA strands and the XG strands. It was previously shown (Figure 12) 
that XG has the largest repeating unit in comparison with the other TA. This repeating 
unit entangles with the PEGDA strands. While larger mechanical strength is achieved by 
higher entanglement of the strands, less water appears to be held inside the hydrogel 
construct. Furthermore, the hydration level was controlled by the TA of choice, as shown 
in Figure 39. 
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Figure 39. Swelling of PEGDA Based Hydrogels by TA (Appendix G). 
4.3.1.3 Fe2+ diffusion through the channels of a loaded aHSF embedded into the hydrogel 
network 
The synthesized scaffold containing a capsule protein provides a host component 
that might offer opportunities for controlled cargo release. One key element is to use the 
intrasubunit channels to extract a desired material. A direct correlation between the 
amount of guest that is loaded into the aHSF hydrogel and the diffusion time of Fe2+ could 
be plotted to determine the diffusion coefficient of a given guest within the hydrogel (D). 
A different approach to measure diffusion is to measure the penetration of a substance in 
a hydrogel network. Such studies have been done in polyacrylamide hydrogels that were 
photo patterned.256 To determine the extent of the penetration into the hydrogels, 
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fluorescent solutes were flowed into specific channels and monitored using a camera 
while making note of the absorption of the gels over time.  
 In the present investigation, the ferritin is loaded with solid iron(III) hydrate cores, 
which can be released by the use of reducing agents to release Fe2+ which could diffuse 
through the aHSF hydrogel network and be monitored. Iron release from ferritin cages 
has been successfully achieved, as previously discussed, by the use of nicotinamide 
adenine dinucleotide-flavin mononucleotide (NADH/FMN) as a reducing system from the 
Fe3+ to Fe2+. The system presents the advantage of being able to be measured using a 
spectrophotometer. Where oxidized nicotinamide (NAD+) absorbs strongly at 260 nm, 
and the reduced nicotinamide (NADH) compound absorbs strongly at 340 nm (16,900 
M−1cm−1).257 Another method was proposed by Vladimirova et al. using a potentiometric 
titration of the release of Fe2+ with the aid of potentiometric titration using Ce4+ as an 
oxidizing titrant.258 However, we envisioned that the best method to do the release of the 
iron cores was to utilize an ascorbate solution in an acidic buffer with the determination 
of the released Fe2+ by formation of its o-phenanthroline complex with measurement at 
510 nm.237 During the experiments, it was necessary to guarantee that swelling 
equilibrium was achieved, because the hydrogel water content will affect the release 
profile. This behavior occurs because water in the matrix is the medium through which 
cargo will diffuse. Water content and swelling are obviously related as both are dependent 
on the amount of water the hydrogel can uptake when hydrated and thus should 
demonstrate similar trends.226 
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Furthermore, it was necessary to wash each hydrogel sample to guarantee that 
the measured iron corresponded exclusively to encapsulated iron release. The exposure 
of aHSF to UV light could adversely affect the stability of the protein as demonstrated by 
the reduction in activity of some enzymes when exposed to UV light.226 Increasing the 
PEGDA concentration in hydrogels resulted in a decrease of D within the hydrogel, as 
shown on Figure 40. Furthermore, as stated by Mellot et al. the addition of PEGDA will 
create a more highly crosslinked hydrogel network which will physically allow less water 
to diffuse in the hydrogel, thus resulting in a lower iron diffusion from the aHSF cores.226  
 
Figure 40. HSF concentration dependency on Fe2+ diffusion of aHSF PEGDA-
based hydrogel networks 
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The diffusion rates for PEGDA hydrogels have been characterized for materials 
that have been loaded previously in the hydrogel matrix. Usually the values reported for 
dextran diffusion in 4-6% of PEGDA 10000 are close to 0.1x10-5 cm2/s.256 For BSA in 10-
20% PEG 2500 values are on the order of 1x10-7 cm2/s.94 In the case for the iron diffusivity 
measured for our aHSF network, the obtained values for no TA aHSF-hydrogels are on 
the order of 4x10-11 cm2/s. Furthermore, as represented on Figure 41, as the TA weight 
percentage increases, there is an increase in D. This behavior favored the reducing agent 
penetration, which as a result gave rates on the order of 1x10-10 cm2/s. It has been 
reported that alginate hydrogels present the disadvantage that they can complex with 
Fe2+, which in turn can affect the diffusion of divalent ions from the aHSF-PEGDA-alginate 
hydrogels.259 However, our findings suggest that the diffusion of Fe2+ is favored with the 
alginate hydrogels due to the fact that it presented the highest diffusion rates from the 
aHSF-hydrogels studied. 
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Figure 41. PEGDA concentration dependency on Fe2+ diffusion from HSF 
bioconjugated PEGDA-Based hydrogels for A) CMC, B) XG, C) ALG and D)NTA 
(Data shown in Appendix F). 
4.3.1.4 Fe3+ release from a loaded aHSF embedded into the hydrogel network by cage 
declustering 
The purpose of the development of the bioink was to exploit the cage protein 
capabilities in a printed hydrogel. One well-known capability that can be harnessed is the 
declustering potential of the 24-mer to release a cargo of interest. This behavior has been 
studied with HSF in solution by Sutisansanee et al.24 There is no study, to our knowledge, 
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that involved the study of the protein declustering within a hydrogel network. To 
understand mass transport within PEGDA hydrogels, Lee et al. stated that large 
macromolecular solutes do not penetrate hydrogel networks easily.256 More in depth, 
there is a threshold value of mesh size for PEGDA hydrogels on which a solute (e.g., a 
large protein such as ferritin) that is encapsulated within a hydrogel network will not be 
able to diffuse into the network due to restrictive entanglements with the hydrogel 
network. PEGDA hydrogels (Mw 575−20000) have mesh sizes less than 0.1−10 nm, 
respectively.260  
The first approach in our current investigation was to select an appropriate method 
to understand the cargo release from the hydrogels. Traditionally, the release of cargo 
from hydrogels was measured using dextran-fluorescein isothiocyanate solutions. 
Theoretically, it could be possible to encapsulate dextran ( Rh <4 nm) within a ferritin 
protein cage.261 However, It has been shown that for diffusive studies the dextran-
fluorescein isothiocyanate molecule has a negative behavior because it is a linear and 
flexible polymer, which behaves differently than globular substrates.94 To our benefit, 
aHSF has loaded iron cores, which can be quantified using a colorimetric assay with non 
complexating buffers such as MES or MOPS (0.1-1 M).189 Therefore the method 
employing the o-phenanthroline/Fe2+ complex was selected.  
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Figure 42. Coarse-declustering profiles of bioconjugated HSF in PEGDA 
networks for denaturing conditions. 
The analysis was carried out in two stages. In the first stage (Figure 42) aHSF-
PEGDA hydrogels were immersed in high concentration of declustering agents to to 
determine the critical factors required for cage declustering. In the second stage (Figure 
43), the aHSF-PEGDA hydrogels were to be immersed in lower concentrations of the 
chaotropic solutions that showed declustering behavior in the first stage. From the first 
stage, it was shown that as expected, the declustering in 1.0 M HCl solutions is noticeable 
(127 mg L-1 min-1). Heat treatment in acetate buffer (1 M, pH 3) revealed a 5-fold reduction 
of the declustering rate (26 mg L-1 min-1), and high salt concentration presented a 10-fold 
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reduction of the declustering rate in comparison with HCl with 9 M urea solution (10.9 mg 
L-1 min-1) and 6 M guanidine-HCl (9.8 mg L-1 min-1). However, high organic solvent 
percentage and detergent concentrations of SDS 20% did not showed declustering 
potential. 
Low pH provided the best conditions to decluster an aHSF hydrogel. However, the 
pH is unfeasible for biomedical applications, although could be useful for non-medical 
applications. To decluster the aHSF hydrogel, the temperature used was 100 °C, 
temperature at which the cargo was released. This is promising for the use of aHSF 
thermal sensitivity for rapid drug release using thermal ablation temperature ranges.255 
Finally, high salt concentrations revealed a change among the aHSF interactions. It has 
been reported that high concentrations of urea can cause partial opening of aHSF 4-fold 
channels through localized unfolding of this protein while keeping its shell-like structure.90  
In the second stage, four conditions were analyzed to study milder conditions for 
the aHSF hydrogel. It was shown, that low pH is still the most efficient way to decluster 
the capsule protein. However, as the HCl is decreased to 0.1 M there is a 25-fold 
decrease in the rate of declustering and even further when the HCl concentration is 
decreased to 0.01 M. Finally, heat treatment (pH 7) and acetate buffer (1.0 M, pH 3) gave 
the lowest declustering ratio. 
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Figure 43.Detailed-declustering profiles of bioconjugated HSF in PEGDA 
networks. 
4.3.1.5 Porosity studies on aHSF hydrogel networks 
SEM was used to examine surface morphology and the internal structures of the 
hydrogel constructs. In the early stages of the research, the samples were lyophilized for 
24 hours and then they were cut to expose their inner structure. This was followed by 
placing the slides in the SEM chamber and analyzing these slices using high vacuum, 10 
kV electron beam, 1.0 spot size, using 0.2 mbar conditions. However, no apparent 
network was identified from these experiments. The hydrogels formed a smooth film due 
 159 
to collapse of the network. This behavior has been reported previously in the literature for 
preparation of samples for imaging PEGDA hydrogels. 
 
Figure 44. SEM image of a 20% PEGDA-aHSF hydrogel (400-µm image 
recorded in ESEM mode, high vacuum, 30 kV) 
Therefore, it was hypothesized that wet samples were needed to structurally 
preserve the hydrogel network. In the literature, environmental secondary electron 
detector (ESED) or gaseous secondary electron detectors (GSED) are used to analyze 
wet samples, in combination with low temperatures, H2O vapor rich atmosphere and low 
laser power.263 The hydrogels were frozen at -20 °C and kept at that temperature until 
they were measured. Once measured the hydrogels showed a random honeycomb 
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network structure, which was not observed when freeze-dried gels were analyzed (Figure 
45). 
 
Figure 45. Images for A) 100 µm image recorded in ESEM mode, low vacuum 
and 30 kV, and B) Negative threshold pore identification by the ImageJ software for 
porosity determination. 
To analyze the pore size distribution, a script was developed using ImageJ, 
threshold values, object counter and the particle analyzer as shown in Appendix I. The 
images were acquired using the ESEM detector and the backscatter detector (BSD).  
Interestingly, as previously mentioned, pure PEGDA hydrogels (Mw 575−20000) have 
mesh sizes less than 0.1−10 nm, respectively.260 This pore size is not suitable for cell 
viability due to the prevention of cell migration. Therefore, it was of interest to determine 
the effect of the polysaccharides in the pore size of the hydrogels constructs. 
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Each sample was imaged using the regular ESEM detector and the BSD. A 
variation is observed and the lowest mean pore value for 7% CMC hydrogel with 14% 
PEGDA is 39.6±3.0 µm, which is significantly higher than the reported values for PEGDA: 
Furthermore, the CMC pore size varies significantly. Barbucci et al. reported a pore size 
distribution change (15-90 µm) when the CMC weight percentage is increased by 1% in 
hydrogels.255 Alginate showed mean pore sizes of 125.1±5.0 µm in agreement with what 
has been reported for alginate mean pore size (20-250 µm) in the literature.264 This 
observation suggests that the pore size is dominated by the polysaccharide content. As 
the polysaccharide content is increased there is a decrease in structural strength; 
hydrogels containing higher than 12% TA did not form. Therefore, further improvement in 
the porosity of aHSF-PEGDA hydrogels by using polysaccharides is limited. It was 
observed that the incorporation of TA acted as a porogen, which increased the pore size 
and facilitated structural integrity of the hydrogels. 
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Figure 46. Pore size dependency of HSF-PEGDA based hydrogels on the 
presence of thickening agent. 
It was shown for hydrogels, which do not have TA present into the construct, that 
the greatest error is due to fast H2O evaporation. Therefore, it was challenging to acquire 
repeatable results when lower TA concentrations were evaluated using SEM due to low 
water retention. To reduce the effects of the H2O evaporation, it might be possible to 
substitute the solution with low-vapour-pressure liquids allowing SEM examination of 
infiltrated samples.265 
 163 
4.3.2 E. coli growth on aHSF hydrogel networks 
To check the feasibility of the proposed hydrogel system, it was decided to 
investigate the encapsulation of bacterial cells by the hydrogel combinations selected in 
Chapter 3 and to bioprint these employing our visible light bioprinting system. The total 
fabrication time for PEGDA blends with 10% CMC, 7% Alg and 4% XG was about 15 
minutes per 0.7x0.7x0.2 cm3 construct. As a result, to guarantee an excellent bioprinting 
process with an adequate cell viability and good bioprinting fidelity a thorough 
optimization was undertaken.266  
Traditionally, to determine cell viability following encapsulation, a Live/Dead 
staining assay is used.  Its functionality allows one to count the live (staining green) and 
dead cells (staining red) in every experimental condition. Furthermore, the samples are 
imaged multiple times in random fields with a desired thickness to guarantee that a 
representative sample has been acquired.225 However, there was an interest to exploit 
the properties of the E. coli mutant His-tag GFP-S65T cell lines available in the laboratory 
in order to have a reference fluorescence signal confirming that we were imaging cell 
growth inside the hydrogel construct. The His-tag GFP-S65T variant allowed for a 
controlled expression of the protein enabling imaging of cells in the green channel. We 
characterized the unseeded cell hydrogel scaffold and the cell seeded hydrogel.  In this 
case, the cells were not selected to eliminate the untransfected cells, allowing us to 
visualize different levels of expression. 
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A preliminary assay was made with hydrogel constructs to evaluate the 
sedimentation profile. A 124.0 µm cross section of an 8% PEGDA-aHSF hydrogel with a 
cell density of 2.5x104 cells cm-3 was imaged using a confocal microscope at the 
maximum excitation/emission spectra of the GFP-E. coli cells at 400nm/460 nm. It was 
shown on Figure 47 that cell distribution was uniform. This allowed us to detect the cell 
attachment in the hydrogels by fluorescence imaging.  
 
Figure 47. Qualitative assessment of GFP-E. coli growth on 124.0 µm cross 
section of aHSF-8% PEGDA-Based hydrogel construct. 
The purpose of blending hydrogels with cells is to protect the cells from the shear 
force generated in the bioprinting process while maintaining their biological functions.231 
As mentioned in Chapter 3, these hydrogels modulated the viscosity and printability of 
these bioinks. In general, high viscosity bioinks offer excellent printability and shape 
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fidelity with the drawback of low cell viability. In contrast, low viscosity bioinks have an 
enhanced cell viability with a collapsed 3D structure as printed in a layer by layer 
process.147 Furthermore, bioinks undergo a non-Newtonian behavior while bioprinting 
(e.g., shear thinning, yielding, or shear thickening) therefore; the effectiveness of the 
resulting construct will be very dependent upon material rheology regarding both 
printability and bioprint quality. As a result it was necessary for us to try to understand the 
differences in cell growth within the hydrogel scaffolds. 
4.3.2.1 E. coli growth on PEGDA-based scaffolds 
As previously mentioned, cell-loaded bioinks are subject to cell-bioink interactions 
while direct bioprinting. Therefore, it is important to control three aspects when pneumatic 
or piston driven direct-write bioprinting is employed: (A) cell sedimentation, which can 
lead to inhomogeneous cell distribution and needle clogging; (B) changes in the flow 
profiles which can disrupt the cell membrane; and (C) the curing conditions, which 
compromise cell viability by dehydration or exposure to crosslinking reagents.99 
To analyze matrix’s impact on cell growth, an encapsulation of E. coli was made 
in PEGDA-based hydrogels. It was also desirable to determine the feasibility of the His-
tag GFP-S65T variant as an imaging probe in the system. Four factors were selected to 
analyze the hydrogel system behavior:  cell density, influence of PEGDA weight 
percentage, presence of aHSF and addition of a protein expression promoter (IPTG). 
Encapsulation of bacterial cells has been previously reported, where it was stated that 
hydrogels used for E. coli bioprinting required low pore sizes to prevent the escape of the 
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cells from within the gel (2.0 μm).267 A decrease of the pore size of low cross-linked 
materials (pore size > 40.0 μm) was achieved by adding a second polymer to the network, 
which increased the matrix entanglements (e.g., bacterial cellulose 8.4 ± 2.5 μm 
decreases the pore size to 1.0 μm once silk fibroin is added).267  
Hydrogel stiffness can affect cell spheroid viability and growth rate. Therefore, it 
was clear that there is a correlation between network structure of the cell-laden PEG-
based hydrogels and PEGDA concentrations. Furthermore, when assessing cell 
arrangements inside hydrogel constructs, it has been reported that, within non-adhesive 
soft materials such as agarose and unmodified PEG hydrogels, the cells aggregate into 
multicellular spheroids over time.268 An incremental increase in PEGDA concentration 
results in an increase in crosslinking within the hydrogel. However, there was no apparent 
difference on cell viability for the hydrogel constructs if the PEGDA percentage was 
increased from 8% to 14%. This behavior suggested that the pore size was successfully 
reducing cell migration from the hydrogel construct due to close crosslinking of the 
polymer network. Furthermore, there is no clear evidence that aHSF had the potential to 
increase the pore size of the hydrogel construct. 
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Figure 48. Evaluation of the effects of PEGDA concentration on cell density 
of a 1.25x105 cells cm-3 hydrogels construct immersed in LB with 0.5 mM of IPTG 
for 96 hours. 
 With respect to cell density, four concentrations were evaluated (5.0 x 103, 
2.4x104, 1.25x105, and 2.5x105 cells cm-3). Nonetheless, the lowest cell density gave 
inconsistent results throughout the analysis. As a result, it was determined to exclude 5.0 
x 103 cells cm-3 concentrations for the cell probing capabilities of E. coli cells within the 
hydrogel constructs. It is evident in Figure 49 that as a higher concentration of cell 
colonies were added to a bioink, more cell colonies were going to be detected. However, 
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it was unexpected to see no marked change in the number of cell colonies within the 
same concentrations over a range of 96 hours. It was difficult to successfully address 
cells that are migrating inside the hydrogel networks within the same cell density. In fact, 
on panel B of Figure 49, the 25 µL aliquot (1.25x105 cells cm-3) showed no apparent 
change over 96 hours. To support this lack of change, the same behavior was observed 
for the 5 µL aliquot (2.4x104 cells cm-3) on the same panel, where no clear trend was 
observed. In terms of cell identification capabilities, constructs that were immersed in 0.5 
mM IPTG solution seem to be more consistent for cell identification. This could be 
attributed to the overexpression of GFP inside the E. coli cells, which would increase the 
intensity of the detected cells as measured by using confocal microscopy. Conversely, 
the overall cell growth was not successfully monitored by measuring the mean cell count 
that was growing inside a hydrogel construct. It was hypothesized that, hydrogel pore size 
might prevent the migration of the E. coli cells; as a result, a better way to identify cell 
growth and viability was by correlating the cell count with the associated intensity of such 
cells in the hydrogel construct.   
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Figure 49. Evaluation of the effects on cell density (2.4x104, 1.25x105, and 
2.5x105 cells cm-3) for 8 % PEGDA hydrogels immersed in A) LB with 0 mM of IPTG 
and B) LB with 0.5 mM of IPTG. 
The intensity was plotted over time for the PEGDA-based hydrogel constructs as 
shown in Figure 50. The mean intensity was directly correlated with the presence of the 
GFP produced within each E.Coli cell; therefore, as the mean intensity increased, more 
cells should be located within the hydrogel construct. Furthermore, it was identified that 
the intensity of the spheroids within the hydrogel construct had a maximum fluorescence 
threshold for the selected window of the confocal microscope data (800 gain, 312 µm x 
312 and 1 au) of 60000 au µm-2 that accounted for the maximum mean fluorescence a 
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hydrogel construct could show. As shown in Figure 51, there is no clear explanation for 
rate at which cell intensity grew over time inside the hydrogel constructs. It was presumed 
that cell diffusion was restricted for the spheroids; therefore, the cell growth profile will be 
characterized for the spheroids volume. It has been shown, that there is no evident 
differentiation in the cell intensity depending on the PEGDA weight percentage in the 
hydrogel for 4 days. To support this statement, a similar characterization was made by 
Lee et al. These authors characterized cells in PEGDA networks during 20 days on which 
the intensity of the measured signal did not vary; however, the size of the spheroid 
dramatically changed over time.268 To verify that the spheroid volume changed over time 
in our cases, an assessment of the PEGDA casted hydrogels was made plotting spheroid 
volume over time (Figure 51). A decreasing volume over time was supported by the 
detection of fewer GFP fluorescence signals. The explanation for this phenomenon was 
attributed to the E. coli death inside the casted gels due to low nutrient and oxygen 
exchange. Furthermore, Steff et al. reported two possibilities that can cause reduced GFP 
fluorescence within cells. First, cytosolic acidification (pH decrease 0.4 U during the 
apoptotic process) which will degrade the protein. Second, the possibility that the redox 
changes that occurred during the apoptotic process reduced the access of molecular 
oxygen needed for the oxidation of Tyr66 to generate the chromophore complex.269 
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Figure 50. Time dependency for mean intensity versus cell colonies count 
for PEGDA hydrogels (Red: without protein and Blue: with protein) immersed in A) 
LB with 0 mM of IPTG and B) LB with 0.5 mM of IPTG. 
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Figure 51. Time dependency for mean volume for PEGDA hydrogels (Red: 
without protein and Blue: with protein) immersed in A) LB with 0 mM of IPTG and 
B) LB with 0.5 mM of IPTG. 
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4.3.2.2 Effect of the delivery of the bioink 
Three-dimensional bioprinting is a promising technique to deliver cell seeded 
bioinks; however, bioprinting is not only about structurally functional constructs, but also, 
these constructs need to foster normal functioning of the cells. Zheng et al. has reported 
that is difficult to obtain a homogeneous distribution of cells within a viscous hydrogel and 
subsequently into the scaffolds.270 This statement indicated that cells distribution within 
the hydrogels without damaging cells was challenging to quantify.  
To understand the impact of the bioprinting process for the hydrogel constructs, 
each bioink was bioprinted and compared to the results with a casted hydrogel. Both 
constructs were designed to have the same dimensions. When comparing each process, 
it was noticed that the layer-by-layer approach gave better curing to hydrogel constructs 
because it cures 0.150 mm at a time, allowing a better mechanical integrity in comparison 
with the casted gels in the press-to-seal silicon molds. Furthermore, it has been know that 
curing potential of a hydrogel is greatly influenced by the thickness of the layer that is 
being cured.271  
 In our experiments, all the bioinks were loaded with a cell density of 1.25 x105 
cells/mL. Furthermore, each hydrogel scaffold was required 0.2 mL per experiment. 
Therefore, it was a good approximation that each hydrogel construct had 2.50 x 104 cells. 
As previously mentioned, these hydrogels were cured by the actuation of a FRP under a 
405 nm wavelength. It has been reported by Vermeulen et al. that long exposure to 
radiation has a negative impact on cell survival and that it can be quantified using the 
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equation 𝑆 𝑆0⁄ = 𝑒
−2.3026𝑃2(𝜆)𝐷, where initial cell concentration (S0), final cell 
concentration(S), dose (D) and an effective wavelength (P2(λ)) were correlated to give an 
approximation of S.272  Furthermore, it is known that increasing solution viscosity results 
in a decrease of radical diffusivity, which can decrease cell mortality.273 This suggested a 
possibility that radical diffusivity affected the cell viability by radical species interaction. It 
was desirable to understand the effects of prolonged exposure of the printed scaffold 
under this wavelength. For all the constructs (bioprinted and casted) it was estimated that 
S was about 20% for a 12 minute exposure at an intensity of 10 mW/cm2 for a 405nm 
wavelength. 
Once the hydrogels were fabricated, they were immersed into the culture media to 
facilitate cell growth.  It was noticed that after 6 hours, especially for low PEGDA weight 
percentage, the hydrogel’s mechanical structure was compromised over time because of 
increased swelling. This behavior was more evident for CMC based bioprinted hydrogels. 
The CMC hydrogels are not as intricate as Alg- or XG- based hydrogels. Perhaps, the 
addition of biodegradable hydrophobic polymers could be done to enhance the 
mechanical properties of purely hydrophilic hydrogels. For example, Annabi et al. 
reported that the mechanical properties of natural bioinks fabricated by electrospinning 
were dramatically increased with the addition of 10% PCL without use of any chemical 
crosslinker.247 It was noticed that casted CMC gels have good mechanical integrity in 
contrast with the ones that were printed in a layer-by-layer fashion, suggesting that it 
might be useful to consider this bioink as one that could be used with the help of a 
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sacrificial mold and then casted into this mold. Once the hydrogels were incubated for 6 
hours, each sample was analyzed using CM and analyzed using ImageJ with the script 
provided in the Appendix J. 
 
 
Figure 52. Time dependency of the cell growth inside A) 
Carboxymethylcellulose 10%, B) Xanthan Gum 4% and C) Alginate 7% hydrogel 
constructs with and without aHSF. 
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As shown in Figure 52, the mean colonies count for the first measurement is below 
the values reported for casted PEGDA-based hydrogel constructs from section 4.3.2.1 
for 2.5x105 Cells/mL. The approximate values that were expected were of 200 mean 
colonies per 312 x 312 x 30 µm3 hydrogel construct. This difference was attributed to the 
fact that PEGDA-based bioink constructs are not as viscous as a TA-PEGDA-based 
bioink, making difficult the reduction of the particle spheroid size and a homogeneous 
distribution of them. Furthermore, because the TA-PEGDA-based hydrogels have 
increased pore sizes, it will facilitate cell diffusion from the hydrogel construct to the 
culture media, decreasing the signal measured with the CM. To our benefit, it was 
theorized that the presence of aHSF inside the TA-PEGDA-based hydrogels showed no 
alteration of the rate at which cells grew within the hydrogel construct. This could be 
harnessed by depositing an enhancing material of interest inside the cage protein to be 
released through its intrasubunit channels or by the declustering of the aHSF, as 
previously shown. 
In terms of cell proliferation, it seems, that because the pore size of the hydrogels 
are bigger, it facilitates the cell replication and the creation of new spheroids due to cell 
diffusion. However, there is not a clear differentiation among the casted and the printed 
hydrogel constructs. From the data shown in Figure 52 panels B and C for the bioprinted 
scaffolds, an assumption can be made on which the cell replication is increased due to a 
higher porosity gel being present. More so, this can be attributed to the interplanar 
spacing that occurs when the layers are printed one on top of each other.  
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To support the evidence of cell diffusion, as shown in Figure 53, for all the panels 
that the spheroid volume decreases over time.  This evidence appears to support the idea 
that cell migration is enhanced for TA-based hydrogels. Furthermore, the pore size order 
distribution, as shown on section 4.3.1.5 is Alg<CMC<XG. These observations are met 
by the Alg and XG hydrogels, where volume reduction is more distinct in XG hydrogels in 
comparison with Alg hydrogels. This trend is not followed by the CMC gels, because the 
mechanical stability of the gels were compromised, therefore it had more surface area 
exposed for cell diffusivity over time. 
However, the criteria for a suitable network remains unclear and should be 
evaluated in future studies involving cell proliferation and migration rates within these 
networks. Overall, it will depend upon the desired application. The thickening agent 
concentration ranges were selected due to previously determined limits in printability. The 
stability of a vascularization network within hydrogels also needs evaluation for the E. coli 
to survive sufficiently long for any future applications.  
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Figure 53. Spheroid volume change over time inside A) 
Carboxymethylcellulose 10%, B) Xanthan Gum 4% and C) Alginate 7% hydrogel 
constructs with and without aHSF. 
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4.4 Conclusions 
We successfully identified a series of obstacles for 3D bioprinting of aHSF-TA-
PEGDA based bioink. In terms of the bioink capabilities, it was extremely important to 
understand how the protein polymer conjugate behaved in terms of the cross-linking 
density, swelling properties, porosity and declustering potential. Furthermore, we 
developed these bioinks to facilitate the growth of His-tag GFP-S65T and be used as an 
imaging probe. It was shown that vascularization within the hydrogel constructs was 
critical to supply oxygen, nutrients and bioactive agents otherwise the His-tag GFP-S65T 
mutant was not suitable for cell viability studies. Furthermore, it was shown that the 
mechanism of hydrogel formation affects the way the cells grew inside these hydrogel 
constructs by the 3D bioprinting process. From the experimental results for particle and 
volume increase over time, a precise control of particle size and monodispersity were 
needed to guarantee an adequate use of the His-tag GFP-S65T variant as an imaging 
probe in the system. Our findings suggest that 14% PEGDA based bioinks with either 7% 
Alg or 4% XG will give the best printability with the highest cell proliferation capabilities. 
Furthermore, if it was desirable to minimize cell diffusion, while enhancing cell 
proliferation, and in order to take advantage of the host-guest interaction capabilities of 
HSF, the optimal bioink for bioprinting selected was found to be a 14% PEGDA, 4% XG 
based bioink with 0.1% aHSF.  
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Chapter 5 Future directions 
5.1 Introduction 
Despite the work that has been performed to develop the HSF-hydrogel bioink for 
3D bioprinting, there are many opportunities to further the understanding of how cage like 
protein can be exploited within a three-dimensional network. Two projects are outlined 
below to develop new applications for the HSF-polymer networks. It was shown in 
Chapter 2 that PEGDA concentrations in a range of 8-20% weight were unsuccessful in 
tuning the mechanical properties of the bioinks. It showed that their primary function was 
to operate as a structural surrogate that will hold a 3D structure together. However, to 
improve the bioink formulation, the possibility of leaving out the PEGDA component of the 
bioink appears attractive. Reducing the components of the bioinks will facilitate the ability 
to control the mechanical properties of the hydrogel in a controlled manner. Furthermore, 
while modifying the polysaccharides used to fabricate the bioink, it is possible to fabricate 
a stimuli-responsive hydrogel. These points are discussed below. 
Another way to increase the contribution of the cage-like protein is by changing the 
grafting approach that is being utilized on the protein-polymer conjugate. The resulting 
approach, elaborated upon below, could be used to either facilitate the control over the 
concentration of the protein that is being used within the hydrogel or, customize the 
mechanical properties for bioprinting processes. Furthermore, this control of the 
deposition can be extended to the ability to bioprint multicellular scaffolds one on top of 
the other.  
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5.1.1 Evaluation of modified polysaccharides for three-dimensional network 
generation 
To enable the crosslinking of polysaccharides into three-dimensional networks, 
various approaches had been reported in the literature according to the type of material 
that is being modified. Crucial to this strategy is to determine the crosslinking mechanism 
that is the most adequate for the system. 
For xanthan gum, we recommend two paths. A two-step modification could be 
used for thermal-inkjet bioprinting methods employing xanthan gum. The first would be a 
condensation process occurring by the mixing citric acid and XG at 165 °C (a temperature 
at which both reagents are stable) and would involve dehydration and ester linkages 
formation between these two components.274 To further the functionalization, this 
sacrificial scaffold could be followed by a subsequent etherification of the alkoxy groups 
with a vinyl halide to graft the modified HSF into the hydrogel network.275 However, an 
approach that could be undertaken with our existing equipment is possible; therefore, this 
approach is reported. A pH-responsive hydrogel has been successfully synthesized by 
modifying Arabic gum, a xanthan gum analog, with GMA to fabricate an Arabic Gum-
Methacrylate hydrogel (AG-MA) having a water intake that is pH dependent due to the 
increase in the ionized groups of glucuronic acid segments.276 This hydrogel can undergo 
FRP using the acrylic moieties of the GMA. 
In the case of CMC, a derivatization of the carboxyl moieties with aminoethyl 
methacrylamide hydrochloride (AEM) and EDC is possible. The result of this reaction is 
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a vinyl-modified CMC which could undergo FRP with a methacrylate-modified HSF under 
aqueous conditions.277 Likewise, the sodium salt of alginate could be modified using EDC 
and a potentially reactive amine. AEM could be used as a feasible reagent for 
polysaccharide modification. A similar approach has been used to attach azide groups on 
to alginate by the EDC/NHS reaction of alginate with an NH2-PEG-N3 analog.278 Once the 
polysaccharides have been modified, it would then be necessary to evaluate the 
rheological properties of the hydrogels such as G’, G’’, phase shift and creep time to 
recover the polymer network. This will further our understanding of how the polymer will 
reform and shear once it is extruded from the pneumatic system of a 3D bioprinter. These 
variables will impact the resolution of the polysaccharide-containing bioprinting scaffolds. 
Also, it would be of paramount importance to verify if the modified polysaccharides 
hydrogels could store large amounts of water compared to with their dry weight. A more 
thorough analysis has to be made to understand the critical protein concentration that can 
be added into the protein gel without modifying the rheological properties of the scaffold. 
Furthermore, an assessment of the gel’s cytotoxicity to various cells is needed to 
verify that the developed network can be used for bioprinting prior to and after protein 
incorporation, with evaluation of the effect of the presence of the incorporated 
polysaccharide. Therefore, cell-scaffold interaction studies would be required using 
RealTime-Glo MT in combination with LIVE/DEAD imaging to validate how a cell 
population spreads inside the proposed hydrogels. This approach could be used to 
quantitatively and continually measure cell proliferation during the first 72 hours of being 
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seeded into a 3D scaffold, with further quantification of cell viability after six days of 
seeding. 279 This technique could allow one to measure virtually any cell line that might 
be of interest. In general, this strategy could provide unique and highly specific 
functionalities for modification of the bioink. 
5.1.2 Variation of the polymer-protein conjugate approach 
Employing a different mechanism to graft the HSF into the network would expand 
the possibilities of using the hydrogel scaffold as a platform for nanotechnology. A simple 
variation from a grafting-to to a grafting-from approach could change the polymer 
properties dramatically. Grafting a given polymer from the HSF subunit has been 
evaluated before, and a water-soluble polymer was employed in that study.86 However, 
grafting-from the HSF using ATRP and combining it with a further step of FRP could aid 
in controlling the spatial localization of each ferritin subunit within the gel. Nanostructured 
hybrid micro-gels have been previously prepared by incorporating well-defined poly(oligo 
(ethylene oxide) monomethyl ether methacrylate) (POEO300MA) by ATRP, followed by a 
derivatization of the pendant hydroxyl groups from the amino acid residues with 
methacrylated groups to generate photo-reactive nanospheres.280  
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Figure 54. Diagram of an aHSF-based hydrogel with controlled aHSF 
concentration. 
By generating a photoreactive ferritin nanosphere, it could be possible to estimate 
the hydrodynamic radius of the particle (RH) and as a result, the density of loaded ferritin 
molecules that a specific hydrogel construct could store. To further this control, the ferritin-
based hydrogel framework could be used as an iron templating scaffold. To characterize 
the HSF distribution, it is possible to use a UV-Ozone oxidation to remove all the 
polymeric material. Later, using AFM it could be possible to reconstruct the three-
dimensional spacing using the deposited monolayer of iron cores.281 Once the ferritin 
density within the hydrogel is characterized, it could be used to bioprint a scaffold, as a 
system could be used to encapsulate a given material in a specific density with a 
controlled distance between hydrogel centers. Furthermore, It might also be used to 
generate a template for quantum dots controlled arrays of quantum dots, a potentially 
useful material for cancer imaging in vivo environments.282 
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Appendix A. Rheology Theory 
Rheology is defined as the science that studies the flow and deformation of 
materials. To fully characterize a material, it is essential to understand the molecular 
mechanisms that govern it. Two key components are studied by rheology: flow and 
deformation. There are two types of flow: shear and elongational flows. In shear flow the 
elements flow over or past each other, while elongational flows move away or towards 
each other. 283 
 
Figure 55. Particle motion profile for shear and extensional flow.283 
Basic concepts that are used in rheology are the concept of viscosity (η), a 
proportionality constant used in the study of the relationships of flow and shearing, the 
study of change of force per unit of area (shear stress, σ), and the velocity gradient that 
is applied to a specific fluid (shear rate, γ).284   
𝜸 =
𝒅𝑽
𝒅𝒉
= 𝜼 ∙ Equation 7 𝝈 = 𝜼
𝑭
𝑨
= 𝜼 ∙ 𝜸 Equation 8 
To understand shear flow rheology, Newtonian and non-Newtonian fluids are being 
continuously characterized. Newtonian fluids follow a decreasing trend in their viscosity 
when the surrounding temperature is increased, but their viscosity remains constant 
despite the change in shear rate. While for non-Newtonian fluids, factors other than 
temperatures, such as agitation or pressure will affect the apparent viscosity of the 
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fluid.285   Another fundamental term is needed for non-Newtonian fluids, the apparent 
viscosity, ηapp, which is a ratio of the shear stress and shear rate.284 Therefore, to have a 
relevant value, useful for comparison, it is necessary to report apparent viscosities stating 
the shear rate at which they have been measured. 221 
 𝜼𝒂𝒑𝒑(𝜸) =
𝝈
𝜸
 Equation 9 
Sochi et al. has presented a comprehensive review on non-Newtonian fluids. 
where they are classified as time-independent, viscoelastic and time-dependent.221 Time-
independent fluid behavior is that for which the strain rate of the fluid is only dependent 
on the shear stress applied at that specific point.221 The fluid would be described as shear 
thinning if the apparent viscosity decreases as the shear rate increases. Conversely, the 
fluid would be described as shear thickening if the apparent viscosity increases with the 
increase of the shear rate.221 
Viscoelastic fluid behavior is the one that is characterized by the need of a 
threshold stress, called the yield stress (σ0), which is needed to let a material flow. 
Therefore, a viscoelastic fluid will behave as an elastic solid if a σ<σ0 is applied, but it will 
behave as a liquid if σ>σ0.286 
Time-dependent fluid behaviors have a complex component because their ηapp 
are a function of σ, γ, and the time for which the fluid has been subjected to shearing.286 
Furthermore, because it has been acknowledged that reversible structural change causes 
this phenomenon during the flow process, they have been classified into two types: 
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thixotropic and rheopectic depending upon whether the stress decreases or increases 
with time at a given strain rate and constant temperature. 221 
 
Figure 56. Viscosity as a function of shear rate for time dependent and time 
independent non-Newtonian fluids. 
It is common knowledge that low shear rates of non-Newtonian fluids cause that 
the viscosity appears to be Newtonian.221 
Furthermore, It has also been reported that some Newtonian fluids, such as low 
polystyrene solutions, can present both Newtonian behaviors at low shear rates and non-
Newtonian behavior when higher shear rates are applied to them.284 More so, to compare 
the behavior of non-Newtonian fluids, many methods have been developed such as the 
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power law method, Ellis method, and Carreau method.287 However, the power law 
method, also known as the Ostwald-de Waele method (Equation 10) has been selected 
to analyze the behavior of the non-Newtonian blends because it has been accepted as a 
power law method for shear-dependent viscosities.288 
𝝈 = 𝑲 ∙ 𝜸𝒏 Equation 10 𝜼𝒂𝒑𝒑(𝜸) =  𝑲 ∙ 𝜸
𝒏−𝟏 Equation 11 
In this method, K is called the consistency and n the power law index. Furthermore, 
Equation 10 and Equation 11 can also be used to successfully reproduce Newtonian flow 
when the values of n = 1 and K = η. As a general rule, when values of n > 1 of the power 
index correspond to shear thickening fluids, while values of n < 1 correspond to shear-
thinning fluids.284 
To understand elongational flows, it is necessary to define it as the one in which 
fluid elements are subjected to extensions and compressions without being rotated or 
sheared.283 It has not been characterized extensively. However, the extensional viscosity 
function is often qualitatively different from that of the shear viscosity. This behavior result 
of interest with highly elastic polymer solutions, which often show a decrease in viscosity 
with shear while exhibiting an increase in the extensional viscosity (Trouton viscosity, μx) 
in function of the extension rate.287 
A material exhibits a viscoelastic behavior if the response to external stimuli 
encompasses characteristics of viscous and elastic behaviors.289 According to Chhabra 
et al. for an ideal elastic solid, stress in a sheared state is proportional to the strain.286 
Therefore, the most straightforward viscoelastic behavior would be the one that can be 
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described as a linear system, such as linear viscoelasticity, in which an applied 
deformation is sufficient to disturb the particles from their equilibrium, but returning to their 
equilibrium state due to Brownian motion.290  
It is vital to characterize materials to determine their rheological capabilities. 
Therefore, uniaxial tests are carried out continuously. For example, one test studies the 
applied stress until it exceeds the yield stress of the examined material, achieving a 
faster anisotropic effect than a recovery. This study is called the creep test.289 This 
phenomenon is usually described as a time-dependent strain, mathematically described 
as 𝜖(𝑡) = 𝑑(𝑡)/𝐿0 (ϵ being the strain, d being the deformation, and L0 being the initial 
length), which results directly from the applied uniaxial stress (σ0) to a particular 
material.291  
Creep is an advantageous phenomenon and it is measured over extended periods, 
however, it is inaccurate for shorter times. Therefore, another method needs to be used 
to characterize the response for the microstructures. The oscillatory shear motion also 
called the dynamic loading or small strain oscillatory flow is a dynamic test in which the 
stress from a sinusoidal strain is measured.291 To measure this phenomenon, a plate, in 
this case, a 4° dynamic cone and a static plate were used. The top plate oscillates at a 
constant frequency of ω, where 𝑥 = 𝛿𝑠𝑖𝑛𝜔𝑡, the plate velocity will be given by 𝛀 =
 𝜔𝛿𝑠𝑖𝑛𝜔𝑡.  As a result, shear rate and shear stress are defined as:  
 
𝜸 =
𝒅𝜸
𝒅𝒕
= 𝜸𝟎𝝎 𝒄𝒐𝒔𝝎𝒕 =  𝜸𝟎𝝎 𝐬𝐢𝐧 (
𝝅
𝟐
+ 𝝎𝒕) 
Equation 12 
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 𝝈 = 𝜼𝜸 = 𝜼𝜸𝟎𝝎 𝐬𝐢𝐧 (
𝝅
𝟐
+ 𝝎𝒕) =  𝝈𝟎𝝎 𝐬𝐢𝐧 (
𝝅
𝟐
+ 𝝎𝒕) Equation 13 
It is evident that the shear stress is out of phase by π/2. Therefore, we can use the 
phase shift (δ) as a method to characterize if a material has a purely elastic  (δ=0) 
response or a purely viscous response (δ=1).286  
The linear viscoelastic region (LVR), is defined by Starkova et al. as the maximum 
level of stress or strain, independent of time and action of external factors, above which 
actual behavior deviates 10% from behavior predicted based on linearity assumption.292 
In the LVR, it is possible to define the complex viscosity (η*) as follows 𝜂∗ = 𝜂′ + 𝑖𝜂′′  
The part that is in phase with the strain is used to define the storage viscosity (η′′), 
and the part that is in phase with the strain rate is termed dynamic viscosity (η′).286 
It is possible to relate the storage and dynamic viscosities to the loss (G’’) and 
storage (G’) moduli, which ′are related as: 
𝑮′ = 𝝎𝜼′′  
Equation 
14 
𝑮′′ = 𝝎𝜼′  
Equation 
15 
These are functions of the frequency, and they are collectively referred to as 
the dynamic properties of the fluid.293  
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Appendix B. Iron determination of ferritin hydrogels 
Materials: 
The reagents (NH4)2SO4• FeSO4•6H2O, hydroxylamine(NH2OH•HCL), O-
phenanthroline, Acetic acid (CH3COOH), Ethanol(CH3CH2OH), NaOH were purchased 
from Sigma-Aldrich (Milwaukee, USA) and used without further purification. Transparent 
Corning 96-well plate was acquired from Corning (New York, USA) 
Iron Calibration Standards: 
Accurately weighed 0.05 g of reagent (NH4)2SO4• FeSO4•6H2O and dissolved in 
10 mL of water. An aliquot (1.00 mL) of the latter solution was diluted 10 times to make 
the standard iron solution of 0.005 g (NH4)2SO4• FeSO4•6H2O /mL or 0.712 mg Fe /mL. 
Acetate Buffer: 
A 1M acetate buffer, pH 3 was prepared. To do so, 30.01 mL of acetic acid 
(CH3COOH) was measured using a graduated cylinder, dissolved in 450 mL  deionized 
water.   
Hydroxylamine hydrochloride solutions: 
A 10% hydroxylamine-HCl solution was prepared by weighting on the top-loading 
balance 1.01 g of hydroxylamine hydrochloride NH2OH•HCL and dissolving it in 10mL 
water. Furthermore, A 2.00 ml aliquot of the 10.1% Hydroxlamine-HCl solution was 
dissolved in 8.00 mL of deionized water to make up for a 2.02% Hydroxylamine-HCl 
solution. 
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o-Phenanthroline solution: 
A 1.00% o-phenanthroline solution was prepared by accurately weighting 0.1039 
g of o-phenanthroline and dissolving it in a 100 mL of a 50% aqueous ethanol solution. 
Preparation of Calibration Curve: 
To produce the standards a specific quantity of the Fe2+ stock solution denoted in 
the Table 15 was added, followed by 50 µL of hydroxylamine-HCl. Then an adequate 
amount of 1 M acetate buffer pH 3 was added followed by 500 µL of 1% o-phenantroline 
and waited 10 minutes to favor the complete development of the calorimetric complex 
generated by the Iron-O-Phenanthroline complex. Adjusted final volume 1.00 mL of each 
solution with water and vortexed to guarantee complete dissolution.   
Table 15. Calibration curve for the iron determination in ferritin based 
hydrogel. 
Std. 
IronStd 
(mL) 
Hydroxylamine-HCl 
(mL) 
O-Phenanthroline 
(mL) 
Acetate buffer 
(mL) 
Fe Concentration 
(mg/mL) 
1 0.0000 0.05 0.5 0.450 0.0000000 
2 0.0050 0.05 0.5 0.445 0.0035597 
3 0.0100 0.05 0.5 0.440 0.0071195 
4 0.0250 0.05 0.5 0.425 0.0177986 
5 0.0500 0.05 0.5 0.400 0.0355973 
6 0.1000 0.05 0.5 0.350 0.0711945 
7 0.2000 0.05 0.5 0.250 0.1423890 
8 0.3000 0.05 0.5 0.150 0.2135835 
 
Absorbance Reading: 
To determine the maximum absorption of the iron colorimetric complex, an 
absorption sweep of different iron concentrations was made, as shown in Figure 57 using 
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a 96-well plate. It was experimentally determined that the maximum absorption is at 510 
nm for the calibration standards, which was used to prepare a calibration curve of 
concentration of Fe (Beer-Lambert plot) vs absorbance.  
 
 
Figure 57. Absorption sweep for the determination of the wavelength of 
maximum absorption of the Iron-Phenanthroline complex. 
All the standards were measured at 510 nm to generate the calibration curve 
shown in Figure 58. Then calculated the iron concentration of ferritin solution using the 
generated line equation.  
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Figure 58. Iron absorbance determination at 510 nm for the Fe2+-O-
phenanthroline complex. 
For further understanding of the results of the colorimetric assay, the F-statistic 
was determined in Table 16 to demonstrate that the set of values, under the current 
degrees of freedom, fails the null hypothesis that the dataset follows a zero-slope 
relationship.  
 
Table 16. Statistical results of linear regression for the iron absorbance 
determination at 510 nm for the Fe2+-O-Phenanthroline complex. 
Slope 64.732 -2.361 Intercept 
Slope Std. Deviation 1.600 2.391 Intercept Std. Deviation 
r2 0.996 5.084 Std. Error for the y estimate. 
F 1636.114 6 degrees of freedom 
  
[Fe+2 in PPM] = 64,732 [ABS] - 2,3612
R² = 0,9963
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Appendix C. Bioprinting Conditions 
 Layer Height 
 Layer Height: 0.115mm 
 First Layer Height 0.15mm 
Vertical Shells 
 Perimeters (minimum): 0  
 Spiral vase: OFF 
Horizontal Shells 
 Solid Layers:  
  Top: 1 
  Bottom: 1 
Quality (slower slicing) 
 Extra perimeter if needed ON 
 Avoid crossing perimeter (slow): OFF 
 Detect thin walls: ON 
 Detect bridging perimeters: ON 
Advanced 
 Seam position: Aligned 
 External perimeters first: OFF 
Infill 
 Fill Density: 100% 
 Fill Pattern: Concentric 
 Top/bottom Fill Pattern: Concentric 
Reducing Print Time 
 Combine infill every: 1 
 Only infill where needed: OFF 
Advanced 
 Solid infill every: 2 
 Fill angle: 45 
 Only retract when crossing perimeters: ON 
 Infill before perimeters: OFF 
Speed for Print Moves: 
 Perimeters: 10 
 Small perimeters: 3 
 External perimeters: 3 
 Infill: 5 
 Solid infill: 5 
 Top solid infill: 5 
 Support material: 3 
 Support material; interface: 3 
 Bridges: 3 
 Gap fill: 3 
Speed for non-print moves 
 Travel: 20 
Modifiers: 
 First layer speed: 85% 
Acceleration control (advanced) 
 Perimeters: 0  
 Infill: 0 
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 Bridge: 0 
 First layer: 0 
 Default: 0 
Skirt 
 Loops: 1 
 Distance from object: 2 
 Skirt height: 1 
 Minimum extrusion length: 0 
Brim 
 Brim width: 0 
Support Material 
 Generate support material: OFF 
 Overhang threshold: 0 
 Enforce support for the first: 0 
Raft 
 Raft layers: 0 
Options for Support Material and Raft 
 Pattern: rectilinear 
 Pattern spacing: 2.5 
 Pattern angle: 0 
 Interface layers: 3 
 Interface pattern spacing: 0 
 Don’t support bridges: ON 
Extrusion Width 
 Default extrusion width: 0 
 First layer: 200 
 Perimeters: 0 
 Infill: 0 
 Solid infill: 0 
 Top solid infill: 0 
 Support material: 0 
Flow 
 Bridge flow ratio: 1 
Other 
 Threads: 2 
 Resolution: 0 
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Appendix D. ANOVA for k and n determinations 
[1] "##########################Alginate##########################" 
PEGDA 08 PEGDA 12 PEGDA 15 PEGDA 20  
    0.57     0.63     0.67     1.08  
[1] "Chi-Sq: 10.0351749229298 |P-Value: 0.981730510018466" 
 
Call: 
lm(formula = log(y1) ~ x1, data = StatData) 
 
Residuals: 
     Min       1Q   Median       3Q      Max  
-2.38530 -0.93822  0.03164  0.95535  2.53225  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|) 
(Intercept)  0.56884    0.89133   0.638    0.535 
x1PEGDA 12   0.05813    1.26053   0.046    0.964 
x1PEGDA 15   0.10108    1.26053   0.080    0.937 
x1PEGDA 20   0.51023    1.26053   0.405    0.693 
 
Residual standard error: 1.783 on 12 degrees of freedom 
Multiple R-squared:  0.0167, Adjusted R-squared:  -0.2291  
F-statistic: 0.06793 on 3 and 12 DF,  p-value: 0.9759 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$x1 
                        diff       lwr      upr     p adj 
PEGDA 12-PEGDA 08 0.05812896 -3.684253 3.800511 0.9999627 
PEGDA 15-PEGDA 08 0.10108369 -3.641298 3.843466 0.9998041 
PEGDA 20-PEGDA 08 0.51023103 -3.232151 4.252613 0.9765688 
PEGDA 15-PEGDA 12 0.04295473 -3.699427 3.785337 0.9999849 
PEGDA 20-PEGDA 12 0.45210207 -3.290280 4.194484 0.9834351 
PEGDA 20-PEGDA 15 0.40914734 -3.333235 4.151529 0.9875903 
 
[1] "##########################Carboxy_Methyl_Cellulose##########################" 
PEGDA 08 PEGDA 12 PEGDA 15 PEGDA 20  
   -0.04    -0.04     0.09     0.17  
[1] "Chi-Sq: 18.0093940721518 |P-Value: 0.999562108231058" 
 
Call: 
lm(formula = log(y1) ~ x1, data = StatData) 
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Residuals: 
     Min       1Q   Median       3Q      Max  
-1.27175 -0.57266  0.07817  0.59027  1.17403  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|) 
(Intercept) -0.037824   0.505358  -0.075    0.942 
x1PEGDA 12  -0.006832   0.714683  -0.010    0.993 
x1PEGDA 15   0.131709   0.714683   0.184    0.857 
x1PEGDA 20   0.211070   0.714683   0.295    0.773 
 
Residual standard error: 1.011 on 12 degrees of freedom 
Multiple R-squared:  0.01089, Adjusted R-squared:  -0.2364  
F-statistic: 0.04402 on 3 and 12 DF,  p-value: 0.9871 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$x1 
                          diff       lwr      upr     p adj 
PEGDA 12-PEGDA 08 -0.006832232 -2.128657 2.114992 0.9999997 
PEGDA 15-PEGDA 08  0.131708692 -1.990116 2.253533 0.9976523 
PEGDA 20-PEGDA 08  0.211069544 -1.910755 2.332894 0.9905736 
PEGDA 15-PEGDA 12  0.138540923 -1.983284 2.260366 0.9972723 
PEGDA 20-PEGDA 12  0.217901776 -1.903923 2.339726 0.9896557 
PEGDA 20-PEGDA 15  0.079360853 -2.042464 2.201185 0.9994812 
 
[1] "##########################Pluronics_F127##########################" 
PEGDA 08 PEGDA 12 PEGDA 15 PEGDA 20  
   -3.40    -2.79    -2.80    -2.92  
[1] "Chi-Sq: 0.183295240552238 |P-Value: 0.0197601280994389" 
 
Call: 
lm(formula = log(y1) ~ x1, data = StatData) 
 
Residuals: 
     Min       1Q   Median       3Q      Max  
-0.82112 -0.12399 -0.02297  0.10195  0.51724  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  -3.3982     0.1636 -20.777 8.94e-11 *** 
x1PEGDA 12    0.6061     0.2313   2.620   0.0224 *   
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x1PEGDA 15    0.6003     0.2313   2.595   0.0234 *   
x1PEGDA 20    0.4795     0.2313   2.073   0.0603 .   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.3271 on 12 degrees of freedom 
Multiple R-squared:  0.4349, Adjusted R-squared:  0.2937  
F-statistic: 3.079 on 3 and 12 DF,  p-value: 0.06841 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$x1 
                         diff         lwr       upr     p adj 
PEGDA 12-PEGDA 08  0.60613282 -0.08059601 1.2928617 0.0904614 
PEGDA 15-PEGDA 08  0.60027337 -0.08645546 1.2870022 0.0943659 
PEGDA 20-PEGDA 08  0.47953709 -0.20719174 1.1662659 0.2164090 
PEGDA 15-PEGDA 12 -0.00585945 -0.69258829 0.6808694 0.9999938 
PEGDA 20-PEGDA 12 -0.12659573 -0.81332457 0.5601331 0.9455111 
PEGDA 20-PEGDA 15 -0.12073628 -0.80746512 0.5659926 0.9521579 
 
[1] "##########################Xanthan_Gum##########################" 
PEGDA 08 PEGDA 12 PEGDA 15 PEGDA 20  
    0.80     0.91     0.93     1.01  
[1] "Chi-Sq: 13.8383367224405 |P-Value: 0.99686632959551" 
 
Call: 
lm(formula = log(y1) ~ x1, data = StatData) 
 
Residuals: 
     Min       1Q   Median       3Q      Max  
-0.63650 -0.57025  0.07752  0.48048  0.58808  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)   
(Intercept)   0.8014     0.3334   2.404   0.0429 * 
x1PEGDA 12    0.1073     0.4715   0.228   0.8257   
x1PEGDA 15    0.1239     0.4715   0.263   0.7994   
x1PEGDA 20    0.2098     0.4715   0.445   0.6681   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.5774 on 8 degrees of freedom 
Multiple R-squared:  0.02443, Adjusted R-squared:  -0.3414  
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F-statistic: 0.06679 on 3 and 8 DF,  p-value: 0.976 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$x1 
                        diff       lwr      upr     p adj 
PEGDA 12-PEGDA 08 0.10729706 -1.402463 1.617057 0.9955039 
PEGDA 15-PEGDA 08 0.12388291 -1.385877 1.633643 0.9931405 
PEGDA 20-PEGDA 08 0.20983814 -1.299922 1.719599 0.9687495 
PEGDA 15-PEGDA 12 0.01658585 -1.493175 1.526346 0.9999830 
PEGDA 20-PEGDA 12 0.10254108 -1.407219 1.612301 0.9960667 
PEGDA 20-PEGDA 15 0.08595524 -1.423805 1.595716 0.9976665 
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Appendix E. ANOVA for detailed declustering studies. 
[1] "################0,01 M HCl########################" 
 
Call: 
lm(formula = log(Iron) ~ PEGDA, data = StatData) 
 
Residuals: 
     Min       1Q   Median       3Q      Max  
-0.65888 -0.22578  0.05979  0.21049  0.51215  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  0.94362    0.14297   6.600 1.98e-06 *** 
PEGDA10%    -0.29285    0.20219  -1.448    0.163     
PEGDA12%    -0.05522    0.20219  -0.273    0.788     
PEGDA14%    -0.26862    0.20219  -1.329    0.199     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.3502 on 20 degrees of freedom 
Multiple R-squared:  0.1388, Adjusted R-squared:  0.009629  
F-statistic: 1.075 on 3 and 20 DF,  p-value: 0.3823 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$PEGDA 
               diff        lwr       upr     p adj 
10%-08% -0.29284669 -0.8587574 0.2730640 0.4855213 
12%-08% -0.05521505 -0.6211258 0.5106956 0.9926535 
14%-08% -0.26862010 -0.8345308 0.2972906 0.5563177 
12%-10%  0.23763164 -0.3282791 0.8035423 0.6487628 
14%-10%  0.02422660 -0.5416841 0.5901373 0.9993632 
14%-12% -0.21340504 -0.7793157 0.3525057 0.7195728 
 
 
 
 
 
[1] "####################0,1 M HCl##########################" 
 
Call: 
lm(formula = log(Iron) ~ PEGDA, data = StatData) 
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Residuals: 
    Min      1Q  Median      3Q     Max  
-1.1321 -0.4293  0.1387  0.4482  0.7708  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  2.54962    0.25775   9.892  3.8e-09 *** 
PEGDA10%    -0.07366    0.36451  -0.202    0.842     
PEGDA12%    -0.04983    0.36451  -0.137    0.893     
PEGDA14%    -0.01083    0.36451  -0.030    0.977     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.6313 on 20 degrees of freedom 
Multiple R-squared:  0.002639, Adjusted R-squared:  -0.147  
F-statistic: 0.01764 on 3 and 20 DF,  p-value: 0.9967 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$PEGDA 
               diff        lwr       upr     p adj 
10%-08% -0.07366319 -1.0939026 0.9465763 0.9969796 
12%-08% -0.04982608 -1.0700655 0.9704134 0.9990563 
14%-08% -0.01083082 -1.0310703 1.0094086 0.9999902 
12%-10%  0.02383711 -0.9964024 1.0440766 0.9998960 
14%-10%  0.06283237 -0.9574071 1.0830718 0.9981166 
14%-12%  0.03899526 -0.9812442 1.0592347 0.9995462 
 
[1] "#############100 °C in Acetate Buffer 1M, pH 3##############" 
 
Call: 
lm(formula = log(Iron) ~ PEGDA, data = StatData) 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-1.2631 -0.4001  0.1445  0.4617  0.6848  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)   1.1119     0.2582   4.306 0.000344 *** 
PEGDA10%     -0.1294     0.3651  -0.354 0.726786     
PEGDA12%      0.1353     0.3651   0.370 0.714929     
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PEGDA14%     -0.1772     0.3651  -0.485 0.632732     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.6325 on 20 degrees of freedom 
Multiple R-squared:  0.04245, Adjusted R-squared:  -0.1012  
F-statistic: 0.2955 on 3 and 20 DF,  p-value: 0.8282 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = m.interaction) 
 
$PEGDA 
              diff        lwr       upr     p adj 
10%-08% -0.1293901 -1.1514185 0.8926384 0.9842947 
12%-08%  0.1352757 -0.8867527 1.1573042 0.9821411 
14%-08% -0.1772096 -1.1992380 0.8448189 0.9614773 
12%-10%  0.2646658 -0.7573627 1.2866943 0.8860224 
14%-10% -0.0478195 -1.0698480 0.9742090 0.9991696 
14%-12% -0.3124853 -1.3345138 0.7095432 0.8271647 
 
[1] "###############Acetate Buffer 1M, pH 3#######################" 
 
Call: 
lm(formula = log(Iron) ~ PEGDA, data = StatData) 
 
Residuals: 
     Min       1Q   Median       3Q      Max  
-0.84077 -0.30475  0.05342  0.24224  0.61193  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)     
(Intercept)  0.6947943  0.1758473   3.951 0.000789 *** 
PEGDA10%    -0.2284415  0.2486856  -0.919 0.369253     
PEGDA12%     0.0009927  0.2486856   0.004 0.996855     
PEGDA14%    -0.2002024  0.2486856  -0.805 0.430263     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.4307 on 20 degrees of freedom 
Multiple R-squared:   0.07, Adjusted R-squared:  -0.06951  
F-statistic: 0.5018 on 3 and 20 DF,  p-value: 0.6854 
 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
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Fit: aov(formula = m.interaction) 
 
$PEGDA 
                diff        lwr       upr     p adj 
10%-08% -0.228441465 -0.9244966 0.4676137 0.7952749 
12%-08%  0.000992661 -0.6950625 0.6970478 1.0000000 
14%-08% -0.200202381 -0.8962576 0.4958528 0.8512784 
12%-10%  0.229434126 -0.4666211 0.9254893 0.7931795 
14%-10%  0.028239084 -0.6678161 0.7242943 0.9994577 
14%-12% -0.201195042 -0.8972502 0.4948601 0.8494385 
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Appendix F. Iron diffusion from PEGDA-Based hydrogels   
Measurement 
Thickening Agent* 
PEGDA 
(%) 
Protein 
(%) 
Diffusion Coefficient 
(min-2 m2) 
1 NTA 8% 0.000% 0.00E+00 
2 NTA 8% 0.275% 4.80E-11 
3 NTA 8% 0.685% 5.35E-11 
4 NTA 8% 1.097% 5.59E-11 
5 NTA 10% 0.000% 0.00E+00 
6 NTA 10% 0.275% 5.10E-11 
7 NTA 10% 0.685% 4.74E-11 
8 NTA 10% 1.097% 4.74E-11 
9 NTA 12% 0.000% 0.00E+00 
10 NTA 12% 0.275% 3.59E-11 
11 NTA 12% 0.685% 4.60E-11 
12 NTA 12% 1.097% 4.36E-11 
13 NTA 14% 0.000% 0.00E+00 
14 NTA 14% 0.275% 3.57E-11 
15 NTA 14% 0.685% 4.16E-11 
16 NTA 14% 1.097% 5.44E-11 
17 NTA 8% 0.323% 0.00E+00 
18 4% XG 8% 0.323% 8.21E-11 
19 7% ALG 8% 0.323% 1.08E-10 
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Measurement 
Thickening Agent* 
PEGDA 
(%) 
Protein 
(%) 
Diffusion Coefficient 
(min-2 m2) 
20 10% CMC 8% 0.323% 8.10E-11 
21 NTA 10% 0.323% 1.04E-10 
22 4% XG 10% 0.323% 1.05E-10 
23 7% ALG 10% 0.323% 1.11E-10 
24 10% CMC 10% 0.323% 1.07E-10 
25 NTA 12% 0.323% 6.49E-11 
26 4% XG 12% 0.323% 6.03E-11 
27 7% ALG 12% 0.323% 1.72E-10 
28 10% CMC 12% 0.323% 5.05E-11 
29 NTA 14% 0.323% 1.31E-10 
30 4% XG 14% 0.323% 1.25E-10 
31 7% ALG 14% 0.323% 1.47E-10 
32 10% CMC 14% 0.323% 1.39E-10 
*ALG: Alginate. CMC: Carboxymethylcellulose. NTA: No Thickening Agent. XG: Xanthan Gum 
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Appendix G. Swelling Capacity of Hydrogels determined by TGA. 
Type* PEGDA+ Temperature(°C) 
Temperature  
Standard deviation 
Water Volume (%) 
ALG 
PEGDA 8% 174.45 
±35.90 
90.94% 
PEGDA 10% 179.67 88.84% 
PEGDA 12% 179.80 89.37% 
PEGDA 14% 249.60 86.87% 
CMC 
PEGDA 8% 176.36 
±6.11 
92.99% 
PEGDA 10% 163.64 91.86% 
PEGDA 12% 175.98 90.21% 
PEGDA 14% 175.05 86.53% 
NTA 
PEGDA 8% 158.86 
±54.41 
88.82% 
PEGDA 10% 274.09 88.14% 
PEGDA 12% 189.14 85.80% 
PEGDA 14% 255.60 87.04% 
XG 
PEGDA 8% 192.76 
±31.56 
92.75% 
PEGDA 10% 249.54 89.27% 
PEGDA 12% 176.83 87.22% 
PEGDA 14% 196.97 83.48% 
*ALG: Alginate (7% w/v); CMC:Carboxymethylcellulose (10% w/v); NTA:No thickening agent; XG:Xanthan Gum (3%) 
+PEGDA: Poly(ethylene glycol) diacrylate average MW:700 
 
 
  
 246 
Appendix I. ImageJ Code to analyze porosity SEM images 
  dir = getDirectory("Choose a Directory "); 
  count = 1; 
 
  listFiles(dir);  
 
  function listFiles(dir) { 
     list = getFileList(dir); 
     for (i=0; i<list.length; i++) { 
        if (endsWith(list[i], "/")){ 
           listFiles(""+dir+list[i]); 
        }else if (endsWith(list[i], ".tif")) { 
           print((count++) + ": " + dir + list[i]); 
           //Calls the function that iterates over the files 
           Porosity(dir,list[i]); 
           //print(list[i]); 
            
        }else{ 
        print("Not what we are looking for"); 
        } 
     } 
  //setBatchMode(false); 
  cleanUp();  
  } 
 
  
 //Check the string to be there to process either 400 or 100 um filesize 
 function checkForMatches(fragSeq,checkSeq){  
 numMatchesFound=0;  
  
  //print("fragSeq="+fragSeq+"   checkSeq="+checkSeq);  
  if(lengthOf(fragSeq)>lengthOf(checkSeq)){  
   return false;  
   }  
   for(i=0;i<=lengthOf(checkSeq)-lengthOf(fragSeq);i++){  
    if(matches(fragSeq,substring(checkSeq,i,i+lengthOf(fragSeq)))){  
    numMatchesFound++;  
   }  
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  }  
  print(numMatchesFound);  
  if(numMatchesFound>0){  
   return true;  
  }else{  
   return false;  
  }  
 } 
 
 
function Porosity(dir,Name){ 
   
  setBatchMode(true); 
 
  
 //Define the new variable 
  SaveName = substring(Name,0,lengthOf(Name)-4); 
  Name=SaveName+".tif"; 
  Address=dir+Name; 
 
  //Open the filename 
  open(Address); 
 
 //Set the scale 
 if (checkForMatches("100", SaveName)>0){ 
  run("Set Scale...", "distance=245.3370 known=3.83 pixel=100 unit=um"); 
 }else{ 
  run("Set Scale...", "distance=382.6760 known=5.98 pixel=400 unit=um"); 
 } 
 
  //Set the measurements 
  run("Set Measurements...", "area mean standard min centroid bounding fit shape integrated skewness redirect=None 
decimal=3"); 
  //Set Threshold 
  run("Threshold..."); 
  setThreshold(0, 9000); 
  //setAutoThreshold("Default stack"); 
  run("Convert to Mask"); 
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  //Analyze the particles 
  run("Analyze Particles...", "size=5-Infinity show=Outlines display include summarize in_situ"); 
  //Save the results 
  saveAs("Results", dir+SaveName+"-Particles.csv"); 
 
  //Analyze the distance optional 
  //run("ND ","entradata=6"); 
   
    //Save it on the folder 
   Location=dir+SaveName+"-Distance.csv"; 
   saveAs("Results",Location); 
   
  //Close results window 
    if (isOpen("Results")) {  
       selectWindow("Results");  
       run("Close");  
   } 
    
  //Save it as an EPS Image: run("EPS ...","save=["+dir+SaveName+".eps"+"]"); 
  selectWindow(Name); 
  run("Input/Output...", "jpeg=100"); 
  saveAs("Jpeg", dir+SaveName+".jpg"); 
   
setBatchMode(false); 
close(); 
 
} 
 
// Closes the "Results" and "Log" windows and all image windows 
function cleanUp() { 
   // requires("1.30e"); 
    if (isOpen("Results")) { 
         selectWindow("Results");  
         run("Close" ); 
    { 
    if (isOpen("Log")) { 
         selectWindow("Log"); 
         run("Close" ); 
    } 
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    while (nImages()>0) { 
          selectImage(nImages());   
          run("Close"); 
    } 
} 
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Appendix J. ImageJ Code to analyze confocal images 
dir = getDirectory("Choose a Directory "); 
count = 1; 
 
listFiles(dir);  
 
function listFiles(dir) { 
  list = getFileList(dir); 
  print(list.length); 
  for (i=0; i<list.length; i++) { 
    if (endsWith(list[i], "/")){ 
      listFiles(""+dir+list[i]); 
    }else if (endsWith(list[i], ".czi")) { 
      print((count++) + ": " + dir + list[i]); 
      //Calls the function that iterates over the files 
      ConfocalProcessing(dir,list[i]); 
      run("Close All"); 
      print("Done5"); 
    }else{ 
      print("Not what we are looking for"); 
    } 
  } 
  //setBatchMode(false); 
} 
 
//Define all functions 
function ConfocalProcessing(dir,Name){ 
   
  setBatchMode(true); 
   
  //Define the new variable 
  Name=File.getName(dir+Name); 
  dir=replace(dir,"/","\\"); 
  print(dir+Name); 
  SaveName = substring(Name,0,lengthOf(Name)-4); 
  print(SaveName); 
  //Name=SaveName+".czi"; 
  //Define Object Counter Settings//show_numbers white_numbers 
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  run("3D OC Options", "volume nb_of_obj._voxels integrated_density std_dev_gray_value minimum_gray_value 
close_original_images_while_processing_(saves_memory) dots_size=10 font_size=14 redirect_to=none"); 
   
  //Analyze the Data in Object Counter 
  run("Bio-Formats", "open=["+dir+Name+"]autoscale color_mode=Default view=Hyperstack stack_order=XYCZT"); 
  run("3D Objects Counter", "threshold=250 slice=10 min.=10 max.=22020096 exclude_objects_on_edges objects 
statistics"); 
  saveAs("Results", dir+SaveName+".csv"); 
   
  //Stack the Z and add the Scale Bar 
  selectWindow("Objects map of"+ " "+ Name); 
  run("Scale Bar...", "width=50 height=8 font=28 color=White background=None location=[Lower Right] bold overlay"); 
  run("Z Project...", "projection=[Max Intensity]"); 
   
  //Save it as an EPS Image: run("EPS ...","save=["+dir+SaveName+".eps"+"]"); 
  selectWindow("MAX_Objects map of"+ " "+ Name); 
  run("Input/Output...", "jpeg=100"); 
  saveAs("Jpeg", dir+SaveName+".jpg"); 
  print("DONE"); 
   
  //Close results window 
  if (isOpen("Results")) {  
    selectWindow("Results");  
    run("Close");  
  } 
   
  //Give me the zstacks of cell distribution 
  selectWindow("Objects map of"+ " "+ Name); 
   
  //Z stack 
  run("Plot Z-axis Profile"); 
   
  //Open a file and store it 
  selectWindow("Objects map of"+ " "+ Name+"-0-0"); 
   
  //Open a file and store it 
  Plot.getValues(x, y); 
  //Loads the results on the tables 
  for (i=0; i<x.length; i++) 
    setResult("Microns", i, x[i]); 
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  for (i=0; i<y.length; i++) 
    setResult("Mean", i, y[i]); 
  print("DONE2"); 
  //Save it on the folder 
  Location=dir+SaveName+"-Plot Values.csv"; 
  saveAs("Results",Location); 
  print("DONE3"); 
   
  setBatchMode(false);  
} 
